%PDF-1.6 % 41 0 obj <> endobj 58 0 obj <>/Filter/FlateDecode/ID[<0CA41935217B874D9086C13DE4C5CEE2>]/Index[41 30]/Info 40 0 R/Length 86/Prev 258243/Root 42 0 R/Size 71/Type/XRef/W[1 2 1]>>stream hbbd``b`Z $CADHrR vDWAbU ;8$ v Hd\b`bdd100Fg K( endstream endobj startxref 0 %%EOF 70 0 obj <>stream hb```c``c`a`! Ȁ L@Q@NI0_X*i~ b&p:P!gWD76@ g`6)p+X Y endstream endobj 42 0 obj <> endobj 43 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 44 0 obj <>stream hެO0{nCxP@1!> v&[;bĿ[&׻o= 9<@[tAu( )@ %t$I:ЍhBWPG 6[9%e*۽mZl'Mváy^sJʑ(ڄ8@4Ee6Kr,GJYtR5}}tDWCUtbw'>2L,֚/F`j fU<)w8gs̔ul ž,s,ɚW g=?bq55 Od n ٥ޚ;a+>vy77Z=w0BɇJ遶?5YmknDH<Al=/!#*k1 endstream endobj 45 0 obj <>stream HWnF}W15/@ ݤ VlHr;˒bd6`IΙ33sF_g Yw4^c|)0ƌOV_g_gT; ?jqPP 6筹e&p.[#>0ַ\MBp.uC,_sYd3 < dV9|3{s~]S*Xp;Ͽ<݊N >Ź3 0ĄLB -` VQ0fQwF Q !W#'<$aW.۷j3γ'M)!A7G #&8E)(N)!TR%?M}xAƤ4%MƹwhWa`VVUϛ.\ֱzl; ~I%)Vl UUsT6pe>}\=gnḮO.ĉ&3OйAB戜8-wJa)=8TqΣjb)r}ۋӈ5$Nס cSvsxXק!yi4BB^,vצaP<֨6];r1X} ȿcS̅@ff}lY֪YYC Bd'hwW0ȏHX%"M㯯MM- G\UӟBPOnt=mA!i_LIvhB8Sb ,r~%pK I 0O$+=0R*9\J1ѢWw%┢Z^7]WDW8ȟӚszXaF,y/AKtǨ{phŒz{i70z8Q.QQKzTL՜{O+80r)N].'g 8L I`^O=n{-%&L>stream HWMo6W-bhEUo Em0$yw(%%n87yf&LFi(0_`DX$1CDiy}}^a]8ġKsp ?սn~H7˥;뼏>|5|?~E۔A"p<$DLL!)Bz_ETXp5UJ8u}huS6gXJ0_D(]VT #8R>gp9Bg!$JAq~nտ\ʪhL_u, ڜPx srg{] B=\$1f jMB 1C솒":.n%2Y)F2yF1.T!V9o2D=Z[QK仪AsKa7d3uJOڝRI rU.ry_fGUʈ&WY]7IlrY; V@bE_4Bd1q6HfJANhTY~*@Wҏxv5{={ s$,uVg}@?H:gSOjjfɪi^;JTJ/,a$(`zI(l>!+K; ',aN!S?2^f<6Y`ƽ.s!jpeYonakT,90?/ U-@[ab g*q/Zݗ15yrZ%"1|@? endstream endobj 47 0 obj <>stream HWێH}cFin !@$0ZL'ؑ0;O8xqwΩS5v]\/zzzj(?m-^x0ȟ6Wϖ/P,rŋD5:>%0"U!eI(۪ Sڻ}/yLz pˇm۵v-,(aRg1'@))11Īy-4eLa,wwP c07dy mS~w W)Ż?+תȟl3" ǿ1:YTb;\32O~k~WUM,?d&H~B ʌpp9—٨0٨B1)4j{|x:I"X3P4{x!z2rTGpO)/$Ĕ>cwU.Eੌde6Or>[F)}42D# b IՌ,.;Z$/KnKer-)OPAvs_ @I73(n.RŪU] u(-KVZ' '6ݶojc]ez ;O@E:PG<狷?}NrhtՊRgɏ{J62z{[6 nNx)ÑOo رxvX?*xhWǽ :Kk_~gP-D2xvö=n11!5iz=&BF{VM=fd˄;MPgT/6&jǜ ՛f =p<%'TOI_;>0|%bIDgmܔJ nznpv6U~pT5""K-s0E|iDBY\3b\!ӡEHzUN"}'Iݓ.4.T"c#(Vx&Ij3goXǶp=#I}PN)6%7E)^3Z],{G)CeTAXT͂Tz~.>wG?qRahP$frǂ4YuPҗwmWd7OvKd,5$+;5'Mc=l|1%m~ :ul?lJ+S^1̱G)_oGEG܇Pw)Yv>stream HWnF}W1޹/ET@"`V$Uc}g/\I>pv̙3CJJc Z7oV߬,{xHdzѾuNWC%%IoEVJgÈaa;([p:깵}xq3zAx۹YS;3xL*v;n>U|zcT" 47]JH(}ݧX0 <T) Ͱ xV?1ƨ)kǏ͐nP<1a}~}sq:\}{{7;{w}beWElZԲ\RC$ >r?xˉ/*/a`,$SR\vH!z0$YE*ϣJ"T,=.]53]8dbn<-WĺTnrd hC60zP3ZQPFtqv(\U1q^!%Q:aLzAn|3a֛v{q!Pa[6)wfѢBHv_,CV+r?])eƁrWOÿ~^9tM{x&y14%\j`8- 1cVOjg("uPv~* 5*M24J>~^k (֚C_K,$i t\.ˀJ\G8Q4%>^^5ԙg7C%gHXdi'y1j ؎h\2f ڔ;PXA@Ya:sok'pX i =rC !tHY)siRzzr\_D. 83qR? */A/2fJrS=2f2.i<,NE$THNWD3+LW(Vd%.?}gw׆0<oҮq&4|DD?c}Q8>*yP#lZ MEk}.>stream HWˮH+b҅Af%2N'Lq/)}&.SBt2+Sd$lWZ/+>E10|G ]$.B{ۣrCãl4ӂz3U,8n60Cg ]`M0o6"ln"Ni|>x+bǰ!&PYAh͠Pf8+XI I()WV1A_01=-r-Rʦnap]4]䅊Mq0_?O$2yS48\$M M)b6gn˸'-2ZK4+OP) Vc|[m`:wPW;h,E㷷K4H; /_C|9#!1d"[7^Š`_3$p>6ݓDN0#;.,P@R\gk=̻fuiOW޺v^~lu|!_5н?rݟS9\S70/:#k;A>4 ^vCـU{cȈ3ORG20)#+mrPi*K iN{mS惼Q*AsW2!Amy[t\z+JМme&S]{{j.* Q2+jFԲ F9̼zT8?Ę`>ME.LbnBƸAlۣ9'L!TNvSaq ЧF-p /;ULD5e5IL}#-XD;r}j(?/>Q ,9IP(\^aϏ/d MnuKޗй=>ǎ(vw*xJ]cO]m%c9vր%,ݾ\&cEkJ6ϘD*n_jB x_U`[0 endstream endobj 50 0 obj <>stream HWK6Х@ d|? )- ڒ w(r(JAkrFoFPnup ZwʧwQ¬-濲#e{{f > bPM4+t=ݽ=zj?oS\Rg  4m:pOqRnBdcC|FO5`UHY QK0Q mw*X >2-fS77M7T*3;x]m8&~76\Hn لDp#U{S{S+C YaYJSRLݥLX*5EU: Pe +lP骁dnti7%1o=}_NTDh/BUH0wDܰ$"48s޽Opp3D ) ʽXLXg ȳ|Q^?6X?KuR,(ԝfoc yz.Pˣhr<j2m45sdlUgmu72] "U2Pna: ` p0\<ɌP4 7߭q)0B 0zd/9A6!BΌh16OY[**l!G im"G}Y cQH̲z2`&QB񴚑0c,pra+f*ȴt3*r^ *)͆͜-o/qM9nŗ$.w0|iᄋTf^PT Tțu[&ilEo8E8I=Bo1ݘŹΕ#*w~Y)#2_+9GDzNoxB^+; A[p~lZE1ծc۠Ṅ)}NqYk endstream endobj 51 0 obj <>stream HWKo6WhYoQ@ I[N]jVPwDrHi7vK`doFPl_e2Wm]?W;J(g;'og03"v0qDZ mb8YAL(M$us-f\|Omߕ%&M}$Ir殚iם< *$Q=:ŠCEmiw\`lL} WՎDß2<ܟ^b1bD?)Ouqu ݣ%р_!G_AA~*S*ŏۘ>:@c4)y!O^&vG.؀#4xNR|_WWPWS{>9ݳYƲP QI ʈ.xhvw?}ƇA WN§X ͻ ^Bl=6Mq*S.ؾ݌$"tJn\B.NmZ^T"%%]>4Քq..<9I6(#8Bfd|dQV(}5/嘦!8VeD+WWm]Ĭ}c/lS";LH ?<%kgH4:/c!\;6Y/Jeōn6Vk; +sUc1;vo. 5^f:aIt:2z6q8SӱBnH7:wl8* ;q|jkq=,4 |[lAh,<_ڏ @6]YY YR4z.].3<紭V}:2['G~ʱ,,nN8 %@L<4VG__nF' k0󰢦`+/t(4pVap~HMun)}̏}{iҠ\h8us}K-"x8m[.F1!wqZN) h'_`ov{JIQݱӢ2 $| W.CHҍjP5DnJg= X7<$.վ%elh ;󹶫6("W}gAeD0[<}һ1|ъf*OͿ.M""GLie7ܪ) <4@_Z2}re.a `Bަue\x-HR.l]N&WhJsVqF]rE~=Kc׶ʪwKƀ c}Zw\AC3{`}P endstream endobj 52 0 obj <>stream HWM61\~KM4=Z(m1EAC{G$o\ r8y#FSHH7O=ZaX)ټ# /KP3!gH^ckr~4;-є rOڭB5rBOlM㹄 !)/}SN1_ Ms귕]|Bz W/]m9b!c&rPj*1֟\@ ;+M BYc/k1ra!}Ҧz,쳈!|]^Ij%/`$|Y3TEg$bg1ld)ܼ,.^n&rwb$[gS:}x2!nw %WG?\ &\P(#\- " cT"VO"9}9M "\nf`iUWU]Op$ۍW$o*# Ay֊4sݩ8^κNcҵvw n"x9N͹ʗ,MJ "V$IhlkO*N($,;Uǟ(_̩I<}<=u{O;®>){8I-?]E&*?0+O֩ ?jp. TPMSyF|XJ=x0%L TȹD%D" fd|x34P.!Dz2Vc>stream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endstr endstream endobj 54 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 22456/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 7eetlrJb25e9 Y݋]}rYY!=GzoA L@2Z!_޲0^InצJE *bE\˻A,]h#ywDFlthҾO7\r Yq|4k[׃~{vk j5'(f/#kjED<}Lz+Re! #'u\E = YɌ5ݏ'SIVh%=.&&ZKYj9Dvw(yĔ3O4t^B6@g߾{y#sLs,c^mC/VHҞaVo8K; <Uɐϔ*2 2ӽ 9$~g[;ƽD5Ε@'٤Vai ē!YBfݒԤv ܽqAgHM5=/d+@$3C/> FǟjMhG꜖CVYI|58mus I e[XLy88ģ7qw_vW'І7-Oa#bP[eL d5D1-OfV Hgb-M2-*;΍^eι4chRI@piF a:L}XC.zoz,5 BEªMǰ['Gnr݉+_).M|bj6`[CՖ] {?G{!;z"MR`:oד徥+Eu`ƍ;d>}` X#|| JBs'Vȓ+x,3$LE1jPGA|@_a9X^JZg#P?ggw=+ ?0w^܃VlTzzm"ًwhޡAQ.74uӐyDsк=ώUz]Ǽ5VHa@&;i}c[#1Ywapň.w F` `p搢^Xۓe-az8VE=TrFI)=ݍꄓFJW-%v ~Xh..D3^lV!p ISҚf-O5l"}bxb[AȶBA5kaͼBϜE}X?_5\syh MlKy\v?MqDcoTKRz \(yXwCz J<\q-^+܋ DBT>v,{L33fbB7:1 7G8AFh!|Ϋըh^[1R{9Mi^ETIoU J8j ֢Vu+ދyDRhƣmgu^u6܋QL-X.hYa_32XWECھv`#-7z[s /*hm&D(>::/tv"]:`״8Ą2~Z R 1&FP~EVTWf `a<9Iػ4 fؤRz?h|0VqS7额[Sg(D8ԅL)Ro](L-EPXE-4;edu!(!x"& (]d'rp5Sr&}l೙Uv1.Vrs'۶rm5cIb;8 +A"_aN%ҘU# lE" x@y.z+ m X[g@8~b.I5J^r/x\YHaGF)5j(Ó I;ޢUWћ(wc3w|vhdÀ.4Y&G7) *8˞6FYʒvoVsOiS&S׋p˶$d3EEJTTߗ,EWf zLXCHӟD y-hcQ9[O>:B}fvնk GYi1L|1 ߠNZSv6tnʀ39tC[-%7`=YFQ0H8pF[PY9z^ĤWEZĠo-'g]P6嬡 vBY` fTǥQZ |ՅAvQ%@$*]<9A]7i ՉYױ1e०Ӿ#A(OXH?fUSʥmR>jD2'D`L7ǏlOh'c|˫k/a1b t0W (CRO2i!3cdH О^ _|>'JpWD3rD?4]bS\q$ -~b}걃K }y]śHQЬ>s[g 0zQ XRp|بhޫ h xT/34"ɱ藚7溮pSAd6?4= *-QQ`y Gv.A1 +#u΁UCZ0ރs]͘Y.)t7 $)IͶqŜ!%s`}Ql\b^J\zg`J?r*Y*AzR "gu&Wu;E\Â`ߡ˄n o+5Mv1,0 D>Ww.~>tZ]|axwJGB/ X:ɩ~d>/Ұ ^/b|k%pZ3َHD>;9]A`{tJwcaYݵܴ((>xm.Z'NrmXj-p-| VqrhXȥɑC:q&uΰy2~t2 L<hg)H`70J`<ߍ؍/~>d])1|){Γt3(gbepH^K. e/h_0r2&ufG777tƜO`=~Oqc9 #Jsȑߨ8W|'jFË9o+ܐkv廩AWN4 }Tk ` u_MXrc&:T(%DAQ76?&anxa<1W6JV2͊ĀD9oJ[>l]6S7:0,r$\:; ~Erb P`gA ZnƗ@fh%:dPfZS}jJO~MR ;QϊI1c;s\3Yݶvn_{uf~@{SDp ,>nk!IUܷ6 #Y}BD  5{_)qy3ɯɡPT+ }ExNFQC1P3PJkWg9?G/;w"d_\-͘7~<+.6#>dv+^2fӄ z#X?D ʜMRPĺ{Y.'4"(U**UTGiʓ͍ʜ 1*P:T+<,'| B><~ow+fR(${~,6d9k|3UWhc?7>Z\r GU۰ZGͰqJ-I_#2:lQΟKEG'avٝjy}nԚtF6ċT5]Dp+NU0IO7$6ZqkC "0Е9Yᴤ% y;FkWlAgIݽ:ۼ*2oj6Qh߯Rpzx;@KhZaT`gh^Ü!2E8ZݔPVt=O3k!R;N:D~FF@+?kbᚺLm$V$gla?azr}PLa*#ܙXͲ,z|=<)<."N)\` *yPv] R#~zrf,TLL|fNTʤ~‚9}= m/1E˪&oB*\Tl_N5R 7%oV}RZSQ濷#RYI8f~W :d 襰! pr, T!x+:e4,RPs@\Pc;#ؿyΈ`~9{50lpDQG+wTR#GLY$\{b`UQX*XmNcL%% t.1Cc;w X*JV^JU[$%$&uepn X{#CUc~KuIU ǜ8OqfqJO{gNا|x]0X^($YDMw} Enn<нCc(V-sa [M޸6p7Ɖ ?}%IQa=+4Xh/өC4Os56aKb걗}6#)7IBg˜D\”FAMx\=W8u x@@ HI ^5lM[20lZ 5F [+lqcPWҐY3+ 8LƵxh7|"B`ދkh32) g ~'s˿'Clz8]6}аLkeaAZuoH&`W ei^ NutְpC<=sM8?%+U'L_'R)iloZ9i/!Ru\}~p115^pN d.^ q{a(WmR ܽW/*ܞVet0,M\BPg%1ma*ۆP"ad0ailɽ9[O86p3xX:NZIAPOXK!Pq\ J?6X32kB:6 ѵ6` fԌk MF, //`H<x/+Fd2b!BN 2Rc1U\J WNl!yhN#׹g +pjĔOXuw Ԣp cm2Rrx1RL(? 0&& aYcjqүjBNpwܽzh.>5Tڅ,\[F:.Cb #[tw:,JRG"p|)B-AxϓNkV?"jj*͕GJYvV=3ÍȶMj^4o#i:$ _3VqQj*E%T[Q)pk )Bj*(W)Ez C>'JTw0:OOwUal_&`P"~| 0ƎiL&|Pg=2^7P0 GX* .r0&[iRXì1 t訾Y r9Ow cYp4R0} T1Q8B+S4# n}L|ISVamϻ/E-u-kG@<:nēopuKQZ &UQ@7!20=)#/ n%rߋ;J ) YB*B!( zHO?6)?;: UXI1 DQZupAoa'O+)&2bJkvtcU[-U%PpLGcyxXc-܋ / ^}yI@vSbb->".,7zEFJ_MqX{ ^[JrWOOfyڱC=ū@c#(Zu㟽V.cZX?m+'B|68#t@3ѭYؘK/CT*:H?{Zψ+CtUXXSUu%~?d)}q9-T.'ܠ?qo,qX\B։z=ćl{A^ , b'_|ET}UY'G-JI\j}\!QO{#\yI[vޓ,dЏef@A[昅sCNZw'h6!\jͶҤlvnmJ+Clj} (eL {,͊Lq e) "9 ˜,V7-;Ljd)iժGY1mQʪl哋#X<"k}%{bMVBcsO{+1;ӽ ihAd|a*gz}Јy_0Fsd$JYtOWߣ_1q 6jg88?6fh8v \?Cv.BiS)>K#Tk r1?_Λ#HKVzŸn ɋ2xKїi|J z^I :w<4.[/)Σ "6qa<(A.za:5)Z2GY(XsO@t k7xg.UJZvUbUćҸ>١p7#%fнgb%*{3|&/SR1?8w*]sc|?'%]D7oAW 1m[;% RsSD;e2$?y57Iuwna[hM$vp{MΨ hoA\HQőEj"풶u*{\ msב ^q~}B^׾[twkraAbD{ C:7#̃@?F\H?:Mk|/fX㸓XT8ϓCœ>ǵ?pD!e:tOᾧɂF36u$wNXC|[Cmjo#yB!?Ҵ$[fYCr3p.*9Vp\ƥJO 6e`(Lt,1w@>L.^}#8"3u>`<Ώg QGEi!%Y_ Q"xݓ4CrTLB5lwzA^'z+^0T֢ڠ-Trŕ9qݦ}@!N}MZ7Q8%ZF?}4Kǵw\{ݟtVP_~ME7[FZ,zMQ m)Ur}4#EFv+s|ǛG(o|Qrٮ=Wa[sxp  _C[aU")D<YH:WIo+PJb rfb'<g֕c}iϛdNqx C4IhUG{+ͅrTWxϋ!)lqsӄ@ H4k}_,\ YίtHɛ[ [lEߴJWi Is?KE@}@ uG쨞ItTd4Xnmrx}`tfH1FHV~IgAm@kH$!²FʦyEvk<?/e<&.6j+=]NNClw-}ӪdyM|OE$&Ϩ٦,ՅYǁ2g\5ӝ_75_bVrӳ947$Hἱ3{;]>;W'>ۘ);PbbTnW⢉$>!zs(1+Ѓ+d#s *aUVv6m.\0?X'n/Xmbkeh>\'P#xdb:p_fUTgґ?>qdƺSUxgJlgy^_qrM@ER<*|HXKMt qEX+zNi"|l,heFצp ZߒU9P/a@8/ z#lʐz`f^UVhxM!b'I P Pp :,evxIF1?N'cST}nkPhYux3rͼTD@{MƓ[i^%PV6Rf`h$C`iD@k17յun N)Jʼnw") Ä/yxܠ?Uja8$8Ub$[X?CjC ~$1O,Mo!Vȸ١UIzfG(ʇ;INR lh~OnxR/pgSTn =dE.O} _̴y \?q=_`_g̙H˧0+s +(@5w.I?řXr/”8S,7K &8yT/!-b +B}!d, "ޯ'*1Ap^+$'ȬHЕHQ54ö }6(0)U= \kWA9_ X*瓟k6bYMԆGԣ.Vң% G bK<WI?sA ^l[09uDtF.*z)-JI|\ hL|,V[vMz]Ւ^I[qIf>SK^Fl(}NX3E=s+C#S}QF TpRAiNP2kvޟ!C=yuYwYu _e;duiu=a.,cG.P '[߈Xc Rr51}d}%eJc(ao1e-̆>:cbq%Q3ĆH{oQP}& IJ3i^d%yuP00cY1:\hҖ_p*ټT %ncwR FgT ]FI'1ėt'}GP701(3v ѴED~][0ӪA4Bي<1c숃elE 6,-2_3_}8^31Z)ĜS5{` œʏ:lpE( _ Tx@/":I n@eqj6Jwk))'9Ҵ'c6Zj "oE'#H!<\QXjt.`:W 6 wZw~eT3*Kr߿#~mt&A`L:rx';JSZVԒEwvI :YMRUkhMP~9>oh{p< >7w!#˧ŤwX0by?S.YP >f|I5r$⮗g#7F"tkݔzMwqm0wH5;aX /CWPhmpR2E.e>f l9;V: $׆d=ӲJ^EHE/$uTۜy1^ wLK"3-6^UkZN"{- TywO$|;u6\7A/2`k!oGÆktpϺ3bN|4tv[ ̼ŋ.)bbLLxH-x[E{/H.Nkzq"`eF]ʱTOxsVK-%@?sfM8D|>@^"ABL{"~$e66}Ue̮_Rۆi"$T23JˎRs* Qp'.Pٰz7d9aw&6ܚ[Eq~~˺ 閏y.$hԊDᮂmvk@D]~nKAՖ,&Hޝ{Ֆ sBv‰2|=޲-ZYV;$eU4 I" KJ|1YD q pq{]0ܚG~FRQFt2a~w} °VEmCO>#yi "9y P,/J >nyfϻ /`g -2تUw>)?=x ="!j̑)ʘCG[63*{?d;;mn塩vUGN 4M/*|!LLw n4ȣr*8E4r+M_\>[D!1*S;#vVKd<^Րe-̍}{&g>ȅUJSʨC!E gruic5/i@'{@ rsuN4͚3M_-(`K3k&u+)ɻ3}qx\FF2nOFtWU =GY9Xn..xP>XL o`1-G.9t6f 3hp*Rg8bZͿՊҝ?hO !h/EC{ƪkq3I `S\U.*e6 N9.ŷzL IMF?mgizwm̰PY/ )A<:6oFs DCH^eȒ%T<]Nh'Z\E(ϔ8 *U= Ɲct7?Q&Ϳx4j9.5D#BW*,jҧ~2d!=tk}2 oF3Eр4^T: LF7B(w(Po5m@D4N)=WAS}^q]:[ki{Z_eK+vK.-ޏh%>&fn ;-yG/vb/%Qʽ ]F<~WrC̉%rf;є&yF6Wvˍo((5υLRʟi濤J+^pM"|JGjKxF+9?ۦAULMQ]E?wj.A22MTtZCO*]]Y٦hPI,"x1]BG#v\h!j~iS8ͅ:勅C8X$NK(a?j|{΂a3ABIisF$V~1.gg{ԑzV#bVI2Ԩ^騯-i,*O[s &(jQNoU3:Yp0)f_ٌhDz*˓w5de`m+ P,+,#H(ՙ^# Kw=BdRm6Y[#=)w)(#ʼn4W0>E$UReOG5IC@Hp{>Ϭ+xOu:J`@\ pݶ"fKL_z^\&-g(fgLSQ ]ZO}Y>X}?iɍa2^X>>;[Y X柳`R {@P# [/AtQnJ&b4`+;SN8tmTFK_d `a/ w@WiHELx}}ᵟD.h'dtJ'a>vyzHVПrұ|O'Q,B.("Ӑ YfG?4&q3ҲYB 9)9i9'fcm*P~]^!O0hw5? {> E7Tg:/ja˞H2i+Yjt4&gc %Ąu[<Usw1io>0شD?T%PQuJW o E  "t[to#z3/LVo1`D,A̻sᔥT=k]*%g^\JhqMHa gph,*S^<0\n3 HW4=4+q`清y'vc9}!xV̽23D (Xn);u'8D탭Uw0]4t#~o/KgQ&z5:$zu,g>|zG^@pƜ3%OAHw:tb?$.=(=mkH p.stexD04Ӥ{ݯD;Z?rYTuj Q)K{4QK(_'»~D'd+p%,fRF)ͯ|OH8}̢哆18t B=[)Dg.5I1a:)?uШpCLc}q)Y9~t3Ҏ: H@$xY{4'eyu >\}}#K=>IyȻM\/%kdc^=~`U\isa[ۍ- L1BD'-m[kɫ8Ki٣yJtpYu~~ _KIpRjV\Z.SXbiH>"n6O:ˮ' C„wax1[.y)*]^g /`‰LfQ;-;4fh;;5$dȔߕ$2RNy*ҭ5[V;~qIwβ]Iw9ֻ:okOu[GZNƼOcxnPT eU$ Fι$4b(PxoŷK3)e1NP\\5'՝cͦU~uy.;lݍqhhM v1/vS0yZ4u-&Ylͯ>bF? d(3 _cX6lov| N*IeZc0cDA7`m LrA_C>ad.zY¥ ߈,Dչ*{_'685灈cXW/gh]v-0@ S#p r@m {)nkxAU[Nse0Ӟӆ56~/i[MTV#>ъfjS#9& yHX-"p[YO<"E8lB2 ïm3NnJoH4A8b+BN7Oxbޠ{ڥ\m SoލEMaAw-P9dV9@ExNyKΒja'Pse EjwYE@>wn * P^_D@S+ 7tw8.aP' n m2ϑHMz@X!bWٽzU->3HLI*<_ zX}&A9"TPq|=ſ*>ɞ5:̰NO]^e]47S>O _P/4$S%05@)`]X4 ݒrOA܌,'mA7M$þh0>E:kQMb᱒ݗP-K}H-:H#)~GC޳ŕad ](˕ھ]Oq32mK!TfʼY(DJBkvO5JG1^˧Kh.bQJ.$fҵ񿄗IN`YXσɣqB9H_F}8&ɼSռ/bLsVN |H|=aV^TÅ !YhiGb9_~@xRJT/ʋ3y+ yx"OAk4é8>oa/@YޱM/pY4u!<쒦+ڰ j(WReqIB onG]Kaq7Ğ1.gQ_H@M$BX':á}#BGgsN:rRQ-}ߛd!37N-GHNWf\r/Rĕq#-\IVZuKb?oPyM} k+s̻r8)t#"W/ziWԉ Dj*dKQh@d#!ڐ a=wV>T,5"ٍ\3 +UYfI{]olJ&Ҕ-G.cq|LZL }*os[;LHV=~x *Q4ެ_{%"'sAIqՇMk;@H\X|:(56:#dd\d򈰂X%?,^~UD\yP=G OQ$S2`zwP jFI֜6(ؖNW# GCyW2MHZ&Q̕*ʃb9oOH'?;;`WsJS8H|QC֛swK_|%8lvmޒ%i>rgww oh<,-^m+PO ovALlrQqWWhy*]x:N=O̞o&P]Н?߇5!b |WeWB(%C>q\3!C֏^q/8^ӝԉK>O[z|(saTl]Snf&2K  ޗ"Ÿu*VwMM/4+hGL8,mkD\_%i^t  7d/Pgfܟ:JE\a|ʴ.g;C #xė~n`6&GG8܄Hk1%c_x5 Cer(ִCgk^6=ok2*L O€rey^3cI nT~ƙ\޹@k `''=R9=>MJye3W dQK |2iJnH%֖UW|ozsb}PĦ sfՕLC J\F_&2Iy,fv?9ڥ)Z4'D'Sd;ѭ1ira!E/݇X4~oA_ t+p`ny`OWv8晚z8_+>}%XP%x{P_=b5+V%{gU76t;y=ZD51"$$/ڼeef:~Yg\0-0Mq#bDO=NE;#?)0Sw_];mOZVxE26+6I7ݿhʫ5FMRB$L Tvnqri% =®;$5fumu) $.c>fJ}/ْ}D7-y p,T$MnS>B\DLvQX9Ne#{zk,zʍoFiGWf<';='_AP̚@C|O.%F}P<]bдي餹"Xa_ [ 6 %1y]KY+#Q.c'@g`I-%!ñ@jT'Aim{BP yoGI a]IR|ZACE><AV_rjBagVpga8oDυ-re"LD}ݯEv& Zё#FWLɿ%ň\6Ta1n0Je5N[A_\)n(}:Ǩ?zP/( 6$ ~xfCL6htKG~ ,3jdh^;I8/rzї EBy>0}#A/Y Oސf>Ű-Lhmo_⳹RgZH"{gB#O"V] 74BCiᴘlLN8WwS>}ǠR4Q=u=c!> t)G"V0'PuCrǰ\d®Tr>rg}:QВȘc?'~?ĊƱI>U.Wb+(Y )rIZT[/آ`nK|Mmr۽SONξ+Ago jՅ*&XjelC@ЧBO {ߨ #gbɜ͡;׾}A-T .{-ȇ?r㶝aV%.?Lɏ. Gw/~t./FT\ 9"/qqPXSL|UhBB}vpS}`"6zX&LVju_2M q4Ug.Q2E|?b<^\g)d 7Cb~>4&aR7z-'I,(Xuix]HN+B PM PzšM@-Jù P[\n瀷L:ɀQ{AMig|J2祭uЍ#DKpjv#]q9fz"YN=4EJ óGTM+V9@m4xk4$Zf-m eS9ޫ:.&ƒs2zCmΏz%|ss8:<OP0>9>9ʇD}8ʮxD>WuOk5rE(m\[R.1J5*+5hd0ìä@;X22,KEn \ |JaO̗ z2Vqt#E v `uw68<&tĻlWR/RuOp6:@ޓ=;kvIb }!2 -d le/f([PH;ʐ◎hqn?.gDžj.ͤlJ* |LC뽾W/ endstream endobj 56 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrqjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  ":  S: ؀ :(_X!   endstream endobj 57 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrpjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ! @ $:@> `C܀ : މ   endstream endobj 1 0 obj <>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 2 0 obj <>stream q 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 595.1999969 0 0 840.9600067 0 0 cm /Im1 Do Q BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 0.029 Tc 3 Tr 7.7 0 0 7.7 181.4 749.05 Tm (EFFECT )Tj EMC /Suspect <>BDC 0.05 Tc 8.0873 0 0 7.7 214.48 749.05 Tm (OF )Tj EMC /Suspect <>BDC 0.025 Tc 7.7 0 0 7.7 228.88 749.05 Tm (OMEPRAZOLE )Tj EMC ET BT 0.149 0.149 0.141 rg /T1_0 1 Tf 0.0194 Tc 7.7 0 0 7.7 286.9919 749.05 Tm (IN )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 0.0172 Tc 7.7 0 0 7.7 299.9895 749.05 Tm (ASTHMA )Tj EMC ET BT /T1_0 1 Tf 0.0264 Tc 7.7 0 0 7.7 337.4115 749.05 Tm (WITH )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.4572 0 0 5.76 362.4 749.05 Tm <005200450049007E004C005500580020>Tj EMC ET BT /T1_0 1 Tf 0.0091 Tc 9 0 0 9 514.94 746.65 Tm (967 )Tj 0.372 0.376 0.369 rg -0.035 Tc 10.3816 0 0 10.6 46.55 722.17 Tm (was )Tj 0.31 0.31 0.306 rg -0.0238 Tc 10.6 0 0 10.6 65.74 722.17 Tm (repeated )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.5732 0 0 10.6 104.53 722.17 Tm (and )Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 123.21 722.17 Tm (s)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.2813 0 0 10.6 127.19 722.17 Tm (howed )Tj 0.31 0.31 0.306 rg -0.0315 Tc 10.6 0 0 10.6 157.82 722.17 Tm (conlinued )Tj 0.235 0.239 0.231 rg 0 Tc 4.132 0 Td (p)Tj 0.372 0.376 0.369 rg 0.441 0 Td (a)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.5459 0 0 10.6 211.17 722.17 Tm (tholo)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 231.27 722.17 Tm (g)Tj 0.149 0.149 0.141 rg 0.498 0 Td (i)Tj 0.372 0.376 0.369 rg -0.035 Tc 10.3978 0 0 10.6 238.94 722.17 Tm (ca)Tj 0.235 0.239 0.231 rg 0 Tc 10.6 0 0 10.6 248.55 722.17 Tm (l )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 10.5178 0 0 10.6 254.77 722.17 Tm (COR )Tj EMC /Suspect <>BDC 0.372 0.376 0.369 rg 10.4122 0 0 10.6 46.44 711.12 Tm (\(tab)Tj 0.235 0.239 0.231 rg 10.0336 0 0 10.6 62.32 711.12 Tm (le )Tj EMC ET BT /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 74.03 711.12 Tm (1)Tj 0.372 0.376 0.369 rg -0.035 Tc 9.9793 0 0 10.6 78.18 711.12 Tm (\). )Tj 0.235 0.239 0.231 rg 10.4294 0 0 10.6 87.75 711.12 Tm (Th)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 99.25 711.12 Tm (e )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.022 Tc 10.6 0 0 10.6 107.412 711.12 Tm (anti-reflux )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 10.172 0 0 10.6 154.06 711.12 Tm (medi)Tj 0.372 0.376 0.369 rg 10.3978 0 0 10.6 173.66 711.12 Tm (ca)Tj 0.235 0.239 0.231 rg 10.2197 0 0 10.6 182.86 711.12 Tm (ti)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 188.06 711.12 Tm (o)Tj 0.235 0.239 0.231 rg 0.507 0 Td (n )Tj -0.035 Tc 9.8086 0 0 10.6 202.55 711.12 Tm (wa)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 213.93 711.12 Tm (s )Tj 0.235 0.239 0.231 rg -0.035 Tc 9.7344 0 0 10.6 221.74 711.12 Tm (th)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 229.33 711.12 Tm (e)Tj 0.235 0.239 0.231 rg 0.417 0 Td (n )Tj 0.372 0.376 0.369 rg 0.807 0 Td (c)Tj 0.235 0.239 0.231 rg -0.0275 Tc 0.46 0 Td (hang)Tj 0.372 0.376 0.369 rg 0 Tc 1.803 0 Td (e)Tj 0.235 0.239 0.231 rg 0.408 0 Td (d )Tj -0.035 Tc 9.7344 0 0 10.6 46.54 700.09 Tm (to )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0223 Tc 10.6 0 0 10.6 57.5 700.09 Tm (omeprazole )Tj EMC /Suspect <>BDC -0.0338 Tc 4.806 0 Td (40 )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 9.6966 0 0 10.6 122.86 700.09 Tm (mg )Tj -0.0328 Tc 10.6 0 0 10.6 139.1 700.09 Tm (daily )Tj -0.035 Tc 9.8996 0 0 10.6 163.57 700.09 Tm (for )Tj 0.31 0.31 0.306 rg 0 Tc 10.6 0 0 10.6 178.44 700.09 Tm (3 )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.4294 0 0 10.6 187.1 700.09 Tm (days. )Tj 10.3691 0 0 10.6 212.12 700.09 Tm (Within )Tj 0.31 0.31 0.306 rg -0.0321 Tc 10.6 0 0 10.6 242.78 700.09 Tm (one )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.5572 0 0 10.6 261.02 700.09 Tm (day )Tj 0.31 0.31 0.306 rg 0.0003 Tc 10.6 0 0 10.6 45.98 689.53 Tm (our )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf -0.0136 Tc 10.6 0 0 10.6 64.3392 689.53 Tm (patient )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 96.33 689.53 Tm (s)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.2813 0 0 10.6 100.79 689.53 Tm (howed )Tj 0 Tc 10.6 0 0 10.6 131.41 689.53 Tm (a )Tj 0.31 0.31 0.306 rg -0.0261 Tc 0.869 0 Td (remarkable )Tj 0.082 0.082 0.074 rg 0 Tc 4.703 0 Td (i)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.3156 0 0 10.6 193.42 689.53 Tm (mpr)Tj 0.372 0.376 0.369 rg -0.0321 Tc 10.6 0 0 10.6 209.18 689.53 Tm (ove)Tj 0.235 0.239 0.231 rg 0 Tc 1.366 0 Td (m)Tj 0.372 0.376 0.369 rg 0.716 0 Td (e)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.3967 0 0 10.6 235.67 689.53 Tm (nt )Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 248.03 689.53 Tm (\()Tj 0.235 0.239 0.231 rg -0.0246 Tc 0.375 0 Td (ug.2)Tj 0.372 0.376 0.369 rg 0 Tc 1.669 0 Td (\))Tj 0.235 0.239 0.231 rg 0.348 0 Td (. )Tj -21.448 -1.042 Td (F)Tj 0.372 0.376 0.369 rg 0.539 0 Td (o)Tj 0.149 0.149 0.141 rg 0.46 0 Td (r )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 9.7344 0 0 10.6 63.82 678.48 Tm (th)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 71.41 678.48 Tm (e )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 9.684 0 0 10.6 80.05 678.48 Tm (fir)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 88.65 678.48 Tm (s)Tj 0.235 0.239 0.231 rg 0.464 0 Td (t )Tj -0.0321 Tc 0.589 0 Td (time )Tj -0.035 Tc 9.9195 0 0 10.6 121.36 678.48 Tm (in )Tj 10.0936 0 0 10.6 132.94 678.48 Tm (two )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 151.67 678.48 Tm (y)Tj 0.372 0.376 0.369 rg -0.0162 Tc 0.398 0 Td (ears )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 176.1348 678.48 Tm (h)Tj 0.372 0.376 0.369 rg 0.444 0 Td [(e )-72(s)]TJ 0.235 0.239 0.231 rg 1.179 0 Td (l)Tj 0.372 0.376 0.369 rg 0.225 0 Td (e)Tj 0.235 0.239 0.231 rg 0.0018 Tc 0.42 0 Td (pt )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 10.4562 0 0 10.6 211.65 678.48 Tm (the )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0207 Tc 10.6 0 0 10.6 226.54 678.48 Tm (whole )Tj 0.235 0.239 0.231 rg -0.0259 Tc 2.718 0 Td (night )Tj 0.31 0.31 0.306 rg -0.0326 Tc -19.744 -1.042 Td (without )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.3644 0 0 10.6 78.71 667.44 Tm (requirin)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 109.35 667.44 Tm (g )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 10.6 0 0 10.6 116.5156 667.44 Tm (3)Tj 0.372 0.376 0.369 rg /T1_1 1 Tf 6.2 0 0 6.2 120.91 664.09 Tm (2 )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.035 Tc 10.4821 0 0 10.6 124.68 667.44 Tm (-sympalhomimctics. )Tj 0.235 0.239 0.231 rg 10.4037 0 0 10.6 206.31 667.44 Tm (Twenty)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 236.52 667.44 Tm (-)Tj 0.235 0.239 0.231 rg 0.317 0 Td (f)Tj 0.372 0.376 0.369 rg 0.228 0 Td (o)Tj 0.235 0.239 0.231 rg -0.0173 Tc 0.508 0 Td (ur )Tj -0.035 Tc 10.3011 0 0 10.6 258.23 667.44 Tm (hour )Tj 0.31 0.31 0.306 rg -0.02 Tc 10.6 0 0 10.6 46.06 656.89 Tm (monitoring )Tj 0.372 0.376 0.369 rg 0.0478 Tc 4.747 0 Td (of )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.5485 0 0 10.6 110.86 656.89 Tm (his )Tj -0.0307 Tc 10.6 0 0 10.6 128.66 656.89 Tm (pulmonary )Tj 0.31 0.31 0.306 rg -0.035 Tc 10.3602 0 0 10.6 178.45 656.89 Tm (function )Tj -0.024 Tc 10.6 0 0 10.6 216.86 656.89 Tm (confirmed )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.5485 0 0 10.6 263.98 656.89 Tm (his )Tj 0.372 0.376 0.369 rg -0.0221 Tc 10.6 0 0 10.6 45.5 645.85 Tm (clinical )Tj 0.235 0.239 0.231 rg -0.0267 Tc 3.171 0 Td (impro)Tj 0.372 0.376 0.369 rg -0.035 Tc 9.5735 0 0 10.6 103.66 645.85 Tm (ve)Tj 0.235 0.239 0.231 rg 0 Tc 10.6 0 0 10.6 112.3 645.85 Tm (m)Tj 0.372 0.376 0.369 rg 0.716 0 Td (e)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.3967 0 0 10.6 124.79 645.85 Tm (nt )Tj 0.31 0.31 0.306 rg 10.5732 0 0 10.6 135.73 645.85 Tm (and )Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 153.93 645.85 Tm (s)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.2813 0 0 10.6 158.39 645.85 Tm (howed )Tj 0 Tc 10.6 0 0 10.6 187.57 645.85 Tm [(a )-77(d)]TJ 0.372 0.376 0.369 rg -0.035 Tc 10.4646 0 0 10.6 201.01 645.85 Tm (efi)Tj 0.235 0.239 0.231 rg 9.7469 0 0 10.6 211.67 645.85 Tm (ni)Tj 0.372 0.376 0.369 rg 9.844 0 0 10.6 219.82 645.85 Tm (te )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0239 Tc 10.6 0 0 10.6 229.82 645.85 Tm (decrease )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 9.2582 0 0 10.6 268.24 645.85 Tm (in )Tj 9.0971 0 0 10.6 46.07 634.8 Tm (ni)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 53.19 634.8 Tm (g)Tj 0.235 0.239 0.231 rg -0.0346 Tc 0.505 0 Td (ht-tim)Tj 0.372 0.376 0.369 rg 0 Tc 2.301 0 Td (e )Tj 0.31 0.31 0.306 rg -0.03 Tc 0.691 0 Td (bronchospasm )Tj 0.372 0.376 0.369 rg 0 Tc 5.692 0 Td (\()Tj 0.235 0.239 0.231 rg -0.035 Tc 8.0782 0 0 10.6 154.47 634.8 Tm (fi)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 160.23 634.8 Tm (g)Tj 0.235 0.239 0.231 rg 0.486 0 Td (. )Tj -0.035 Tc 9.9092 0 0 10.6 170.54 634.8 Tm (1\))Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 178.82 634.8 Tm (. )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.3703 0 0 10.6 183.79 634.8 Tm (Durin)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 206.79 634.8 Tm (g )Tj 0.31 0.31 0.306 rg -0.019 Tc 0.678 0 Td (days )Tj 0.372 0.376 0.369 rg 0 Tc 1.951 0 Td (2 )Tj 0.31 0.31 0.306 rg -0.035 Tc 10.5732 0 0 10.6 242.29 634.8 Tm (and )Tj 0 Tc 10.6 0 0 10.6 259.56 634.8 Tm (3 )Tj 0.0025 Tc 0.681 0 Td (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 10.0379 0 0 10.6 46.06 623.76 Tm (the )Tj EMC ET BT /T1_0 1 Tf -0.0223 Tc 10.6 0 0 10.6 62.3 623.76 Tm (omeprazole )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 10.5199 0 0 10.6 114.69 623.76 Tm (treatm)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 140.05 623.76 Tm (e)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.3967 0 0 10.6 144.47 623.76 Tm (nt)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 152.47 623.76 Tm (, )Tj EMC ET BT /T1_0 1 Tf -0.0232 Tc 10.6 0 0 10.6 159.2646 623.76 Tm (oesop)Tj 0.235 0.239 0.231 rg 0 Tc 2.226 0 Td (h)Tj 0.372 0.376 0.369 rg -0.035 Tc 10.5579 0 0 10.6 187.57 623.76 Tm (ageal )Tj 0.235 0.239 0.231 rg 9.7794 0 0 10.6 214.1 623.76 Tm (pH )Tj 0.31 0.31 0.306 rg 10.0572 0 0 10.6 230.87 623.76 Tm (was )Tj 0.235 0.239 0.231 rg 9.2582 0 0 10.6 250.96 623.76 Tm (in )Tj 10.3833 0 0 10.6 263.01 623.76 Tm (th)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 270.61 623.76 Tm (e )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.499 0 0 10.6 45.59 613.21 Tm (normal )Tj -0.0226 Tc 10.6 0 0 10.6 77.74 613.21 Tm (range )Tj -0.0252 Tc 2.48 0 Td (\(table )Tj -0.035 Tc 9.6857 0 0 10.6 131.18 613.21 Tm (1\). )Tj /T1_1 1 Tf 0.0082 Tc 7.2 0 0 7.2 56.48 587.76 Tm (Peak )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.05 Tc 7.6915 0 0 6.3001 76.3 587.76 Tm (flow )Tj EMC /Suspect <>BDC 0.149 0.149 0.141 rg 0 Tc 7.5001 0 0 7.5001 60.97 579.12 Tm (/)Tj 0.372 0.376 0.369 rg 0.292 0 Td (\267)Tj 0.235 0.239 0.231 rg -0.0218 Tc 0.2 0 Td (min\267\225 )Tj EMC /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.8359 0 0 8.1 61.35 567.12 Tm (700 )Tj EMC /Suspect <>BDC 8.8901 0 0 8.1 60.84 511.92 Tm (500 )Tj EMC /Suspect <>BDC 8.9054 0 0 8.1 59.9 456.72 Tm (300 )Tj EMC /Suspect <>BDC 0.0264 Tc 8.1 0 0 8.1 60.68 402 Tm (100 )Tj EMC /Suspect <>BDC 0.0188 Tc 7.6 0 0 7.6 86.62 365.53 Tm (10 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 7.848 0 0 7.6 100.53 365.53 Tm [(12 )-190(14 )]TJ ET BT /Suspect <>BDC /T1_0 1 Tf 0.0188 Tc 7.6 0 0 7.6 128.38 365.53 Tm (16 )Tj EMC ET BT /T1_0 1 Tf 0.0126 Tc 7.6 0 0 7.6 142.782 365.53 Tm (1a )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.3795 0 0 7.6 155.47 365.53 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 8.3795 0 0 7.6 169.3883 365.53 Tm (22 )Tj 8.845 0 0 7.6 184.27 365.53 Tm (24 )Tj 0 Tc 7.6 0 0 7.6 199.64 365.53 Tm [(2 )-1209(4 )]TJ ET BT /Suspect <>BDC /T1_0 1 Tf 7.6 0 0 7.6 228.8468 365.53 Tm (s )Tj EMC ET BT /T1_0 1 Tf 7.6 0 0 7.6 241.3564 365.53 Tm (a )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 7.848 0 0 7.6 253.17 365.53 Tm (10 )Tj EMC ET BT /T1_1 1 Tf -0.0106 Tc 7.5001 0 0 7.5001 196.75 353.53 Tm (Time )Tj 0 Tc 2.996 0 Td (h )Tj 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0025 Tc 7.7 0 0 7.7 43.65 335.76 Tm (Fig. )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_1 1 Tf 0.05 Tc 13.3884 0 0 7.8001 60.11 335.76 Tm (I.-)Tj EMC ET BT /T1_0 1 Tf 0.0076 Tc 7.7 0 0 7.7 79.18 335.76 Tm (Values )Tj 0.05 Tc 8.3469 0 0 7.7 104.08 335.76 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0185 Tc 7.7 0 0 7.7 114.25 335.76 Tm (peak )Tj EMC ET BT /T1_0 1 Tf 0.0271 Tc 7.7 0 0 7.7 132.3989 335.76 Tm (flow )Tj 0.025 Tc 2.316 0 Td (measurements )Tj 0.0382 Tc 6.413 0 Td (over )Tj 0.0294 Tc 7.6 0 0 7.6 216.92 335.76 Tm (24 )Tj 0.002 Tc 7.7 0 0 7.7 227.99 335.76 Tm (h. )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 0.05 Tc 11.9196 0 0 9.1 235.56 335.76 Tm (0: )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf 0.0218 Tc 7.7 0 0 7.7 249.11 335.76 Tm (without )Tj 0.0242 Tc -26.69 -1.122 Td (anti)Tj 0.372 0.376 0.369 rg 0 Tc 1.557 0 Td (-)Tj 0.235 0.239 0.231 rg 0.0091 Tc 0.322 0 Td (reflux )Tj 0.0047 Tc 3.053 0 Td (therapy; )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 6.3751 0 0 7.7 115.55 327.12 Tm (.0.: )Tj EMC ET BT /T1_0 1 Tf -0.0087 Tc 7.7 0 0 7.7 127.67 327.12 Tm (with )Tj 0.0181 Tc 2.369 0 Td (ranitidine )Tj 0.0321 Tc 4.479 0 Td (and )Tj 0.0176 Tc 1.996 0 Td (domperidooe; )Tj ET BT /Suspect <>BDC 0.149 0.149 0.141 rg /T1_0 1 Tf 0.05 Tc 7.7286 0 0 7.7 243.68 327.12 Tm (... )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf 0 Tc 7.7 0 0 7.7 252.77 327.12 Tm (: )Tj 0.0121 Tc 0.834 0 Td (with )Tj 0.0285 Tc -28.06 -1.184 Td (omeprazole. )Tj /T1_1 1 Tf 0.0146 Tc 6.3001 0 0 6.3001 296.02 722.65 Tm (Peak )Tj 0.149 0.149 0.141 rg 0.05 Tc 6.6513 0 0 6.3001 313.27 722.65 Tm (!low )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_1 1 Tf 0 Tc 6.3001 0 0 6.3001 300.49 713.05 Tm (/)Tj 0.482 0.482 0.471 rg 0.2 0 Td (\267)Tj 0.235 0.239 0.231 rg -0.0069 Tc 0.313 0 Td (min\267)Tj 0.372 0.376 0.369 rg 0 Tc 1.908 0 Td (\225 )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_1 1 Tf 0.05 Tc 6.4203 0 0 6.3001 320.52 713.05 Tm (no )Tj 0.0424 Tc 6.3001 0 0 6.3001 330.69 713.05 Tm (therapy )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0341 Tc 6.3001 0 0 6.3001 357.9379 705.3576 Tm (Ranltldine )Tj EMC ET BT /T1_1 1 Tf 0 Tc 5.4001 0 0 5.4001 390.63 705.36 Tm (+ )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0218 Tc 6.3001 0 0 6.3001 397.35 705.36 Tm (Oomperldone )Tj EMC /Suspect <>BDC 0.0415 Tc 8.609 -1.676 Td (Omeprazole )Tj EMC /Suspect <>BDC 0.05 Tc 6.3116 0 0 6.3001 447.7 685.68 Tm (Ranltidlne )Tj EMC ET BT /T1_1 1 Tf 0 Tc 6.3001 0 0 6.3001 481.34 685.68 Tm (+ )Tj 0.149 0.149 0.141 rg 0.05 Tc 6.3713 0 0 6.3001 487.54 685.68 Tm (Domper)Tj 0.31 0.31 0.306 rg 6.4473 0 0 6.3001 511.56 685.68 Tm (ldone )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 0.0449 Tc 4.7 0 0 4.7 320.61 556.56 Tm (IS )Tj EMC /Suspect <>BDC /T1_1 1 Tf 0.035 Tc 6.3001 0 0 6.3001 337.8 556.56 Tm (rr )Tj EMC /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0094 Tc 4.7 0 0 4.7 354.56 556.56 Tm (19 )Tj EMC /Suspect <>BDC /T1_1 1 Tf -0.035 Tc 7.5666 0 0 13 370.92 554.17 Tm (\225\225 )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_1 1 Tf -0.001 Tc 6.3001 0 0 6.3001 313.24 543.61 Tm (1986 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0402 Tc 6.3001 0 0 6.3001 329.677 543.61 Tm (September )Tj EMC /Suspect <>BDC 0.05 Tc 6.4897 0 0 6.3001 456.87 544.56 Tm (Oclober )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 0.0183 Tc 7.7 0 0 7.7 295.65 509.53 Tm (Fig. )Tj -0.035 Tc 8.2747 0 0 9 310.99 509.53 Tm (2. )Tj 0 Tc 9 0 0 9 319.58 509.53 Tm (-)Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 0.026 Tc 7.7 0 0 7.7 327.33 509.53 Tm (Daily )Tj EMC /Suspect <>BDC 0.372 0.376 0.369 rg -0.0273 Tc 9 0 0 9 347.05 509.53 Tm (pa)Tj 0.235 0.239 0.231 rg 0 Tc 0.957 0 Td (t)Tj 0.372 0.376 0.369 rg -0.035 Tc 8.3008 0 0 9 357.58 509.53 Tm (tern )Tj EMC ET BT /T1_0 1 Tf -0.0128 Tc 7.7 0 0 7.7 372.9 509.53 Tm (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 8.0796 0 0 9 382.09 509.53 Tm (pea)Tj 0.235 0.239 0.231 rg 0 Tc 9 0 0 9 393.1 509.53 Tm (k )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf 0.05 Tc 7.9178 0 0 7.7 400.31 509.53 Tm (now )Tj 0.001 Tc 7.7 0 0 7.7 418.07 509.53 Tm (without )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 7.6897 0 0 8.3 444.88 509.53 Tm (a.nti-rcOu.x )Tj EMC ET BT /T1_0 1 Tf -0.0211 Tc 8.3 0 0 8.3 482.38 509.53 Tm (therapy; )Tj 0.0121 Tc 7.7 0 0 7.7 511.67 509.53 Tm (with )Tj 0.372 0.376 0.369 rg 0.0019 Tc -27.99 -1.184 Td (rani)Tj 0.235 0.239 0.231 rg -0.035 Tc 7.4325 0 0 7.7 308.62 500.41 Tm (ti)Tj 0.372 0.376 0.369 rg 0.0115 Tc 7.7 0 0 7.7 312.89 500.41 Tm (dine )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0415 Tc 7.7 0 0 7.7 328.7212 500.41 Tm (750 )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf 0.0365 Tc 7.7 0 0 7.7 343.1895 500.41 Tm (mg )Tj 0.0329 Tc 1.613 0 Td (daily )Tj 0.0009 Tc 2.43 0 Td (and )Tj 0.0222 Tc 1.809 0 Td (dompcridone )Tj ET BT /Suspect <>BDC 0.372 0.376 0.369 rg /T1_0 1 Tf 0.05 Tc 7.9139 0 0 7.7 432.91 500.41 Tm (20 )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf 0.0365 Tc 7.7 0 0 7.7 443.51 500.41 Tm (mg )Tj /T1_2 1 Tf 0 Tc 7.6 0 0 7.6 456.43 500.41 Tm (q)Tj 0.577 0.58 0.565 rg 0.629 0 Td (.)Tj 0.31 0.31 0.306 rg 0.05 Tc 7.694 0 0 7.6 462.64 500.41 Tm (l.d)Tj 0.482 0.482 0.471 rg 0 Tc 7.6 0 0 7.6 471.29 500.41 Tm (.)Tj 0.372 0.376 0.369 rg 0.257 0 Td (; )Tj 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0087 Tc 7.7 0 0 7.7 480.47 500.41 Tm (with )Tj ET BT /Suspect <>BDC 0.372 0.376 0.369 rg /T1_0 1 Tf 0.0156 Tc 7.7 0 0 7.7 499.1271 500.41 Tm (omepnl)Tj 0.577 0.58 0.565 rg 0 Tc 3.105 0 Td (\267 )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf -0.035 Tc 7.6425 0 0 7.7 295.42 491.76 Tm (1.ole )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 0 Tc 7.7 0 0 7.7 311.97 491.76 Tm (4)Tj 0.372 0.376 0.369 rg 0.555 0 Td (0 )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 7.983 0 0 8.3 323.03 491.76 Tm (rng )Tj 0.31 0.31 0.306 rg -0.0087 Tc 8.3 0 0 8.3 335.92 491.76 Tm (da)Tj 0.639 0.643 0.631 rg 0 Tc 0.914 0 Td (.)Tj 0.31 0.31 0.306 rg -0.035 Tc 8.116 0 0 8.3 344.09 491.76 Tm (ily. )Tj ET BT /Suspect <>BDC 0.372 0.376 0.369 rg /T1_0 1 Tf 7.207 0 0 7.7 357.63 491.76 Tm (N'o )Tj EMC /Suspect <>BDC 0.31 0.31 0.306 rg -0.0182 Tc 8.3 0 0 8.3 370 491.76 Tm (change )Tj EMC ET BT /T1_0 1 Tf -0.009 Tc 8.3 0 0 8.3 395.9292 491.76 Tm (in )Tj -0.0102 Tc 1.108 0 Td (bronchospasmolytic )Tj -0.017 Tc 8.208 0 Td (medication)Tj 0.577 0.58 0.565 rg 0 Tc 4.382 0 Td (, )Tj ET BT /Suspect <>BDC 0.482 0.482 0.471 rg /T1_0 1 Tf 9.5 0 0 9.5 514.94 491.76 Tm (0 )Tj EMC ET BT /T1_0 1 Tf 9.5 0 0 9.5 523.4425 491.76 Tm (: )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 8.3 0 0 8.3 296.15 482.65 Tm (r)Tj 0.372 0.376 0.369 rg -0.0093 Tc 0.222 0 Td (egis)Tj 0.235 0.239 0.231 rg -0.0142 Tc 1.622 0 Td (lrat)Tj 0.372 0.376 0.369 rg -0.009 Tc 1.272 0 Td (io)Tj 0.235 0.239 0.231 rg 0 Tc 0.759 0 Td (n )Tj EMC /Suspect <>BDC 0.372 0.376 0.369 rg -0.035 Tc 7.9356 0 0 8.3 335.46 482.65 Tm (in )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0016 Tc 8.3 0 0 8.3 344.62 482.65 Tm (the )Tj -0.0271 Tc 1.561 0 Td (morning; )Tj ET BT /Suspect <>BDC 0.082 0.082 0.074 rg /T1_0 1 Tf 0 Tc 12.8 0 0 12.8 391.06 482.65 Tm (e )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 12.8 0 0 12.8 399.9944 482.65 Tm (: )Tj 0.31 0.31 0.306 rg -0.009 Tc 8.3 0 0 8.3 405.05 482.65 Tm (in )Tj 0.235 0.239 0.231 rg -0.035 Tc 7.7875 0 0 8.3 414.7 482.65 Tm (th)Tj 0.372 0.376 0.369 rg 0 Tc 8.3 0 0 8.3 420.87 482.65 Tm (e )Tj 0.235 0.239 0.231 rg -0.0005 Tc 0.753 0 Td (aft)Tj 0.372 0.376 0.369 rg -0.0002 Tc 1.04 0 Td (ernoo)Tj 0.235 0.239 0.231 rg -0.035 Tc 7.7975 0 0 8.3 454.55 482.65 Tm (n; )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 5.95 0 0 7.7 464.04 482.65 Tm (.0.)Tj 0.482 0.482 0.471 rg 0 Tc 7.7 0 0 7.7 469.73 482.65 Tm (: )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 7.9356 0 0 8.3 474.66 482.65 Tm (in )Tj 7.7875 0 0 8.3 484.3 482.65 Tm (th)Tj 0.372 0.376 0.369 rg 0 Tc 8.3 0 0 8.3 490.47 482.65 Tm [(e )-58(e)]TJ 0.235 0.239 0.231 rg 1.223 0 Td (v)Tj 0.372 0.376 0.369 rg 0.454 0 Td (e)Tj 0.235 0.239 0.231 rg -0.0322 Tc 0.472 0 Td (ning)Tj 0.372 0.376 0.369 rg 0 Tc 1.716 0 Td (. )Tj 0.31 0.31 0.306 rg -0.0253 Tc 10.6 0 0 10.6 304.61 458.16 Tm (Subsequently )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 10.4277 0 0 10.6 362.77 458.16 Tm (anti)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 378.12 458.16 Tm (-)Tj 0.235 0.239 0.231 rg 0.326 0 Td (r)Tj 0.372 0.376 0.369 rg 0.308 0 Td (e)Tj 0.235 0.239 0.231 rg -0.035 Tc 9.7626 0 0 10.6 389.65 458.16 Tm (flux )Tj EMC ET BT /T1_0 1 Tf 9.7344 0 0 10.6 410.38 458.16 Tm (th)Tj 0.372 0.376 0.369 rg -0.0291 Tc 10.6 0 0 10.6 417.97 458.16 Tm (erapy )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.032 Tc 10.6 0 0 10.6 445.424 458.16 Tm (with )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.0227 Tc 10.6 0 0 10.6 468.4684 458.16 Tm (ranitidine )Tj -0.035 Tc 9.8683 0 0 10.6 511.58 458.16 Tm (and )Tj 0.31 0.31 0.306 rg -0.0283 Tc 10.6 0 0 10.6 295.58 447.12 Tm (domperidone )Tj -0.035 Tc 10.0572 0 0 10.6 355.19 447.12 Tm (was )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 10.3686 0 0 10.6 376.79 447.12 Tm (re)Tj 0.372 0.376 0.369 rg -0.0194 Tc 10.6 0 0 10.6 384.33 447.12 Tm (star)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.5677 0 0 10.6 398.85 447.12 Tm (ted. )Tj EMC ET BT /T1_0 1 Tf -0.0211 Tc 10.6 0 0 10.6 419.91 447.12 Tm (The )Tj 0 Tc 2.138 0 Td (b)Tj 0.372 0.376 0.369 rg 0.442 0 Td (e)Tj 0.235 0.239 0.231 rg 0.417 0 Td (n)Tj 0.372 0.376 0.369 rg 0.489 0 Td (e)Tj 0.235 0.239 0.231 rg -0.035 Tc 8.886 0 0 10.6 461.66 447.12 Tm (fi)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 467.42 447.12 Tm (c)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.0127 0 0 10.6 472.24 447.12 Tm (ial )Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 488.53 447.12 Tm (e)Tj 0.235 0.239 0.231 rg -0.0319 Tc 0.452 0 Td (ffect )Tj 0.0025 Tc 2.311 0 Td (of )Tj 0.31 0.31 0.306 rg -0.0273 Tc -20.966 -0.996 Td (omcprazole )Tj -0.035 Tc 10.3816 0 0 10.6 346.55 436.56 Tm (was )Tj 0.235 0.239 0.231 rg -0.0327 Tc 10.6 0 0 10.6 365.74 436.56 Tm (maintain)Tj 0.372 0.376 0.369 rg 0 Tc 3.297 0 Td (e)Tj 0.235 0.239 0.231 rg 0.454 0 Td [(d )-108(f)]TJ 0.372 0.376 0.369 rg 1.132 0 Td (o)Tj 0.235 0.239 0.231 rg 0.506 0 Td (r )Tj 0.31 0.31 0.306 rg -0.035 Tc 10.147 0 0 10.6 430.02 436.56 Tm (24 )Tj 0.235 0.239 0.231 rg 0 Tc 10.6 0 0 10.6 444.46 436.56 Tm (h )Tj 0.31 0.31 0.306 rg -0.0119 Tc 0.808 0 Td (only )Tj 0.372 0.376 0.369 rg -0.0336 Tc 2.125 0 Td (\(fig. )Tj 0.31 0.31 0.306 rg -0.0339 Tc 1.954 0 Td (2\). )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 10.5133 0 0 10.6 511.15 436.56 Tm (Re\255)Tj EMC /Suspect <>BDC 0 Tc 10.6 0 0 10.6 295.7 426 Tm (p)Tj 0.372 0.376 0.369 rg -0.0234 Tc 0.441 0 Td (eated )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 324.9454 426 Tm (m)Tj 0.372 0.376 0.369 rg -0.035 Tc 10.5295 0 0 10.6 332.53 426 Tm (eas)Tj 0.235 0.239 0.231 rg 10.1058 0 0 10.6 345.6 426 Tm (urem)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 365.65 426 Tm (e)Tj 0.235 0.239 0.231 rg -0.0039 Tc 0.417 0 Td (nt )Tj 0.31 0.31 0.306 rg 0.05 Tc 11.1292 0 0 10.6 381.01 426 Tm (of )Tj 0.235 0.239 0.231 rg -0.0326 Tc 10.6 0 0 10.6 392.18 426 Tm (pulm)Tj 0.372 0.376 0.369 rg 0 Tc 1.981 0 Td (o)Tj 0.235 0.239 0.231 rg -0.0324 Tc 0.507 0 Td (nary )Tj -0.035 Tc 10.1077 0 0 10.6 439.57 426 Tm (fun)Tj 0.372 0.376 0.369 rg 0.0246 Tc 10.6 0 0 10.6 453.02 426 Tm (ct)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.0769 0 0 10.6 460.72 426 Tm (ion )Tj 0.31 0.31 0.306 rg 10.2207 0 0 10.6 476.54 426 Tm (and )Tj -0.0189 Tc 10.6 0 0 10.6 493.86 426 Tm (24-hour )Tj -0.0276 Tc -18.694 -1.041 Td (pH-recording )Tj -0.035 Tc 9.9195 0 0 10.6 352.24 414.97 Tm (in )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 9.7344 0 0 10.6 362.38 414.97 Tm (th)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 369.49 414.97 Tm (e )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0229 Tc 10.6 0 0 10.6 376.698 414.97 Tm (oesophagus )Tj 0.372 0.376 0.369 rg 0 Tc 4.659 0 Td (s)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.1936 0 0 10.6 430.55 414.97 Tm (how)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 447.25 414.97 Tm (e)Tj 0.235 0.239 0.231 rg 0.454 0 Td (d )Tj -0.035 Tc 10.4562 0 0 10.6 460.29 414.97 Tm (the )Tj 0.372 0.376 0.369 rg 10.4905 0 0 10.6 475.05 414.97 Tm (same )Tj 0.235 0.239 0.231 rg 9.1679 0 0 10.6 498.25 414.97 Tm (pi)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 505.34 414.97 Tm (c)Tj 0.235 0.239 0.231 rg -0.0339 Tc 0.505 0 Td (ture )Tj 0.31 0.31 0.306 rg -0.035 Tc 10.3825 0 0 10.6 295.57 403.93 Tm (as )Tj 0.235 0.239 0.231 rg 0 Tc 10.6 0 0 10.6 307.69 403.93 Tm (b)Tj 0.372 0.376 0.369 rg -0.0168 Tc 0.442 0 Td (efo)Tj 0.235 0.239 0.231 rg 0 Tc 1.231 0 Td (r)Tj 0.372 0.376 0.369 rg 0.308 0 Td [(e )-74(\()]TJ 0.235 0.239 0.231 rg -0.035 Tc 10.3624 0 0 10.6 340.29 403.93 Tm (tabl)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 355.09 403.93 Tm (e )Tj 0.235 0.239 0.231 rg 0.881 0 Td (1)Tj 0.372 0.376 0.369 rg -0.035 Tc 9.9793 0 0 10.6 368.58 403.93 Tm (\). )Tj 0.235 0.239 0.231 rg 9.976 0 0 10.6 304.23 392.89 Tm (Th)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 315.25 392.89 Tm (e )Tj 0.31 0.31 0.306 rg -0.035 Tc 10.4256 0 0 10.6 324.5 392.89 Tm (patien)Tj 0.149 0.149 0.141 rg 0 Tc 10.6 0 0 10.6 348.93 392.89 Tm (t )Tj 0.235 0.239 0.231 rg 0.635 0 Td (w)Tj 0.372 0.376 0.369 rg -0.035 Tc 9.7717 0 0 10.6 362.78 392.89 Tm (as )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 10.4177 0 0 10.6 375.33 392.89 Tm (then )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 396.39 392.89 Tm (g)Tj 0.235 0.239 0.231 rg 0.543 0 Td (i)Tj 0.372 0.376 0.369 rg -0.035 Tc 10.1053 0 0 10.6 404.62 392.89 Tm (ve)Tj 0.235 0.239 0.231 rg 0 Tc 10.6 0 0 10.6 414.23 392.89 Tm (n )Tj -0.035 Tc 9.8232 0 0 10.6 423.27 392.89 Tm (om)Tj 0.372 0.376 0.369 rg -0.0176 Tc 10.6 0 0 10.6 435.73 392.89 Tm (ep)Tj 0.235 0.239 0.231 rg 0 Tc 0.914 0 Td (r)Tj 0.372 0.376 0.369 rg -0.035 Tc 9.1583 0 0 10.6 448.71 392.89 Tm (a.zo)Tj 0.235 0.239 0.231 rg 0 Tc 10.6 0 0 10.6 463.59 392.89 Tm (l)Tj 0.372 0.376 0.369 rg 0.225 0 Td (e )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.6 0 0 10.6 474.19 392.89 Tm (2)Tj 0.235 0.239 0.231 rg 0.493 0 Td (0 )Tj EMC ET BT /T1_0 1 Tf 10.6 0 0 10.6 488.6272 392.89 Tm (m)Tj 0.372 0.376 0.369 rg 0.718 0 Td (g )Tj 0.235 0.239 0.231 rg -0.0215 Tc 0.859 0 Td (daily )Tj -0.035 Tc 10.33 0 0 10.6 295.57 381.84 Tm (for )Tj 0.31 0.31 0.306 rg 0 Tc 10.6 0 0 10.6 309.96 381.84 Tm (3 )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.3588 0 0 10.6 317.74 381.84 Tm (month)Tj 0.372 0.376 0.369 rg 9.9525 0 0 10.6 343.06 381.84 Tm (s. )Tj 0.235 0.239 0.231 rg -0.0211 Tc 10.6 0 0 10.6 351.75 381.84 Tm (The )Tj 0.372 0.376 0.369 rg -0.0183 Tc 1.764 0 Td (effec)Tj 0.235 0.239 0.231 rg 0 Tc 1.955 0 Td (t )Tj 0.372 0.376 0.369 rg 0.492 0 Td (o)Tj 0.235 0.239 0.231 rg 0.496 0 Td (f )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.035 Tc 10.3645 0 0 10.6 407.42 381.84 Tm (omepra.zole )Tj EMC ET BT /T1_0 1 Tf 10.3816 0 0 10.6 457.43 381.84 Tm (was )Tj 0.235 0.239 0.231 rg -0.029 Tc 10.6 0 0 10.6 479.02 381.84 Tm (maintained, )Tj 0.372 0.376 0.369 rg -0.0059 Tc -17.352 -0.996 Td (as )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 307.565 371.2824 Tm (a)Tj 0.372 0.376 0.369 rg -0.0333 Tc 0.449 0 Td (ssessed )Tj EMC /Suspect <>BDC 0.235 0.239 0.231 rg -0.035 Tc 10.5506 0 0 10.6 345.61 371.28 Tm (by )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0328 Tc 10.6 0 0 10.6 359.9 371.28 Tm (daily )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf -0.035 Tc 10.2935 0 0 10.6 384.5 371.28 Tm (peak )Tj EMC ET BT /T1_0 1 Tf 9.5616 0 0 10.6 407.96 371.28 Tm (Dow )Tj -0.0327 Tc 10.6 0 0 10.6 430.54 371.28 Tm (measur)Tj 0.372 0.376 0.369 rg 0 Tc 2.708 0 Td (e)Tj 0.235 0.239 0.231 rg 0.461 0 Td (m)Tj 0.372 0.376 0.369 rg 0.716 0 Td (e)Tj 0.235 0.239 0.231 rg -0.035 Tc 9.7469 0 0 10.6 476.63 371.28 Tm (nt)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 484.17 371.28 Tm (s )Tj 0.31 0.31 0.306 rg -0.0297 Tc 0.728 0 Td (at )Tj 0.235 0.239 0.231 rg 0 Tc 1.141 0 Td (h)Tj 0.372 0.376 0.369 rg 0.4 0 Td (o)Tj 0.235 0.239 0.231 rg 0.551 0 Td (m)Tj 0.372 0.376 0.369 rg 0.671 0 Td (e )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.6 0 0 10.6 295.5536 360.2454 Tm (\()Tj 0.235 0.239 0.231 rg -0.035 Tc 10.5359 0 0 10.6 298.46 360.25 Tm (data )Tj EMC /Suspect <>BDC -0.0255 Tc 10.6 0 0 10.6 317.75 360.25 Tm (not )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 0 Tc 10.6 0 0 10.6 332.4946 360.25 Tm (s)Tj 0.235 0.239 0.231 rg -0.035 Tc 9.9886 0 0 10.6 336.95 360.25 Tm (ho)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 346.54 360.25 Tm (w)Tj 0.235 0.239 0.231 rg 0.635 0 Td (n)Tj 0.372 0.376 0.369 rg 0.447 0 Td (\) )Tj 0.235 0.239 0.231 rg -0.035 Tc 10.2207 0 0 10.6 364.22 360.25 Tm (and )Tj 0.31 0.31 0.306 rg -0.0299 Tc 10.6 0 0 10.6 381.02 360.25 Tm (oesophageal )Tj 0.235 0.239 0.231 rg -0.035 Tc 9.7794 0 0 10.6 432.98 360.25 Tm (pH )Tj 0 Tc 10.6 0 0 10.6 447.82 360.25 Tm (m)Tj 0.372 0.376 0.369 rg -0.035 Tc 10.5295 0 0 10.6 455.41 360.25 Tm (eas)Tj 0.235 0.239 0.231 rg 10.2333 0 0 10.6 468.48 360.25 Tm (ur)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 476.53 360.25 Tm (e)Tj 0.235 0.239 0.231 rg 0.461 0 Td (m)Tj 0.372 0.376 0.369 rg 0.671 0 Td (e)Tj 0.235 0.239 0.231 rg -0.035 Tc 9.7469 0 0 10.6 493.43 360.25 Tm (nt )Tj 0.31 0.31 0.306 rg -0.0342 Tc 10.6 0 0 10.6 503.39 360.25 Tm (\(table )Tj -0.035 Tc 10.1955 0 0 10.6 295.81 349.69 Tm (1\). )Tj 0.235 0.239 0.231 rg 0 Tc 10.6 0 0 10.6 310.61 349.69 Tm (N)Tj 0.372 0.376 0.369 rg 0.665 0 Td [(o )-106(s)]TJ 0.235 0.239 0.231 rg -0.035 Tc 9.9195 0 0 10.6 331.12 349.69 Tm (id)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 338.29 349.69 Tm (e )Tj 0.0136 Tc 0.815 0 Td (ef)Tj 0.235 0.239 0.231 rg 0 Tc 0.769 0 Td (f)Tj 0.372 0.376 0.369 rg -0.035 Tc 10.3941 0 0 10.6 357.97 349.69 Tm (ec)Tj 0.235 0.239 0.231 rg 9.9261 0 0 10.6 367.18 349.69 Tm (ts )Tj 0.31 0.31 0.306 rg 0.0478 Tc 10.6 0 0 10.6 377.66 349.69 Tm (or )Tj 0.372 0.376 0.369 rg 0 Tc 1.177 0 Td (o)Tj 0.235 0.239 0.231 rg 0.551 0 Td (m)Tj 0.372 0.376 0.369 rg 0.672 0 Td (c)Tj 0.235 0.239 0.231 rg 0.0364 Tc 0.419 0 Td (pr)Tj 0.372 0.376 0.369 rg -0.0309 Tc 0.803 0 Td (azo)Tj 0.235 0.239 0.231 rg 0 Tc 1.406 0 Td (l)Tj 0.372 0.376 0.369 rg 0.179 0 Td (e )Tj 0.31 0.31 0.306 rg -0.0266 Tc 0.869 0 Td (were )Tj 0.235 0.239 0.231 rg 0 Tc 2.265 0 Td (n)Tj 0.372 0.376 0.369 rg 0.444 0 Td (o)Tj 0.235 0.239 0.231 rg -0.0316 Tc 0.505 0 Td (ticed )Tj 0.31 0.31 0.306 rg -0.0101 Tc 2.166 0 Td (except )Tj -0.035 Tc 10.33 0 0 10.6 295.57 338.65 Tm (for )Tj 0 Tc 10.6 0 0 10.6 309.01 338.65 Tm (a )Tj 0.372 0.376 0.369 rg 0.63 0 Td (s)Tj 0.235 0.239 0.231 rg -0.035 Tc 8.5757 0 0 10.6 320.09 338.65 Tm (li)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 324.87 338.65 Tm (g)Tj 0.235 0.239 0.231 rg -0.035 Tc 10.4051 0 0 10.6 329.75 338.65 Tm (ht )Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 339.25 338.65 Tm (e)Tj 0.235 0.239 0.231 rg 0.455 0 Td (l)Tj 0.372 0.376 0.369 rg -0.035 Tc 10.3684 0 0 10.6 346.45 338.65 Tm (eva)Tj 0.235 0.239 0.231 rg 9.9541 0 0 10.6 360.46 338.65 Tm (tion )Tj 0.31 0.31 0.306 rg -0.0092 Tc 10.6 0 0 10.6 377.66 338.65 Tm (ofplasma )Tj ET BT /Suspect <>BDC 0.372 0.376 0.369 rg /T1_0 1 Tf -0.035 Tc 10.3905 0 0 10.6 418.47 338.65 Tm (gas)Tj 0.235 0.239 0.231 rg 10.5029 0 0 10.6 431.49 338.65 Tm (trin )Tj EMC ET BT /T1_0 1 Tf 9.7344 0 0 10.6 447.82 338.65 Tm (to )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.016 Tc 10.6 0 0 10.6 456.9 338.65 Tm (220 )Tj EMC /Suspect <>BDC 0.235 0.239 0.231 rg -0.0218 Tc 1.68 0 Td (U\267/')Tj 0.372 0.376 0.369 rg 0 Tc 6.2 0 0 6.2 489.39 342.49 Tm (1 )Tj EMC ET BT /T1_0 1 Tf 10.6 0 0 10.6 494.75 338.65 Tm (\()Tj 0.235 0.239 0.231 rg -0.035 Tc 10.1369 0 0 10.6 498.23 338.65 Tm (normal )Tj 10.1399 0 0 10.6 295.66 328.09 Tm (valu)Tj 0.372 0.376 0.369 rg 0 Tc 10.6 0 0 10.6 312.37 328.09 Tm (e )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0347 Tc 10.6 0 0 10.6 320.108 328.09 Tm (<150 )Tj EMC /Suspect <>BDC 0.31 0.31 0.306 rg -0.0218 Tc 2.268 0 Td (U\267/')Tj 0 Tc 6.9001 0 0 6.9001 359.76 331.44 Tm (1)Tj 0.05 Tc 9.3796 0 0 6.9001 362.34 328.09 Tm (\). )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_1 1 Tf -0.0019 Tc 9.1 0 0 9.1 43.14 300.72 Tm (Table )Tj -0.035 Tc 8.1087 0 0 9.1 70.78 300.72 Tm (1. )Tj 0 Tc 9.1 0 0 9.1 81.52 300.72 Tm (-)Tj 0.149 0.149 0.141 rg 0.003 Tc 1.041 0 Td (Results )Tj 0.235 0.239 0.231 rg -0.0207 Tc 3.811 0 Td (of )Tj 0.05 Tc 9.2846 0 0 9.1 137.2 300.72 Tm (24 )Tj -0.0029 Tc 9.1 0 0 9.1 151.99 300.72 Tm (hour )Tj -0.0063 Tc 2.426 0 Td (pH-recordings )Tj -0.035 Tc 8.8795 0 0 9.1 235.03 300.72 Tm (in )Tj -0.0051 Tc 9.1 0 0 9.1 245.72 300.72 Tm (the )Tj -0.0066 Tc 1.893 0 Td (distal )Tj -0.0052 Tc 2.743 0 Td (oesophagus )Tj -0.0311 Tc 5.908 0 Td (and )Tj -0.0059 Tc 2.101 0 Td (pulmonary )Tj 0.149 0.149 0.141 rg 0.0038 Tc 5.027 0 Td (function )Tj 0.235 0.239 0.231 rg 0.0018 Tc 4.007 0 Td (tests )Tj -0.0093 Tc 2.623 0 Td (under )Tj -0.0018 Tc 2.916 0 Td (variable )Tj -0.0032 Tc -49.478 -1.055 Td (therapeutic )Tj -0.0126 Tc 5.366 0 Td (regimens )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 0.0189 Tc 9 0 0 9 155.56 272.41 Tm (Normal)Tj 0.149 0.149 0.141 rg -0.0159 Tc 3.177 0 Td ("' )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf 0.0046 Tc 9 0 0 9 218.443 271.933 Tm (No )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0003 Tc 9 0 0 9 266.845 272.41 Tm (Ranitidine)Tj 0.372 0.376 0.369 rg 0 Tc 4.149 0 Td (\225 )Tj EMC /Suspect <>BDC 0.235 0.239 0.231 rg 0.0007 Tc 3.099 -0.053 Td (Omeprazole** )Tj EMC ET BT /T1_0 1 Tf 0.0062 Tc 9 0 0 9 406.525 272.41 Tm (Ranitidine)Tj 0.372 0.376 0.369 rg 0 Tc 4.149 0 Td (\225 )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf -0.0055 Tc 9 0 0 9 466.474 271.933 Tm (Omeprazole*** )Tj EMC ET BT /T1_0 1 Tf -0.008 Tc 9 0 0 9 156.46 262.816 Tm (values )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 5.2 0 0 5.2 181.42 265.69 Tm (4 )Tj EMC ET BT /T1_0 1 Tf -0.0101 Tc 9 0 0 9 210.7 262.81 Tm (therapy )Tj -0.0005 Tc 5.491 0 Td (Domperidone* )Tj 0.0061 Tc 7.519 0 Td (2nd )Tj 0.0297 Tc 2.077 0 Td (day )Tj 0.0186 Tc 2.078 0 Td (3rd )Tj -0.0005 Tc 3.9 0 Td (Domperidone* )Tj 0.0194 Tc -39.73 -2.08 Td (number )Tj 0.05 Tc 9.4598 0 0 9 73.83 244.09 Tm (of )Tj 0.0135 Tc 9 0 0 9 42.71 234.97 Tm (reflux )Tj 0.0065 Tc 2.763 0 Td (episodes )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.0023 Tc 9 0 0 9 160.754 234.493 Tm (<50 )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.0151 Tc 9 0 0 9 219.254 234.493 Tm (96 )Tj -0.0247 Tc 6.993 0.053 Td (43 )Tj -0.0219 Tc 5.943 -0.053 Td (12 )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 0.05 Tc 9.0021 0 0 9 368.06 234.49 Tm (30 )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf 0.0379 Tc 9 0 0 9 424.7 234.97 Tm (76 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0475 Tc 9 0 0 9 485.639 234.493 Tm (50 )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf 0.0087 Tc 9 0 0 9 42.713 215.764 Tm (number )Tj 0.0407 Tc 3.458 0 Td (of )Tj 0.235 0.239 0.231 rg 0.0135 Tc -3.511 -1.012 Td (reflux )Tj 0.0065 Tc 2.817 0 Td (episodes )Tj 0.0154 Tc 3.793 0 Td (>5 )Tj -0.0014 Tc 1.496 0 Td (min )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /C0_0 1 Tf 0 Tc 4.5601 0 0 6.72 160.33 206.16 Tm <007E00330020>Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf -0.0219 Tc 9 0 0 9 219.53 206.16 Tm (16 )Tj 0.0314 Tc 6.987 0 Td (16 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 9 0 0 9 338.312 206.16 Tm (0 )Tj EMC ET BT /T1_0 1 Tf 9 0 0 9 372.431 206.16 Tm (2 )Tj -0.035 Tc 8.5945 0 0 9 425.46 206.16 Tm (13 )Tj 0.0104 Tc 9 0 0 9 42.64 187.93 Tm (longest )Tj 0.0013 Tc 3.251 0 Td (episode )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_1 1 Tf 0.05 Tc 9.185 0 0 8.8 102.54 187.93 Tm (min )Tj EMC /Suspect <>BDC 0.235 0.239 0.231 rg /C0_0 1 Tf 0 Tc 4.8 0 0 6.72 160.33 187.44 Tm <007E00390020>Tj EMC ET BT /T1_0 1 Tf -0.0049 Tc 9 0 0 9 219.2 187.44 Tm (89 )Tj 0.0379 Tc 6.992 0 Td (62 )Tj 0 Tc 6.248 0 Td [(4 )-3030(9 )]TJ -0.0049 Tc 9.587 0 Td (86 )Tj 0.372 0.376 0.369 rg 0 Tc 9.1 0 0 9.1 488.96 186.97 Tm (8 )Tj 0.31 0.31 0.306 rg 0.05 Tc 9.6473 0 0 9 42.62 169.21 Tm (%time )Tj 0.235 0.239 0.231 rg 9.574 0 0 9 72.49 169.21 Tm (pH<4% )Tj -0.035 Tc 8.9737 0 0 9 160.28 168.73 Tm (<4 )Tj -0.0211 Tc 9 0 0 9 218.83 168.73 Tm (27 )Tj 0.31 0.31 0.306 rg -0.0219 Tc 7.064 0 Td (19 )Tj 0.235 0.239 0.231 rg -0.035 Tc 8.5014 0 0 9 334.04 168.73 Tm (<1 )Tj 0 Tc 9 0 0 9 372.43 168.73 Tm (2 )Tj -0.0219 Tc 5.838 0 Td (18 )Tj 0 Tc 6.963 0 Td (4 )Tj 0.05 Tc 9.0825 0 0 9 42.24 159.61 Tm (upright% )Tj -0.035 Tc 8.9737 0 0 9 160.28 159.13 Tm (<6 )Tj -0.0211 Tc 9 0 0 9 218.83 159.13 Tm (28 )Tj 0.0322 Tc 6.987 0 Td (26 )Tj -0.035 Tc 8.5014 0 0 9 334.04 159.13 Tm (<1 )Tj 0 Tc 9 0 0 9 372.38 159.13 Tm (3 )Tj 0.0322 Tc 5.766 0.053 Td (27 )Tj -0.0058 Tc 6.606 -0.053 Td (56 )Tj 0.05 Tc 9.1694 0 0 9 42.11 150.01 Tm (supine% )Tj -0.0138 Tc 9 0 0 9 160.28 149.52 Tm (<1.2 )Tj -0.0211 Tc 6.506 0 Td (27 )Tj -0.035 Tc 8.0574 0 0 9 282.44 149.52 Tm (11 )Tj 0 Tc 9 0 0 9 338.3 149.52 Tm (3 )Tj 0.05 Tc 9.2906 0 0 9 368.11 149.52 Tm (>BDC /T1_0 1 Tf 0 Tc 9 0 0 9 287.48 130.8 Tm (4)Tj 0.082 0.082 0.074 rg 0.517 0 Td (.)Tj 0.235 0.239 0.231 rg -0.0184 Tc 0.224 0 Td (08 )Tj EMC /Suspect <>BDC 0.0084 Tc 6.139 0.054 Td (4.04 )Tj EMC ET BT /T1_0 1 Tf 0.0156 Tc 9 0 0 9 429.977 131.286 Tm (3.78 )Tj 6.24 -0.054 Td (3.88 )Tj -0.035 Tc 8.9128 0 0 9 42.7 121.2 Tm (VC )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 64.72 121.2 Tm (J )Tj /T1_0 1 Tf 0.0084 Tc 9 0 0 9 164.12 121.2 Tm (4.43 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0228 Tc 9 0 0 9 206.843 121.2 Tm (4.10-4.02 )Tj EMC ET BT /T1_0 1 Tf -0.0093 Tc 9 0 0 9 287.006 121.2 Tm (4.51 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0262 Tc 9 0 0 9 349.403 121.2 Tm (4.70 )Tj EMC ET BT /T1_0 1 Tf 0.0084 Tc 9 0 0 9 430.043 121.2 Tm [(4.63 )-4198(4.66 )]TJ -0.0021 Tc -43.093 -1.12 Td (FEV)Tj /T1_1 1 Tf 0 Tc 5.5001 0 0 5.5001 59.35 107.76 Tm (1)Tj /T1_0 1 Tf 0.05 Tc 10.3474 0 0 9 61.97 111.12 Tm (NC )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0072 Tc 9 0 0 9 164.55 111.12 Tm (0.79 )Tj EMC /Suspect <>BDC 0.0424 Tc 4.693 0 Td (0.70-0)Tj 0.372 0.376 0.369 rg 0 Tc 2.816 0 Td (.)Tj 0.235 0.239 0.231 rg -0.0151 Tc 0.223 0 Td (92 )Tj EMC /Suspect <>BDC 0.0105 Tc 5.921 0 Td (0.90 )Tj EMC /Suspect <>BDC 6.88 0 Td (0.86 )Tj EMC /Suspect <>BDC 9.013 0 Td (0.82 )Tj EMC /Suspect <>BDC -0.0072 Tc 6.08 0 Td (0.83 )Tj EMC /Suspect <>BDC 0.372 0.376 0.369 rg 0 Tc 4.8001 0 0 4.8001 41.74 94.8 Tm (4)Tj 0.879 -0.598 Td (: )Tj EMC /Suspect <>BDC 0.31 0.31 0.306 rg 0.0216 Tc 9 0 0 9 50.87 91.93 Tm (noons! )Tj EMC ET BT 0.235 0.239 0.231 rg /T1_0 1 Tf 0 Tc 9 0 0 9 79.661 91.93 Tm (v)Tj 0.372 0.376 0.369 rg -0.0036 Tc 0.526 0 Td (alues )Tj 0.31 0.31 0.306 rg -0.0326 Tc 2.452 0 Td (for )Tj 0.372 0.376 0.369 rg -0.0211 Tc 1.446 0 Td (24 )Tj 0.31 0.31 0.306 rg 0.0125 Tc 1.391 0 Td (hour )Tj 0.372 0.376 0.369 rg 0 Tc 2.189 0 Td (p)Tj 0.235 0.239 0.231 rg 0.528 0 Td (H)Tj 0.482 0.482 0.471 rg 0.687 0 Td (-)Tj 0.31 0.31 0.306 rg 0.0014 Tc 0.33 0 Td (recording )Tj 0.372 0.376 0.369 rg -0.0043 Tc 4.258 0 Td (according )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf -0.028 Tc 9 0 0 9 242.39 91.93 Tm (to )Tj EMC /Suspect <>BDC 0.372 0.376 0.369 rg 0.0045 Tc 1.12 0 Td (the )Tj EMC /Suspect <>BDC 0.0169 Tc 1.539 0 Td (cri)Tj 0.235 0.239 0.231 rg 0 Tc 1.128 0 Td (t)Tj 0.372 0.376 0.369 rg 0.0057 Tc 0.204 0 Td (eria )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.4598 0 0 9 295.11 91.93 Tm (of )Tj ET BT /Suspect <>BDC 0.235 0.239 0.231 rg /T1_0 1 Tf 0 Tc 6.8001 0 0 6.8001 305.72 91.93 Tm (J)Tj 0.372 0.376 0.369 rg 0.0183 Tc 0.49 0 Td (OHNSON )Tj EMC ET BT /T1_0 1 Tf -0.0226 Tc 9 0 0 9 341.67 91.93 Tm (and )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 0.05 Tc 6.9847 0 0 6.8001 358.05 91.93 Tm (DEMEESTBR )Tj EMC ET BT /T1_0 1 Tf -0.007 Tc 9 0 0 9 405.86 91.93 Tm ([9]; )Tj ET BT /Suspect <>BDC 0.577 0.58 0.565 rg /T1_0 1 Tf -0.035 Tc 5.2715 0 0 9 420.85 91.93 Tm (.,.)Tj 0.372 0.376 0.369 rg 0 Tc 9 0 0 9 424.57 91.93 Tm (: )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf 0.022 Tc 9 0 0 9 430.069 91.93 Tm (nonnal )Tj 0.372 0.376 0.369 rg -0.008 Tc 3.252 0 Td (values )Tj -0.0326 Tc 2.871 0 Td (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0004 Tc 9 0 0 9 498.73 91.93 Tm (pulmo\255)Tj EMC /Suspect <>BDC 0.31 0.31 0.306 rg -0.022 Tc -50.722 -1.068 Td (nary )Tj EMC /Suspect <>BDC -0.0213 Tc 2.123 0 Td (function )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 0.0023 Tc 9 0 0 9 93.991 82.318 Tm (according )Tj 0.31 0.31 0.306 rg -0.028 Tc 4.328 0 Td (to )Tj -0.0222 Tc 1.173 0 Td (the )Tj ET BT /Suspect <>BDC 0.372 0.376 0.369 rg /T1_0 1 Tf 0.003 Tc 9 0 0 9 157.351 82.318 Tm (criteria )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.4598 0 0 9 185.67 82.32 Tm (of )Tj 0.31 0.31 0.306 rg -0.0222 Tc 9 0 0 9 196.78 82.32 Tm (the )Tj -0.0042 Tc 1.543 0 Td (European )Tj 0.372 0.376 0.369 rg 0.0008 Tc 4.156 0 Td (Coal )Tj -0.0226 Tc 2.293 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.003 Tc 9 0 0 9 283.999 82.32 Tm (Steel )Tj EMC ET BT /T1_0 1 Tf -0.0007 Tc 9 0 0 9 305.671 82.32 Tm (Community )Tj ET BT /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 0.05 Tc 9.7011 0 0 9 352.25 82.32 Tm (Ill\); )Tj EMC /Suspect <>BDC 0.0123 Tc 9 0 0 9 372.29 82.32 Tm (*: )Tj EMC /Suspect <>BDC 0.0151 Tc 1.14 0 Td (rMitidine )Tj EMC ET BT /T1_0 1 Tf -0.0029 Tc 9 0 0 9 420.458 82.32 Tm (total )Tj 0.372 0.376 0.369 rg 0.0146 Tc 2.127 0 Td (dose )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0356 Tc 9 0 0 9 459.257 82.32 Tm (750 )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.035 Tc 8.9209 0 0 9 476.14 82.32 Tm (mg )Tj -0.0037 Tc 9 0 0 9 490.48 82.32 Tm (daily )Tj 0.372 0.376 0.369 rg -0.0226 Tc 2.346 0 Td (and )Tj 0.0016 Tc -52.212 -1.067 Td (domperidone )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0318 Tc 9 0 0 9 92.122 72.717 Tm (4x20 )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.035 Tc 8.9209 0 0 9 114.22 72.72 Tm (mg )Tj -0.005 Tc 9 0 0 9 128.56 72.72 Tm (daily; )Tj ET BT /Suspect <>BDC 0.372 0.376 0.369 rg /T1_1 1 Tf 0.05 Tc 11.0296 0 0 6.4001 152.86 72.72 Tm (U: )Tj EMC /Suspect <>BDC 0.31 0.31 0.306 rg /T1_0 1 Tf 0.0053 Tc 9 0 0 9 167.91 72.72 Tm (Omcprazole )Tj EMC /Suspect <>BDC 0.372 0.376 0.369 rg 0.0286 Tc 5.232 0 Td (40 )Tj EMC ET BT 0.31 0.31 0.306 rg /T1_0 1 Tf -0.035 Tc 8.9209 0 0 9 227.98 72.72 Tm (mg )Tj -0.0037 Tc 9 0 0 9 242.32 72.72 Tm (daily )Tj 0.372 0.376 0.369 rg -0.035 Tc 8.2233 0 0 9 264.39 72.72 Tm (fo)Tj 0.235 0.239 0.231 rg 0 Tc 9 0 0 9 271.19 72.72 Tm (r )Tj 0.372 0.376 0.369 rg 0.683 0 Td (3 )Tj 0.0017 Tc 0.856 0 Td (days, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0079 Tc 9 0 0 9 307.667 72.72 Tm (results )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.4598 0 0 9 333.99 72.72 Tm (of )Tj 0.0061 Tc 9 0 0 9 344.59 72.72 Tm (2nd )Tj -0.0226 Tc 1.916 0 Td (and )Tj 0 Tc 1.812 0 Td (3)Tj 0.235 0.239 0.231 rg 0.543 0 Td (r)Tj 0.372 0.376 0.369 rg 0.312 0 Td (d )Tj -0.0014 Tc 0.853 0 Td (day; )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0092 Tc 9 0 0 9 412.603 72.72 Tm (***: )Tj EMC /Suspect <>BDC 0.0053 Tc 2.144 0 Td (Omeprazole )Tj EMC /Suspect <>BDC 0.05 Tc 9.3105 0 0 9 478.99 72.72 Tm (20 )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 8.9209 0 0 9 491.98 72.72 Tm (mg )Tj -0.0037 Tc 9 0 0 9 506.32 72.72 Tm (daily )Tj 0.05 Tc 9.424 0 0 9 41.66 63.13 Tm (af)Tj 0.235 0.239 0.231 rg 0.008 Tc 9 0 0 9 48.94 63.13 Tm (ter )Tj 0.372 0.376 0.369 rg 0 Tc 1.378 0 Td (3 )Tj 0.31 0.31 0.306 rg -0.035 Tc 8.4297 0 0 9 69.58 63.13 Tm (montJ1s; )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0288 Tc 9 0 0 9 102.2 63.13 Tm (FEV)Tj /T1_1 1 Tf 0 Tc 5.2 0 0 5.2 119.36 59.76 Tm (1)Tj 0.562 0.648 Td (; )Tj EMC /Suspect <>BDC /T1_0 1 Tf -0.0236 Tc 9 0 0 9 128.54 63.13 Tm (forced )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 0.0061 Tc 9 0 0 9 154.46 63.13 Tm (expira)Tj 0.235 0.239 0.231 rg 0 Tc 2.569 0 Td (t)Tj 0.372 0.376 0.369 rg 0.0104 Tc 0.259 0 Td (ory )Tj 0.31 0.31 0.306 rg 0.0097 Tc 1.714 0 Td (volume )Tj 0.372 0.376 0.369 rg -0.035 Tc 8.5969 0 0 9 226.01 63.13 Tm (in )Tj 0.0354 Tc 9 0 0 9 236.07 63.13 Tm (one )Tj 0.0022 Tc 1.809 0 Td (second; )Tj 0.31 0.31 0.306 rg -0.035 Tc 8.7637 0 0 9 284.14 63.13 Tm (VC: )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0155 Tc 9 0 0 9 302.38 63.13 Tm (vital )Tj EMC ET BT 0.372 0.376 0.369 rg /T1_0 1 Tf 0.0001 Tc 9 0 0 9 321.514 63.13 Tm (capacity)Tj 0.482 0.482 0.471 rg 0 Tc 3.349 0 Td (. )Tj ET endstream endobj 3 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>stream jP ftypjp2 jp2 jpxbjpx rreq@ .-jp2hihdrcolrjp2cOQ)R \#B@HHPHHPHHPHHP((( 9߇Dǽ+8 ou;sN6H`F!0 $%dJB}͎ 62*p $%{EdQ%ټ*fCPҞp@*%V@U|/wL5E` $&*0\!b<& nb}'Rx -w·_.4=W3i:1RSB(_SwCWGZa  7iۤ2coYW[pjR'*4rmhH Ĉ-hg-&ef`tg5Ⱦz J;'^,Qoy6 מՀn{Nۖ>2l~ 1z3+OM;Akk9cNRIq15P醇K~P e Gww^Dx6ru6XhEGb6MlS:ۆ0hbQkҶ(k Ͱ.x.iOGKWԞuYPy(Fo=T7/ GC>D;eA7`M[@Gz#)ADd/ ? ߃?g~QQOHi[p4Lc 2yfȿ >;IJItܛYBwGCh7.hm'͛f?zYUDj8# ߆|x3F$m`u14ZP~j0bI[2=2Ui KM? df qɊoQm:񏄘w#"jﴻi.Z;liIq#u8 X|{ S )OPy-$1DD[rf `?YITXlرbb1W1HzrB n$~E #GV\ԡ8G :ZOzGܧ0{{4z|x=CbY&zp}St%@I >S~l@:]zBG4fz5i8 (7E劸m~p֬,G;1 J!Y&[5wB/$6, ӢIphc*HNu[&n`ٜ -EФٵ7zb`h`tHO_ -;wb1Ĺ?ru8nx[PdJ?<سn2 Z/ olvS*Ï~(nj& HLfrk̜B{'x'BtOp] mingaTTl,~!iZh҆-&c@y`K1뀐 x`![FUBY\вiNJ^ .*z2ˇ.f09-=* {蠼I?9ZDS 4q~8*Yh&t/hd$5W DD^WA@VeT$bd5p-a\&j<z-歶hk4V8-k^,5|NؤxFh 22Z=Q*y!&ߞ=%-\Ҩ < K#7KH( 1ccul^YW[eLd&uSCӲR<,&-6C鰷vVJ 4Y˔aR<:5QtX0(i ȪA}wJ`?IUVLtq=QvIa;RHD_Tu"&(ᗰҥ.6F\L@E/WG?V9+ b BqRoؚ?SA5S#sOQ Z匠O^c€(i] 07ڎ9 f~¨,٬/hl:N3+_26hN[2[l?d[qqK̉CHO /(! s5tM7~w~M'|C?}(> Tcm RsEaKY{ZAy:dR1|MSہHq?y{~:LJU٥&,ty/(m tgkzFJ!MlbFۀ {XKުOdҙefIR ɛʮe*NxnslegcUEw(ޒe'c:n-@ZZTZvK-tjJ](`q(=9rV̺ZKMFo#M+l0VˌYcC 6jdebpyeUΒTb c\KKjQr2Q3?"vpl K|ﲲ;>\E"9~up eO =j܎:MIn$%mzig-CѼ"̯ã '9߇B~2.ҧ>D i deŧՁj+bjfw자۟[GNd](fj=7z9f|G"2O" [9NJUs(^6=qo |={:Q|뗮hۿç_g_zcݣ~=u ízwaZ:3}ʋnGr^&F7oG:^sg҅U)m"NhK>b (Aܵ6Y:: ,qIu@}DI*`J*rUP>O59'MQy9=E.{А<TYꆑtkZ&yDtg kA0s ɏ覕wɾjܨ].~,q3ё=ʨmār!LbKd|m` ܟ$PjcP=PDQF~)UNJVHE5ŧzc+t$]%ȼUxm M:؞5 E%yyX $IqK|분zw O Ȝİח~ VEkzAX#Cs$ż" #.؟x|~6ey5Z3dx3& :;/JH|eϞޑ֋Hv8%]]%nrH Q>/(:'Tb4:| ,< ;jcRrK"o 8ˁ'M(B IlQ≆a*-pk48n1@9T(C :ʠU]|,w:/kyZbA16B$[ 6hօs$09A`2\=?v̕HZ>x{ǟf:/([{~8: EV*J:n%̭Z CYN⍰(iUhF x4nY,$dIm :!K{88Ejh!(=EcJպfj;_$Su"=OcxΩ? r0px8Gp/ߐ0|`Ff(G>ys>~`?Ona0R;8jڴl._^ڒ!j[b=ʣ?vkc]W[aV6(3F \ ə7|~))gF쯍T~n% J&p3A)y_ w˦A0sLq#..*4SPdU)CBOיEqnRw bJ-c4apx) cɉJ* wo.sj4U@?;R_B< S#Z)L"_ohKս|H[@{iʏ#ɯ+;y~7FH=(afƎѤH7y'HC$JS\sgUX9WfcVVpeM.6lqjG+eH,KN Jy^J^) w,P.m\Ö·pB~]8BRtнK$%Y35.džz]+%Α#B/24twfd@pv <:^,QAPhm!\* .;$UDM2SAWO9(Of0,1a%EY g#^\e\1P%Ϲtl5ùۖ%&\$8<:)̥a +3c!chѣf"-/T#uZ4O{,Z)=G%kt~Srn@w @S2bg8YR0$.\V5ڕz+ @^7 ?웴=Ɯ`SvIˢ8 rU6u/V4FMgEǙ\Xs3c>xV@P$+2{M;;'@9J` '&MJ?g>7S-ыHqB*Chnl)g$2!4g_f|Cڏw(:wU0-LXP^|&K< =!ofz+PzDR^A&U@ztP;np"MvؘߛпxFpmE\ZF8J/n{|*iMpFDlmK70Yt]ʣL]9+23 cZezS=ư>O5Ѧ1ե6īx%4 c6.r#tE/!N{ZyA#OA2!6hJ 3;~z-M"-k#AD,׉cy{<-2Ⅎ,UL1#4'UGL9GkaM I!NL?d䍲M`Ђ+4&F] gr|F,'4atSJ$z?7+ ϙc֭W|*fBĊX)2 V-':. !K(S>5hEԲQ œ'\'V2˲l`;SY{24HんZR׵6UO$*f6] Lv &<_vUAoGݣϽ5jר( K*>{5ߨ4LNC8SO[#f_ w \dZ=Ҏ34bxp~\Nڀe TTL CF/C@%v3NEb ,&UwcuTZF 9=:> 9(mnr Euֵd,e,`A$m&sfC*Sqzi#I3TIt´@V';U{mu7?49Ry=wCP͞G7(Av3/v<>sg4/>U푢jm:Ք4qm` q,Ie^lJ sp~$D"zh;x;ib|ZYqA}՚w=V k)8\3?`Y6䇵<@zs$wL/d@Gllң7092 Fe6?UuyUh(,2Ck-#*zAUsahvwxyݴ ٿ\5;0EcIy ~f/ZB4 [wOR|!..{cSm:GAa*O sJS?.#f;P?]Lf  "sE+U*Fm oL9|*ԯ&y:cA0̊ѐO_6ͼ Yj t"kHę8c^#p}Z^D9h!M온u@rHZ*_=ۇExH%RzMItYs>##(P6~o=X"JF܋3\n-)ۋs~-[3.y9A6r]>AKgLTG} (4VHU*ŇmgoJW@TcfɄ@^FMqRRtW~J82q4motԧ+ QlEe8(ne{e8t=p\-7/Dkɑg$#?Rc /N[Gy"a@B6fвZJ UiX*}vt~$ X/$mll_LJ>=6g~ݗZJ0qZ^{ Q5La耑eTBB[SlH9@QkK{(0@ !YXR@qY%Oɻ3pefy14|n>Rw OCDS{˩5(b/nP  x^`ECo&ݕ," jHSo>3սgk ubt{42D lp0j>$7)7)`ZP̪F ~)Q߰fOeȍa)ԦA3ڤck/:/ Iq]{kt2\]%"gO"<jfM}3)~|Y U1Gr2r^"|JVMTK}-~('͸LZB95K[p~t jBmTE[,9%)>l+^Wc#nrEu&4" z  XX;-H:vq~'4onc|7?~M=|W oî~Civ WEX-ժL߯>`N㓄C=H+q]Bqs<HY>={F{)FAsԔq3?J'8+KPzj4jg#9K>-lC)JR)G l}̋# <"t gщc[. Ej}pegFa¹7SEoIpl8\ܸ~ n:j0tpla:C6ӅAWǏľmd$ 9L;a .Aht8XhWC /G,l&mH(ģ"طdaZ58G&&q-=K"xVXIt.X 8ޯw.DfRTs bL׀]\tpQ9㈔A[G aS> pFa2jhTP kvsr7D% }dӋȈ6!kr}u@G1=B$)k]x% Nne0 ৺pEҷPEDpqlMbP0F4m%^L G$PB` pkMw:QA; $d߆Ym(.\Cٟ?ü\whû~ڿY]QuJKOøu??YR]{NLg_cu-6_ý\ o=z#_7&nW+?~;% 4ړ__PrdFo/v]]Oqou6m|\˳Y)gGwQ:ܣww׻_߽*af$D 7W^bu<-Eql8ޛkѭ"P EdF}9xrwP-Τ̀ā ~ۊkU$`mf)I7ӞF$wjkIѿSglRζąrf;9ܮzrW}Atj9JύzC4 > :۶k1{%O_biUrPh)V,ĺ"#>.HTF]a ' )kk'M ̪FiSf:hmRX2ݟ_gb 0?2B Ҟt*cқ쟷/aC!,$?gܖkdA8E"z/{d/#t,'hR[//x<|c5w( 6*v~y0TVapɴAx6pN 7"G/ύ|[0ӒtKʪyeFO/Ѳ=!0S?iy%Ѭc6&DzN~A˿*r$bѲTG Fs]^m΀S䒍bخYUC%^ nP]y1Aɳ;v{莾m/ϞJՋnA$@<`s6T5+#rRhI϶fP"IqR~9^1\CϜyo/t붠\W1D64įbWp?c@z#^Pa]c.W\I:F4࿤5QBh#F:1ptbTbaAQF,bķM2Q"z@`QjxCf) |e~ M]ޤQ+u Lf*v}WՀP]Hv}&q[)48U&Hy=eq^%' `rѤ=哝Eࣱb y%tͭ cs/L S0=;lmWwW0-3L?Lr|6ֆ*n=ruzߣ-vKp@Vb rAPlHXB@ŀhO?,7*F_&e, n:0QJlNd~H:;;EA2zcqX LǕ)mNʉH3I+' 52\}ViWb\uCPP,rWF<- 5D,o >9R)DqML2Si޵pܹ~~}9vqU<fMNeti~mhMQJU31Sk8AOw2dY*>uj #;DjGpOGK'Z9;MSag-G}h|qXy'LVR\eJ'lIfz_m'e뒙QhR6A26ϢxԀ.(opTmJK ]xE9B_|­2 wȏcrLi3v ts*ְ&ISoGOA]A@,Ōh@<GژsW.T&oFyZde{zͫݝ]9w!cYXߴZP %f fŔ<f@YEѡtW"K9 _ʗ0' x_ '>yp30l> ;vxb]jlcg+:OOqkSTkwEq:W~9l$N؅Zjbƈ6*fmMoP({ܱy`&Y}H܄3_Ĉ[9D%hy.`^)#>́+l1=Tir1[JȘU&J|BdrUi nYԥNGQfڿ0,Q2nJ!=78)ktU.=GѮUJ2 (Qe/IؙG`uqa>#F6#hF(K1vV ~ys]_9U5@mAL?x\:bb~0u#W jAZP\ƷDHDO6nϘE9a;Ƒc g} Z#mġ<uCSj֞fw|0/odp<1r%09 ckľ^*NcMfj@>E섈釉{Dsw!Ÿ~l6>H1x x1%r˒h)=ofP B,ҫIi/Se ݦ֭!;oC":S<֧nԮJU]1w\JhYĐ ~Y1zc/EAM/Ofa1 W`sέ(3:ҸƐc 7`_ȸC6ʭx0V2}VXP:54֖)M+lҁ}7U&0|q棹IBrGYՙ]X U1#i# ԭC[Z|7niDj/GQLkGVXwMWSұ_ + *ɉb(~.Q᠅L*&ALRB.w0w* &ԡ,0cV1zKB;[oaLZDkJ4yWōYݘK=@0NawNcT0حb+̪-ٯ^ls29f_#n 4BB4]]Q,{UE۞KWGN4a"b.amۭV.F(KQٞ<םG_F>*Ntr.rkܣx%Wr+Y6bDzSHgTEr+B?Dzl2NI>A5 dwL^TKscfQɂ`Eh}YלQD l?jyȅǂmϏ/*jd*wv c nMGִ4?4L#f":>hQǘg# +- U #]^"KYhO8rb "\wRP0۬0v$_?-QJDl qHJFŜ.4AGfUQ K^C`X4?6+0pеa? 4K}mu.g6FJ,s`%G<=,kx]C澯_2%xYhu8R,%!AgnY~kg@~b(,5%duF |{ >P̡I_$PoKLLvdpJӈ:垚z̗Վ\]h78}t; X!?ò5a&M5F SC a4W(ṹ!r^cZT Y0Lv05\zԾC9ƧSc5e#Ή,ׅhA*0{v6 M,6y*nhtb\RH^sѢ|U@L|aQdm,<-xTzѵjFq8e}L|/g;NXOS4҈:2XgB of8YpRXM6?TI"°K <`炦b L@2H.<#F'W0z$Jf+ QJ% {&В,b>~kfea}u>1 C>^e9*)+!"m^Lrtv'a2cUxpպt]FwE:S+n/lm)[.Xt3ξk3Uo*a*Qmcqm1wY &T6c EPA2Ub4O( G.L5?;(3Mx/z'X@/t aQ es*T6vW[)ɿ@md %:]c%ЇT-vUR|$%,r?`L{ e|e?ܙ|>a6B$z3Fڑw sA7}#;"Pg 6u5 w^^.Aw!t~댘428S@ L=|Rh(*2 n+967E CD[%* /u / 8%%Vaګs> ^PaD Z~t}i4M>^hmX ܧk/ ƌY˨UBU;|ZNf+x=TP5a"PJW ƫ$W OӴ>C+mFL.V(`&n8'Zg'+>ddfD੊U43l{;r?RnU)l<FJmQ ;xU^qߣN6jfƪ<˨[_>cŬpR dtkv#?YiB8i~|[ݴS?PBc-5 ly)MI).w6flw2/5ir3`<15DNz >-us>F6ܗ> 2U9^ MO?iҐ+D?goL`K.u e=-ƧxȈ@sj7 (V6"F3J'O N}VA}),|O*]HVD-q=!v<2CȮSu] H;A uvLSJ64/.SSdC`ڭ~E!aYc%*ԉS^l@ꕟ>V1/X\"' I;RINegvԞzic]Hc ?'ԑCR^9U⼿?<􀂵tq򾤳d`e%D_y37~q V1mڨ lmD1KIi C e率ܫɏrw䥅Y3?! *x~km`+=7H3Ϭ%!Mwkr_ N/~)g+gr/QveQ]Ǯm Na@IM)JͰ D؄Oga<$b7 dKZ/lQ&Pvgh AXFJ!A$~[}Z6oP2颌Rw%+> סi$q PJ9>}1ߐuxqVw3@YPJ{ ylеVsTup\fQjpӼ3gfG8i.FGIId"[gXeB9͹v՚{s'v#uk.P t`'6KJ_`n|-wtą^c2QA9Ǖ7E2XYȯG -9LHƒ}^{9bx,""|q"3y&hKpS] b!Kt4KE]-y򂶟2S[&܅|8zD~i|~*&MhJ}pl ewIFOq"J](\܂WK_?h`Ct"ͼlW(PW+$A瞚}~ӷ15A6 auJW`|}_Ve1+W/ơ[ud:p#s C:'S=}Ud܊#<~[ӊzK;x8]O9ٟ]_?_ @!oRMK wt߇lhcql.V~;j?|]n蟆,گyKݳ{`/; BA`OUywCs*=!1jWa_wwc; qyW'ħu|_5LԽ;ʾU@xC*lY[}1\`M>X[źu})`Pnmņ19X 폘$۶|U\Hfv}{hXSޕnw{uľ[?<2 C A6}e0`%1ák٧3 ̫Fù,fy|?Gu^e) cl]&udϻoIpxn+lв\fIb6@7`~ Skb^S5&˄RЏ<@JBP`TY=!]̿t>c>&SL@̠nB[لg]V];wmRy" =#,T S/CY`FPǕ|FKik- [xZ6Ψ҇  c[~`7 .jxe%V()TgǽI="Q5ֈ` `CR~K2Bhpǒ,i@yz,ڔ 53pcQB}`$fsmxlPX HGlv/$'l1GEEL no|VP͙ĝ?d]`/wXf Ir=^PSyjb?qc) 9vMfMl:OBLĴAE?7 Ժ!%?t@2o0@tQįZۤ~@ wບ4vC:`p*e -׼ ?Q?HJ<-iƔk!޹Us6z c{Bv@7(Cڱk Z`,F́ ?4[BX?pr]f]I_\J`r6n{]%F/F|J}ǔ-2/YS1$d“o>Nuݥ|=X+Лxݱ3+j'MtMrDR&'< {@b=85"xC$uc7kkO;a/I!z0*L HdKr> 9z֏8o;-`7 (-,Qi;(@w 'hօ߱Ԃ0]YHuۡS@W1Zzt aZw݄ۺh?EYԴ1ګ >TO#-n/C Æ>+f ͌32e7BcL.+y@S["ɣ2%Hl 4 N~3K 6T0W,rA᪔{1(<R3P^sؚBi>|@USOp33 Xhs6){TH2Z>(Lʵ2'#``ה@9=fZU|Xkz'fyb؜f1%$վ5P,dFیdz4LIkˡ쌒 ]p7ʓft&e0iR,Tew YF|cUh<,`wajv옠XSt=j@tuz M)ʊ,9H6L{!&5dO# o:mPn1;0@\w&up }*u_Lr1 #%Op)Ĵ{#_DEN[)%'k5؞c%G1& = APtَCyvd)(|{KT"ٵ)8ӂ/ YqLRo ؔ̿'^ C C5?L@:9S/n?m9ڊ5 ;0ROؾl1^mWzRTmSD -hlEt$ .NŠ];Pv8yiu,펹uSf Ulx0/8-k0drCqR ic4qddt"Bv͍3غMu̗?>;Y-Ff'&qV%&"~.+,=LYlDc q&R= 5y ޚY:bޤ9tכ_*vǩ. X:jgF}. ՘UQbҝ.{jgm4L5 POM;ߋt@uP >~hs{DrݚCZg1jw3%hWQQDɻ-=['Yag噛4ZLT_#O9nymoWfQ5}NR>Z7h9 ex,b+nY'wh&3 B>S30=|sunPnxm3w5kBbJq5ȴ2;P+Pyu:穘XKCߌ"DlR)þ",I͓F\_lnS$c/Y܂ąS2Ȥ KӇn 6 h4(+}=`m\9[`yUza`^(,IR\YIGtbOݭyC-L]z3÷X{}mݶ95x-iҔNǎM, sӽ2!.'IXjlDJ䬍l{^ ~dx/LOy.7ݸTE~G"q:)DyT2NE/JjuB6o7y9g; L%c~D(JtADQDъ %v~ 6XO%TWZHj# FQ臍`ϐbEƟl3b`9F9sk.2vR.//VɾCs-KďB)% `;C'bo7vꃎwҖ-jvaI&ٲ.=ƂF{P6! $~Zqx~hЧt?ۣtz3ίΊ_,}ӻw݇mO[{y鉏SJ+r;AShj~zu|wh8i)e, nx+ 0S@&,2f?\κ9j$Ty,͈ h~V^zC-PԯT)4&=WacZ-ab,|TȀ%l<_jB`5H~&ɣrd֧T٤[t e@k1;Tg7YW^s `vaInBjd[ᲅ/Yxw9;YYp4^{M~f^:_>dX#oXv_ x6κYJhaؽCno92QGG@ZX,"gDh 84R= &7a \ nQgJJ<OQ{RaQE1]ORT2RC`WU q! A hG8߻ixc1>򌹵"Lֳs&Ml P$F9a';ڳ/ ]O)lf_ G>.q鲊05 sOEVEu QMFdBـ*;S[̀%6Z{)@*[?H7DΎIys{6TA]w͉`f]#weġ$p"!{ovʯ }i|-, E ʺ@3H#0u+]%bV}‹i zcny'YVM`@NqU8ڬb{ho镕 i΢WEمk{%Qm*s2%: ~w|׀z;ݖ_]囶)R"Ucx DP<5]DlrZZ@3;Cn#figqch=HPӨ\ J-c!&Խ CIm6nA(\b˶SQ*Y+>dkdTBt'HP;r'm=?)IiyC#I@E _,lR1 GfZEd&Km6q.1Sʷp'd}De֞wMaE5[z7$^Ȭۧ[_c7j/[K03(.Z2S>nu{2s!.%Oӑ018E'ŲT?#ܟ73|)6ɰAcՊ$AbvUr&L b0 8uYC*T:)z`15QIk0g;|kܱR GK",ZϣP Z8cv@"_tFejQdl^A >0q^і +uͣsN$-o& MtvG;t/ 5߃M\wVN)fSX%U4HB`N*ho +o;8j^RjiQ3>j`'oV<_m8_?cIxb{lJTqm-3XD?ѡƊ]A q-~$Yv3C_-@!cAe-y%_bTCm(wNA!+Bd/B?__q?䝱!s| x [ `~=D/ Ҧ^jCSF;uvfbfq52T2̣譀F~ `9}Zᓫ8O zkTp,l>0\8[A6OjEENۆLT5ǟ S3ƵxP8p :츓6l"[i,a\rY$btO !l5qE|i2-sG+bz r v.CZ3s  G{&HHeug\jF[/ S0 㕓OdQkv3==eE ;k{ !WvǸF#.en^%b3lx6:,Lk 8DNQ)jYLMsIN,iIQ2_s̻&"HVuY'TP;1 ?9vro\N| ~^Lpxv p, ?i7 ,D[ҫ,E1ޕp&/EfpKOؽX9=4J<{ݟו_"$pр{$d9^~ CΛ=N5@ mRR- Vo;'4r- (al1nb#gtu?%NEq0S&-PXelZ"HPTH/{N%h8pJD$6*ТI GNFGhIj~xAl|ѷa-P;"͠Pmy+T)R=E47D`0G$^-P 0iW'6NRv;Sȝf#$H=Vۖ +Eȃ&>Pٯv& !̋~}<:p^|W6{Ƹ㖢YEoH|zJGvU0nWO(2ObxqI?.3 =iBG9bL r Y PuZl5"8C6pѠY.nf. #1<ҡB{eKMeTzN;ǚbp}$Tcf`}e-8w *bDtgf) [qL'Kxto缶7:=9/=u;v#mEˠV [3;(-x$׋60I /[k(@k+Ky6½6oFD3 Wfc,wI 6a^YT~ttn0n*V5zPgNԷ1ͬ9x4n2:5۬t 2|j TxRUHߏ +쟎ݸ ZG9+OSm 8>;B[;CX.eh6,3^~^?ڞ_QM_OP@+Z *QW%$*CXNj$%ϫTGl >Cz- SEB(jÕMɣ-CBA;F/,u+eHmAXK{?B9dX^F bo3=Qұi{4[~jM_0eԐbNO{2&Ƈui,c-!6/ymbx|Pl7c0b-)ɝ{v:Ӌ|&Y3q`ɞئG\ Td[;;Auc3qpHHX.*y\T!Ԍ,ψN][DgL ,%̣{]>% jT8"]#t?8{|So? 0g YLr;3Z&kǝgw.63xy H+ނoO knkH 2U&q".[-52m4] <<$&Lâ& ,DlWnC*3Ø%RvS]X@z708=mb]#D:䠨|wL8f:l)(RLyrk֢[ zm}/s$\gN[_8v,)MܒDx-}*xV=S׺h,}ujA} +[S2f-| n\d JS6X^j?o\a sܻƑiMvW䪟sQ]}(ZfӠ-kC+T7e4:,AmsnȚ0 z*Z|g[ٚ͹VTL>ΒHWk6+"9AzI;`wѴd]< ^2\RJOߴ&>^8~;X:i_[nh9BǛI(yŔ*"/ɖ]T 3GdtBE{Nb4Y9s]m 6 #Qkgr%faU1L<-fN.2Br|N=5{q;9B @RA1ERσ,0d뉕!OddR07 [&($mRj樃)#C'H-kL 񎦐2vm_'={I1CϾLd7-.ukЦˈtFUDj?kf98z`S ؀6q3N#?kH 3;uqD8EȵZ7J$hJڴrXb4{~sVHv5~vGWb2%MHľAߑw\RRYQ\_H1 i̬RPRGZMc(ѭXLpT)9˯™9Ƨg`85b ô[&P]Sʟf)B\`āʃflh@x5 E-Ck %SKX3[.IlH*S:e`@nz'\ևlS:uڒ{QPYFq`-qC=BϞߕioreW;T3LLlDA>SL#r:7(i}+Kl)WV`'jpkvUmBg9\s d5>t)(>Žx *f=YVį$z{.^H T^Tx=R7ӶYnx&H^O0CU-haR˗ OJ3|K9& m]Y^Ym3ޢk,(B ʳޛ&Q$7lc!s[мW]ȰVs &ԏ";!/!UU ϥ A#T;q3}ޛ/ykC+3?nQ*rMr`ɏ._?BAo?Ց 2Č@V%i&i}ℎQr@O jZK9Y1!D6_8U|Q_7jDj7̒Fn)#|j{@Az2-RseJ)$ @;U'{9F.iMގ*b ~/ɒl ޴+ivF[$૕׏|n8>=Eugat bЈgW}[{[F2kϓ;)SܩC r "j\ O~v4*( 7:ӁBYY#@h% 7_U/YʼnGJZ9 ? - D>(3 ȿǓ=<%4 ɩV7 PLA)[EH}QR?X=o.X{e5diwdId1Oᄰ3!2=Ȭ\s%M:X~J_gcRIUv0|-$D(ūZE} njʼS-YA$ p)uf&b/VucU@#[Fo%qTqqgvJ V$NUˑ HMɮm%58Yv"LD6In|CvQ<$cjmv,lAIO'&~TXkN7L(`Ʃq }u[[1:XgeElQan_ M{% P&Dyἂ9{P_xMrf-WZF*N]@ML;G"mDOf^Fu|k.09C5OO<Ӊ4_(+MF$~0^5AB&>J6c_C.h^kCzޭT15 |N3 }Ǻ&fN ɴdr>b%"}8n4  漪kB" Sxt*X9?{:AB;u!}.@2YF:A+:}d?4RdöG.b rM !Ҷ cΗ]T:G<X!KW[K>&.t]_.L3fUxLPy ;RHSBd.nG=/$LLYk\$dfL_i;wtes8o~+Ւ$k/_@e:\G l!H |V eҺh:++b#>o~:`?h8a v-m̑c6͙ jYO~IA잃-ڜ3rn9L`P?<O:Tr(9r3JSoﯱ444l;h =5l0ruMYB]r;YצQd= T_X2->? /!e])@]nAΏa#L$Pg>Uq-()e͛$Ek#'8)K}\6ٹ< ױ6"t{Q2I|~w/+}75w/p E^ͳ)#w5?~dcmDeK%Ʉ'ڎARZR>Wl1c-K}l~\"f%|f QClG[ Y 3N"N 3W3%`ݓč0fE-p=V̴JG"X}hVݳu\]B_׉z2Ѩ/ P:fq8v*#m"d QIOֶ&'GA%u@7w$|r3?M;T| `Z:63i<]ho &!Uy0r@bIqxڸXN@0Մ5лKx4n"ZI2-r:'e If"JӍAPMZ==!XQ`NS/lDt %*eA|M[4cwo6f&4 3ǴރWVp$-!i$")W0K\_Ku\qt:PAydM;Y+YqJ0i 8FW]9^eJiWDȭq^ (0>Ndf+P{\6=M|7HZz-S(, X +)uM<.7OA!˽?n57MAI1Le^KtQXR\4͐df+{.D-ka%eWqa[7++%YJFҋp@ .1~΍[^F)D.lb }.B"E :*w:=LdP=+&K"=T8ac3U9įs^0 l?0QtkPkfB9Ol8&d}'Opaܶ!' /ZWdf1"~$;y87cŅ̯uԄE z*g !A2`+ŵQI xOS:2 vMW,Ax9T_ <֦ILvP|bqHY9u(3,]7)S'YiC%\feJZjf+1g.VO ) nJUsRy<>ȁP_1}')EY2ƌsO863=`]:c87#C;lpb+eD5O40 ._'ءX5A8>J Ow  qwv'ءaYb. {!#l=>k12v6?w/)6r$byߓۧz(udk!歑5nY fiiˊ+ q4ANqė5z.8n9.ZŢLsi)cSHՍ1>Wlv2ʡΈ 83nÖYe,h6"t? L)R~.,#7b vG-Ћ pXPyݽOq^=qMa ݫ㣟Ndٵ :|7=XƖ*jbBm\d*k.󶤜pߵy#l`{tZ^.AiH SP @"4Ԗz-V&j"V487c:sY6rhXӧ𴏦"\,=SDG8| СӃtuSf% e ۨqƿ 9xIHcCgU)ޕ‰su뢿+ppJJLBܚtPrns\/=r `;g0MY7 &$g+A\Rf4m& gK!c~"1Pm$IMV,0 z@ȂeXT=s@>*ׄ|6vH +tӄM|5LC}7čtFΐՙmr KOV1F};s|rXawlR$#KwPwUT ^ՙ3Lf'q# {(F(1;Ğ\kWf#%bN!j~jѻ|XPK e*2|MT(^0C׏Ezk0KYJw'{mЄ9gO´ bS}@֖Ց:Z%8Fw]xѯFڝ̚10z}/225ff>E٠;ܾʋgoVଲ)uj岍Z!S@Qaew(~>= wO_L1[4N xbZ +&sڦX:L%9/٦oI1(Lt^tjȁ7hٛHSBEēC5tl)?ZqJ'$xi8IlЋn8sxҒ\ƙ65kY-@IQjc3U/Rcq4`m5 qK5vW{*S-`J`f /g3f)? Иb`û ұm2zr%aM0FHw ~)j_j{N,Q ɝg֐HkK)%:`Kl!nu 2nkyjafxc5LǢ" ֛@J\Dϻ$4}`xLC> 2/|t~3mfXc2 b>@yB 'õW53uIêZ?x %=`((Ď $רCѳ#õ /n>҇ t{?,Mja!o~Ky!Λh Gj8s3h^/fgEW9me >]AIPƯ툥nPw4ݸ$1r4E6|l`f[ * 'QгuvT>=C7jVS9»BVt1oc,K+]a気 ȹv.mdjRުi/\qSU+=(1] c^n `(l<̊Q}wɰglh5Z8JФ-ghR [*谠`l!#W!jvFY]hmbL6Ϧ„h Y]QEfe&|UZ֣ | @f6| j=x!(&EaWWzhrAoո#". Q b+~V/їl\%xoLR{u[C ٶO/%r 7DcEyGO :~W\;(˸8x}XQF; ObwШFfߌYټcAIOhdm*/ B/QO0;sΔtoVԹPǫ|_;9g8,}{՝97^*>\YҴq?4&xb2&aEV 1 / F}MIZ:-aYLecq]TH-d>7 &4Dw_z DF$ϥfχfX(r瘌6zP+[U`1 K CS&Yxm`% n!mA9Fc_c. v}tETIč lţC'1#v/v9ե3~#X^_!,~2Uɗ-6 ityTų#c0VgPoX"=ne/5Q8kvٰr*m8kTr?^]Lu-]un5~o"iBB:/q:hemЛيqk/!(@=DT!7NVo2Bb2qܶv"vp\9J 5QV X&LnjޚbD֊D7}M<7f_}*M~Τ~l̬m=|4 c&2EaDz4 KK?) wE? 87迖۝sO}3}9ZLO<:dsuB `!CN_r?l+ޯ3q!"{Abn! hf 5t}5Giu[O2azmQBH]9yH8vrzi Dof8V)0ǔ1_׸r沗ۛ?b25OR fo>ynߚ}<5мoRj>)O(GʄlGj|N Ki>SWm]@宣-es6==~j}Ѿ}V:NysY惴^~^ S[[mֿkZ~>~TԽ7zwW:lj}?u_?heuZ^o.x,I#gRX;{Gu﷾to>\~ ?_`pV][]w_>[߮~@Iy?S_(ެu_)7Tz<Ԓ.#MzhW.4~U@u¦8[0Ѝs͛ ؚڤ؎ ( Y \m4H1֘pzm"@Hm83A Q,Ri %UY&ޱD&Զ(^LJ0lXFqĪ"$lPbTj,fyF`r6 F7 c:F[-v>?y^S:P ZC|QRW#8^]tqi̢ElޭԹ)D(@<NZjoGßhI163vP SĒE'YPm(7ߪ.f== ¯"-/#X2|/&ppJ2bo;zp%[ VE9tPeEJ;LYXTU m`K?⓴Ჲ;cT@b56ָjY\^Iy3φ]v:<7݀Ƃ vnwW@4R~1H&inGÈfU15n#^N; ucY&:M;' _vĩ3$L0я!ڹCV4A7ư5A*;o \#Pp7݀uroY9C}!+ZSZ) _<WXqwP*@wT k~EE͚|yXOATmX|<ĚsӒ(Lkgݔ$B#;^gϷfvX;9a}90j%Qn,zFA.}^Ӆvb[ :j?>ȝihYYכBE*0yFN[/@mjoQLw=7i^HNCz6BR%],u KY~O{ܻ}EhҀNs삝1eF.SfiGKK?p0%&x%͆Jf6?>B|%7kGln #fn"w ճWM,j?d0徇14&ೂ/@\Ju0O~xDF}3,Լ drD8S;DhHO5N~~pz u/YC`\>',y^}Vz-<Upay] דx⡭nnǣdG^4f7l,n鏽wEod{Q錔<L'Ms\"it Nv$UDRɠև@ŞLK|z͞;3vTky/݄j+2! NLJwEWNF *ԫD)"ɲ ěK1/D*_j3.a^tqtIˏT Jxr47'6i_y[b&#Y ePЦߠ35Ka#yU|"̀DJ%"ʺvs}e;LE w^2uaڼf"-@GvLKS 6i;,-,Cد+_ŘGC{v. .ˉ;;=dq^%A犀B,hv v֟*e"^B.x +8{h?f^*>^atMQ2TRfUJ G6){/.^P!AayrK~֬OnPH d2T/J²M"nVjg Al" t%H4`aF(YO"*'?؅ǬĊ IR NPtb&Q è~5>_%J`W7}ķ"#S2GTWéT?\v ""/Y8 kێF߅\[pnU+jwa+!Q6 Ďk` apKMo:ndLvSw*cdFvvkO \/M%MndL f8ʸsl:T!CR.|D#)Xs)U&_^׀A1pCQaPk.X9oz{1~vK--)GNP'N! -|I@@Tv÷UDZ*Z2 2Ybm0ဟFM A _}SrΡ X wҼivkK6OHc؜Nz9ɒmVZ_,-3ꤘVIqC],JGxi5 [|}t{"O';;ģ|:E9# oh'3++wX ƍ*XSw8L̺'q,96V&`7x &`@F{{{ܷG32E1nOvS{=,l<̵~N!|M/i骯||ըyxͯOAGs CoEx$=CH%gM٭EeT: jbs:ǤϠ` DP]9EIPNp" ,(N{.ZHV}s8oq4OQp95."A4N1}A>hj4%}6R9Sxu I{l[m:h< p7rN }~|OUl:/л"7%2}Wr9+u+03WԠt\y=?cl |ĝ^@4t1x-HJ#Ku?vEvD I`0+wҤT6"8TmX!;pO^FX6!I8E}b#IB|f[z*jt+1xaSWO;>c.N!YtsS {@M=kodyO#vQt_bDY *ycuZ9tL):[~]Uc' \P|GN0Rӵ=7[}}=/5Dn&Wgo8+$fԮ ^fW!rkܨJcpRԎ.!:P4i*Ψ~(Vq:pnBۖf_oD[24y3-XV 2R:<+ :f]ܛ*u}0tesO'zSwM/ğB+Ĕ턞77>A˧Ŀ8Ȟ6rL\pu+"ӽ}^4E' VAT5? Gq8G)VLXu9&`}}@rS]i쳶?oE % I]k6? $UW:IVOWp1ђ3tmg6?$`erWN?H7vHHB֪OF McQ3z^SB\mf q2N  @/!+GeBr[)f~d;&EډB[Պr}23_+ﲬ:0@)ss@ưF lN!2nr`wb (rPAC:/iAIQZ Q@hp Ss•C)aiՃ9觲#8|V3n=*]8dmH͎SZrpg}ˬ+ ^S{@ⶁ]Wsʺxq!%Rm?>Oa R.v6,35rw

,j9I5YfDa vr4\U׾! A3"w) ,?>q h z$-ڰhB/pA@zkjeWC9HD Wˎ!! @9_Ɉyd:ª ^.\]3L,˦O[ uSAM 3Ǒ+4L `Ox[I>80u$gGCsyrW]B=u8 : Gɋzh5l8e;@lRov=^3U,,_ |2м`O/ZPrEgEv(k\~HEzN%ܐ:%ZpʗjE҉]ΎEgG8>>A^6:b$U6";a.t!2,%]"kpQ H ]Xg;SJ~^2uDrB:~b#HbݓauŊ_''ӶHDI5 fs@83++7q8Hǖf7epq{+t*mܳ8gdJ}Bq9\BMݾ51a97lBR~ͭ0uo14줝k_?S&HY4H@N+[f`;8Z:b1*Q ]MZݬob3\?okr{Ngm?*ڳ0u^膆0oEu{L43yjS:S6FyG2;T.x"vbGfѲ!fg4J^EW" vf/qe5_%)1\.:ve?  }ح]F A8'U@Y8X!K?w&8`!րz0;:xz3Ь h^0FTw 8ХJ@TsɢSm |/xi̼*ZboT[Tn-\/%DgZ>$ ~IN[ gw΋ySr+v`RF>JS;N|X+`!Hը>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 20341/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 0  ` `!sWl!"dk/ks]SboE;Zhԕm؀ pgxld;e -sV VP,-ԭ68;x;}k Mǂ[%#qR]#u)3oZU,b?_|{o5^ӍX@-G<\U'6]ܱ>>i z/\w.uʡ<sZK[>TB}%ב!_?wtlK]}`͖'+Xq S(`(@$39%z I29{&C{<ʣBe˄}и1NfUpRSxHIt a+pcV^, /YD+$Z8Sf&]!B p*u$!K~WM&98IvXt_ cH%vIV];cґ(W95ALp] T̿m!'h; 5Ƥ9@nMf|%gѣF}9(64Dq 8JOp 6a2\M!3u?e=Eߕr{Aol~bEa~}ƥ. 'zƦ'i8Θ=<.W랉wdhJ4Qr ?||ʇrbMË-Lx!0t]9eџR?:@~aZ> N޵qDp1HQ 5/A+C`5&ZF,<@bkkZ+0ŧhtWGfwdEi )2Jڼ\X%QB~w*yKIHk9>>h_Ńic3~< 01pm[cz0l{zLZAGm̡b*5 H[̏df3&h/'wcS;S~aRxa@SfعFsf =/`&e(6(bpac.BG⢩xwS39Β'o@ i..kdOb8iTc.GJC_KcR'L3M$?C}6!dM#@r !8eL!Z1g`lr졬Q܈J/ e3P'v"k]' 뵐 4Jb.(U׀}stz<񕸁K"ND;IgG.Z̩hBED$2waa.;ur^AܓT.$^ w!H1cьdI%onf?1$cTpIV=g dVnMHʐILg<|i2JBx-Sr$JKiPEWU7o؝s#ǾMef%ܲac?Zz#嘆hB6^pg]%ّ25whZ{O$H ;MFXE!˟j&97L8qvWQl> y)odrbv]JlMLQWteؗS4dqj(؈nL%HZ}N`9f uz6u8^bh+eZ:^J^k/kSՖ,#TÖg p3g6|*^#38M#9Iٳ 5駽LKo &չnv㐯"ɧ M:o{/,Qn[Ҍr.Hju%L.~J-Wy |Vo,!9(pNovSτFA N!\YJVϪ$̀םUpoﲹj͊sJ,ZDjqaf(w=&M%4 ](X*7`Gǝ̣S]}3F̻1ECyBz_. 745pL*~EGͼ2F%gE*I 4!֓x3>Rk,.7p#q(u-p'w˱vȦsZ}QOyȗO.8W0?0gn;})WtRv?{tltg#8PgE ;sոAN )!xT/#o*K>SpO2!&i&/vy)eܿ b 0\@[OU9(ŐƳePCyFM fMItr`0h/&Y,SCS7j(mf hc!`anݪɧ<*ej1VX.0mjcUI4i&ᜀCUa&; J -yQI3=I5]'.C*R;,M_9i9ܶ t|xhr<|YЯR=VQ?`udq=H5 3Kf7lO+ riI gmyRVrrDz.}O z5oO)L%?ma~Zia  3,L5 &ns mY7gGK kn$߮Q~s5>g ^%|Ja4Tە>{mz,hwk[F<N7&tփH8huЎJ~OF TH.5wEgxsF4b~Ƒr)1sJ?Vc>6+N6MKgi2`q=_ˎ=EC`>Vګ6uTP4b vA{})aŹ}1(Iaf.߃d~r 텎6| T]@4cG>TYsbj1B M蠎$9 k͉L2oko$q=j:rdB4kR-ϠW<`wrg3#JyL`ہ@#,JL 풔`QJn#N#l3S"J|6Cw\pšI*9>hSU$<ED)Ƀ`8]JT6Ybc u?$cL\ aCzJ,o}>@,fɜ*ݡal׳V* ݫ`sYߥ=RR'^pI~4SreD(OvWк\Շl\G0IU }^Sx0RPcvnpv4ah ]H i1j  ,s}4@Q3aL]w\TѷmmkȈPH\kыNK t{B:Ʉ, ?חb<ހ9Z.X.sl5d6Ѻ `j0X+x!Yև*XJ;Aɻx8kzxRwUf 9O58LE a-WE,Q -!k\')ۨ!(%w3!ܡK7b+b)S?[K}wB#y1N +9'pJ8Br"eR'-WCmB*_ lnC $r4zS@\8GTe,AueN}kH9ݭ$h/2:370oNygEu!8),WZ,FY]`١Cux5[.AկA^4FL&\|쾱82\Wћ K]W82G^v&Zݙ)ldr@ᷯqÃHzu@Ԝ` Lq^%K-)^ k<1k,&>b4 Wg eܝ.8g:LZufِ^lK6H'`Y,ҹ۬q'YTc|.@2¶~ołiPš~OR.}< .Uƺɰ7: 3%E A,f)X?'C"}x>2m(t-{e a4r Vo-d1wbH?cZqLMDȟ֊Bi^wY!*"A@J3 | (u8ZM,q*J]sap$tYvOD_D v*Jl K^fKF5Lc0q'--kG pym3D*xP6">a+?5 i1hӸ9Kmlrsf]B@ob`F)@4\XPǯ0G=Imꑪi,RPsuy,F!@69)XA9#CY<)lv-eb$iht.Uy't M-kEETzIbʨ(0RAIm,`k/QҺƧ^JVYוw)VLoS@[lr<3-oV2 O2ytr^4^4 H šCn#-i$]GRz*l6SK83D68wDEnQ\*Qj OB& -okva] }V=эEBPNV!$.#_@Ǹ5͹Z(CoPC&8z6w 4ie֭g%g|3 j'&.XԦOT4~ ]XqE'"Bv=` QF wliʚ& }c,ԁ e[sXۘD&}aJR bF{ZbEp ~~qmCD+Ly䔭:Us FȌDdA^G%~킅soW9I K#Zie1r? {F׷~r0"+c<dO҂hdpr~;#J(*yqݕQEun p4"n''RWe j*FB;f;&eCwzd1=.eXzM"6SS2AyJk!? 9d ̿Y+&C#SdO-^)3"9C 6L ,Y{Ǟ/wv# [8M"T0cHY|u! e\~W )IrWwKWaV(U8eIջ_v㩯BM1 jUT+=sA1F56G!#=5yGDr!@7i;G}tW!7 ::HMD8_ΞW;"l'Lhm4yjST]7MXK.`㷍rp0,9ucgVj էwE)]Mmf+,MAHk՜WiڹԲ_PIA[BcbHCuU!! 7'Q0"pkdMT3Z1sp{Ck'CoT𼃭^ %x_xcܹL'U@nt5x{$K㚭B<)`.͌RnOӋ/CIv(*Riii[J8,ſu ~0Gʄ9u]}069nXXʲR顶oA4gS]cIu1e*0^SÎN.dzc2,^A}FF# dP.Y|#?TeDː߷,ue3[9eoPnghp :+c*3%s3n›Ox j;):X[!q o_L200~}3`Lgjs rEۤj~?,HEaKO&'Hv@CB{{q'$o)ֈ 0Y|Xٻ^=Nӥ>g۹^v@IRlbs"`dY(g' \UUCMLxԳY4b**_R`kL ekh@|cbMLd,DkhY sBGIVa5ȬJFuĦ$:4zwcJ{p/TKh}b]26&l/D>aqkFla%0e*-y*x @齦}?k80?VU$IN|W ^϶ 9@]Ao]&jv(,zXŚE$)ljW`#K?' ~I9wC._l0w+]zy]S;q]Ѹ(ȾK`z&~x~}U#s/;iN-fޔtP"S8,0sdg 8׫] ֛IVx^eGuy H=% 24W&A#WX}Vl\q_j#f;&&m;vJ Cx"/ b\7a¤ OG49%4HGng5IgPY—tg nbs+|8vr3)8M:w@8* g=(T:4“Dj/6uB@!L$۬W %~!fkmNze{ܦrq|.56ڙpmƞx>ۖ. KQsKw`b$2R?I/ mLZ3똜ysH* (5Eߍ' 5L8뵭 A~,$(XeZlS=-6pv* v08LS8u'(!G^+,)Z$UX0uGYrA)11@B x‰ca^,b%qp}GdX@cNg}i>eTBPE%L^ SYdl=GZrFahaT*`8MpU.]?lY%MOFQdvVxk5HGk֙}-OH@ކ.2A.R9Z&#x!ԯʟ$8q0s[ nx_,f׭>bEs S?zhV{j⸬y wFUM.ҕ`x,QQ{f>9HKeIUqZQ&Fu ̈˜N`}L+g'߫^7h#ԽrzKlr$Ea'D|t' 8Ca;dF] B0n)?c)5As$_sjImN@,"zhdV(n4p'dGIe[LPn_i\iX)f}1UP+ZAh. lVp9Kqt'o ѮMSFԭdwްͮ- 4%Mk#?LTv @Q4E77"xf_P7#(Wk0WJkQXC DNg,ʆwJo32drf ms(*RCo0bq0h{ 4IV'WWdQqX%G.,9C9 Luhz9:Ef"}׉pŴ$7UϮ/5~cE%qlP};~cZ}e>l ETZkb=1*jbԹCsppS+kS8O2۬J^m'm]@@ PjB<&rC )p5;m9 2edkmE3ih1V!MlTU(M+Ή$fn?8s3',&e6n4e^"|;@"7@_Z`Vu}a#IAux5 $1z"9PO7@c,l<6`zcZAb3Q 'bQS?ӧ q |^[brΨח\ffzX$כ@BHpZ+u 4>X9Κ2& ˛mф,g^8s=O%ƒC|:\>';I;K(] ۼ3X MUӢ>T_-q2pa73rzr"n he2ħJ)P-^{p};qC6-u/P(kǨB:iG ؤﭬC_:խL ق ,n_,hB FMw'rnJ#%ƚ) Ƈ#RUW߈f!bl@b5;ulleu7;=5p;Ebͱig56aQ$m[F?"oHj{+^$S[J&\B?8 Àf: U~ϸ*&W !#ix~J A4I*;a fqzdu54ׄKev=ՅOm|u,_LsUC)\cgw%u[4(R8q:z+ly qDK2SUAH7(fЌ3~ě:95' PL l3t䈢k>rex<ԾE A ^e9Ԁᧀ'JD'D<* `V TV/rk"m 0?>B^=(Œ0ߋ ̰tmV O"^uu}-}u' y2%SM~,$ N :.R^k5P7)8?G |qOfFrr {RNRsbO_Ia>/90Ocq+C;أL˯rc+C OSl8u8y'Esge OF!uc|xIbmQ]iV$hh!vt0&}!k3(?'˲+ PqzfBV&G`I(щ+@mjitx-}<DRUH﷨̡[ƞV> HQ U us#XanѲ# ^#JtG_&y%ߑ94ֶW0 #~5q6BXFsD|r5 F]e&d]IQ2,0hatV/kug«(:-W0B(ʀ8'wpj5TܪU1;TXPjtО%lwj :zk5Jx^'IeLGuf//؁7;m(-0ڏ&>3ʧGLi=ຉH4ޟAYV'rʝ#z0M$}:"NmH*JWaH6ǸvdR!_ekH@B<{*)l+J0%VE?$Uoo[a]Bo\5tl#7CX郱队0p:&7uX@ՠ:ek$&a4Vh}/Ż" ]͎zyDu]9@ed0@-oP`zIP(S /qCMAmL,H1aї%^[rxօLʖhJEKsk1@I=؛*ɟޱr=C6Ylӱtp8QI܍*rRd%萍<2dkpw ,ª'ir⠔WԌ60zs'eKTu9-:l}=6f4/H鱁*Jn Ĥ]$%ke&8̤XF%z)t[ΗM'6 0&3Qi$p& aWSA5HF !@AQ(,|oT;$'Z{\~LYqXHa'G@ ZK(W=)F3 8WGeMW^5Cbss u6?uR:=3~te\ANé~+_/ XR#W?knl7 F!\:/t8 B:˸A?~IxJ#G#|y~OC 7t=&inaᶽex'*Ue|Y%IpL6[Tfg5l}/, #:]6*r( $K?{4kjkB}.1&z\UBaagK6PH3ܞ8`_I"ٚ0Q4?;g&PʂI!K5県 xƮp'7Ƅ®QSa.a" _@GΜ=(Mu3-<_r>dFVW%ZI 

ݺ$hIH\Ae kAoMm VJ+`5h <ʔew;us:' kbCsHzXL'HYb oMI7e z7BNjO[&K2&[bv=IᡝB{b:Jkw]r$y}Fƽ~F' 0֖Fqae_k9LD[*^vRZR\" -!L%lBn iIXJMFDbҡwf-eX7;+9_TB U9|dR87=Wno }SV sv?]促Qy^$;I.$"-{<x`rL4̶m8n#2/OQ 7J+5.;eއ%gO7Z)#z\޸[55mٱ7[Cq{W a1=hI.̎K@c 43g[^a;ac8s 40DO6%g %>lK(&V=[B6n#RrNGs^F rq]SZ{?m1:~KԳMM r(z0tU;V7caoՎ*K@2ٹN̼S`xG | sX]`:,1,T9L mpVԟ`/DeaiTm(]zḢK,ܰb,/ϊ(G< +E-w=}\GE<."Ji$"TNK (A>l8MD mӊ$EUR fm~~z nKQ& ڧ Z2j".N]8Ra݅&3f*h˕^SKD:ߛû 7{|x2L'}(WA1=^cU5ǚ&y/y $jO) >n;& L_k;*ui9&jn/azC1,]TQG[I D'tM CYLtYvs1/:W!Ycg<"!65gĠdnIFBbbU(%xdgfh Wyr<ʇkPa=J^P&!/*5y XX LH$^N!#BV ɂ hC{!0NBYne 8k#Fڨ>\m{Ql&8 ϞHFSqC4)j{L "/ѣަ}`.<m]]MN6:it^~͸@c  R Qn_A4uSSa)4}*/3ڪ׌{ #s'jz74+]*=oxr:42r SKe:e92((3N (wlM &o%YXC(ȧ:𲝙SXdAg eLGKyQ.tݮ~#ôaFoPfBՅoJo \wSov L S{p[# hқB<~t8TWمohoh'2G>EAT#R*Im26JIۚ Fd~+^PV<٪4o:pkl)ͳ4^Yl ? x{ ಢ(*l2ܡnJA [@&~c/܇N>9yHBUl b'F9f];|HBB'p9Hq.?Z)X. ܚ2P\SSfi@?b[ 0Gl6za-][AsJآɎE[L#>GꘘdXbJ}í='w-{j; ;i6/28+3y,Qj3eS:ⵕ>(T<}([27Vդ{OYR `d}Z1u*飷HKG忳^,"ެ>1$`^?z#`|m+9ܹON`TVD`tyYSF#8'+kO5|ldϫpqdW=$Ɋd+$̬*-xD]ENhOUp7l/aI1nIǏ 5O/dAnUCݮ/OZ2|v2Ff䒒{q%sPq_`=s 7M o@(lD=O1\a(|Lڒ$;s" ܮXB.'o{e[' OKW;6 3{7`Awg5 3̿#+h!$00rծ g}Pm s`2"e| a&jpf[Op 7y]zpy(L꾵S˾T#!.$Έu\J(Xwt_f%U7!}= w`BP))#~p :X ,_zqC-Fse%VKI,qAS%.iL_?mfYQ wx[ r5Y;"\bn-,sD㳉 m.)L` 7_nF@n₭BwD|> y?ăbO0^Rp?Θ`j-t0R +h<dCnܜ00mL"B^D%<Hڥmm1R"Ռբ0%(&1l@ͨ $Q\9*n~Q? LF]'.tdžTD [ROV2؊]XݠYtPF^Ch iO:4tl)OlЅE hJ Q>94FR]XbP ๺~F}9^׆ᒠ>:[YYoGI.% 7C+occgS6lr:5  !qԋ%\ypsF3%Κf/CSAr9kx~;.ˡ5sٺ WNa[p\Ը՛:T@qN(9V4~6` ց"Pcs${|Y/=DqtމZh褐W;Ij*"s@kL*HYV{IgF0s0 fLn0>};[DuxM+*{4nmIFzk2$9pS.HJp!zghu)p,'qbka40ݶo͙טo~@?8Bu\A|rT@ȅJtpMDKPm }T]UoI-JtdTI hsfiCdKj9xkOY^>Ϟ~9m~HZS'S];TwZwrz g-J#MەEXn6nJcQlF}#[>stream jP ftypjp2 jp2 jpxbjpx rreq@ .-jp2hihdrllcolr7jp2cOQ)llllR \#B@HHPHHPHHPHHP((( Ϸ\4 oY^^qi9 Oհ*>XD1\u^9Zb d,B]heCÎOdbSd I0z\ؗ\|@A2;in>2}< ^;dt'&Ժ'i8g?*i_DED)L| ~HNw6JV^^WY)f/x68fyq {(|4_/7gg1tU:Qu{bB;Lh7p7i3 t˲ny)?"\r5%I[Q/<'lgW7 b1Yn |ýd'a| z+pѕ΍:)^T>eYw"LTeK14Ԭ9 `4Ou ֝-e..\ QȧAM'Pt2iFH˽K!]p_  O}EDU%Q  Pb9ԻH$,*l6ھנJg= p~r%G1y+Lca~@1߫GbY(@\[5\+Kf<뫽$~Ð;s+vf$VU͙oE_U ߫_ {lj@GrMsYDkh^k3y*Y3a5`\]A"׎%K󃈲-F2Aܱ-^%גDN' 4' ixG~Mu۴_2̲>3_3 VN [9?Lɥ Y5NxOoWéM#۲A$:/~{Ԗ;s~XIh pU1< z:*zz\OgEs;RE(6$&[4]HpG6,|!^ Ԝen1ͱt /OQko"ķEK.!>>](\I_atpnPu҉Pc.Kw}\VxWvøxzVOvu R%",/ BoTDf&DU`~Zxx6 }nؽ[#_ }+fZ zķnt^0cw&vO̎(yT<[o@CTbK{gۋ eqMv:b_'" %hsDZZ:2b-k ;2B,'_Kf7n2֞5͸֮Dg̝hF'#/4 EǷiͱa/|AA'}I*py>n?Q(ӷ*v1͍`ѯә"㩣UX_Q`<l %Ǻԩ|jx}әGg0*5_S2-,ٱ^Fq0vK? z `[ogGGwh pcsN0ג#Lϒuq!7:zij Vyuz[xy}}BA'DGYfH6'8 B(J?$ ^iWXiYLށ'E|c+|":L$[D28)]+Ebrx`˒qJHd$u Gs[63,~A_;'3&l6U;zWl#j /R-B*!h3ĭE^ur Hhל0ss[BJQ,E4[1Ae=EP0NJ.tƴaqΡ6 K2f:4B'sFSY`|טR*yS.-OM(vw(+r,$;}jGzɗL&.'k,tĤ bJjnEV.F|"Ӹ]x%hY T4ezh\/'qЉJb2Y;Z"ʼZRwf 3#g䚑mbHP *?YJxEּ݀Ӣcs h۠G-Uoi{*;*ԝl{GV?^^?ϞԀ+,E-LHuTkkd@.}:4^kJtsdj# TL`pGХYQn0DV \쁚HI0 h1tGQbMh RC5@yCJOR@v*voUَ>;b:mBAQ"uلMY,Bg֣b5t4/E4M!-ҒP6rE4Yz33>3MUgۺ*|YO }|sm/FxD)l.=R+21FۋQ|׀WhgJ>1dߌ&Q[Y=o%:}{,; ંg%]Yh5,Na}.5_ʧd.q!<# ~+}2~Ol5>=gY'3Wjo헶?폶铈ng[8riUӂk UꝪku}hF.VӀZu 'O~mNBJQ}b[HHT1!3M{b, Axg{ݞ"K Iד }sմ$1[֯IH׌ o ~o1'`WYeP+uwsqUA1%|-DsG4֔_ץJ>z&W^=FRF[m*Abx0\B^vFƘY2,|9Ydjw(~ʄz 'z˜`R)$̠pEnnwqw-:{ǡe8d1:'խebzG.y|{s{X*GYjG(2%\ .,p桀<ᙜ)J0[6t)wGGwvXϙ%{E6jJOqTݧ^ҬO6=Y3ܛ8[ *1|HI>#"X-]йsyi#UCJU'+*1ȿl)pUr C n|Z/v[2s=TROhN I:.C{<~듏k}@ɘƏʝH3_Z?MaK?RaTkbAKv95X, G;`fs:ӁUBY=rh endstream endobj 7 0 obj <>stream h 0+/;5ˢN^< endstream endobj 8 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 9 0 obj <>stream q 0.192 0.192 0.192 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 12.4799957 0 0 12.4799957 86.8800049 784.8000031 cm /Im1 Do Q BT 0.251 g /T1_0 1 Tf -0.0012 Tc 3 Tr 8.8 0 0 8.8 56.54 747.61 Tm (968 )Tj 0.05 Tc 8.0308 0 0 8 260.15 748.56 Tm (A.C. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0091 Tc 8 0 0 8 280.76 748.56 Tm (DELPA )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.0182 0 0 8 311 748.56 Tm (ET )Tj -0.0081 Tc 8 0 0 8 325.43 748.56 Tm (AL. )Tj 0.18 g -0.0091 Tc 10.3 0 0 10.3 150.19 722.65 Tm (Discussion )Tj 0.0366 Tc 9.5 0 0 9.5 66.16 700.56 Tm (This )Tj 0.251 g 0.0403 Tc 2.273 0 Td (case )Tj 0.18 g 0.0176 Tc 2.275 0 Td (illustrates )Tj 0.251 g 0 Tc 4.495 0 Td (a )Tj 0.0352 Tc 0.86 0 Td (close )Tj 0.18 g 0.0221 Tc 2.576 0 Td (association )Tj 0.0364 Tc 5.064 0 Td (between )Tj 0.251 g 0.0388 Tc 3.879 0 Td (acid )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.05 Tc 9.6221 0 0 9.5 57.02 689.53 Tm (GOR )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0419 Tc 9.5 0 0 9.5 84.38 689.53 Tm (and )Tj 0.0405 Tc 2.119 0 Td (severe )Tj 0.18 g 0.0419 Tc 3.338 0 Td (and )Tj 0.0232 Tc 2.123 0 Td (disabling )Tj 0.251 g 0.0221 Tc 4.496 0 Td (asthmatic )Tj 0.0267 Tc 4.645 0 Td (symptoms. )Tj 0.0244 Tc -19.542 -1.163 Td (Although )Tj 0.0082 Tc 4.446 0 Td (this )Tj 0.18 g 0.026 Tc 1.871 0 Td (relationship )Tj 0.251 g 0.05 Tc 9.6021 0 0 9.5 169.36 678.48 Tm (is )Tj 0.0301 Tc 9.5 0 0 9.5 179.9 678.48 Tm (assumed, )Tj 0.18 g 0.05 Tc 9.7985 0 0 9.5 221.2 678.48 Tm (it )Tj 0.251 g 9.6021 0 0 9.5 230.8 678.48 Tm (is )Tj 0.18 g 0.0343 Tc 9.5 0 0 9.5 241.43 678.48 Tm (remarkable )Tj 0.251 g 0.0407 Tc -19.403 -1.162 Td (that )Tj 0.18 g 0.0082 Tc 2.324 0 Td (this )Tj 0.251 g 0.0371 Tc 2.226 0 Td (patient )Tj 0.041 Tc 3.573 0 Td (showed )Tj 0.0372 Tc 3.894 0 Td (evidence )Tj 0.18 g 0.05 Tc 10.5727 0 0 9.5 213.5 667.44 Tm (of )Tj 0.0272 Tc 9.5 0 0 9.5 228.97 667.44 Tm (bronchospasm )Tj 0.0252 Tc -18.141 -1.111 Td (restricted )Tj 0.0221 Tc 4.344 0 Td (mainly )Tj 0.251 g -0.029 Tc 10.3 0 0 10.3 129.09 656.89 Tm (to )Tj 0.048 Tc 9.5 0 0 9.5 140.14 656.89 Tm (the )Tj 0.0319 Tc 1.608 0 Td (evening )Tj 0.0419 Tc 3.688 0 Td (and )Tj 0.0148 Tc 1.929 0 Td (night, )Tj 0.0195 Tc 2.779 0 Td (whereas )Tj 0.18 g 0.0354 Tc 3.792 0 Td (pH\255)Tj 0.251 g 0.033 Tc -22.587 -1.162 Td (recording )Tj 0.18 g -0.003 Tc 4.692 0 Td (in )Tj -0.0025 Tc 1.472 0 Td (the )Tj 0.0286 Tc 1.812 0 Td (oesophagus )Tj 0.251 g 0.04 Tc 5.506 0 Td (also )Tj 0.18 g 0.0222 Tc 2.283 0 Td (revealed )Tj 0.0313 Tc 4.145 0 Td (prolonged )Tj 0.251 g 0.0309 Tc -19.919 -1.112 Td (episodes )Tj 0.18 g 0.05 Tc 10.5727 0 0 9.5 95.9 635.29 Tm (of )Tj 0.251 g 0.0388 Tc 9.5 0 0 9.5 108.38 635.29 Tm (acid )Tj 0.05 Tc 9.8813 0 0 9.5 129.62 635.29 Tm (pH )Tj 0.18 g 0.0255 Tc 9.5 0 0 9.5 146.79 635.29 Tm (during )Tj 0.0228 Tc 3.241 0 Td (the )Tj 0.251 g 0.0156 Tc 1.711 0 Td (day )Tj 0.0236 Tc 2.019 0 Td (\(data )Tj 0.18 g 0.0453 Tc 2.537 0 Td (not )Tj 0.251 g 0.0277 Tc 1.806 0 Td (shown\). )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.0244 Tc 7.5001 0 0 7.5001 56.61 624.24 Tm (DAVIS )Tj EMC ET BT 0.251 g /T1_1 1 Tf 0.05 Tc 9.93 0 0 9.4 82.95 624.24 Tm (eta/. )Tj /T1_0 1 Tf 0.0048 Tc 9.6 0 0 9.6 105.85 624.24 Tm ([12], )Tj 0.0288 Tc 9.5 0 0 9.5 127.11 624.24 Tm (observed )Tj 0.18 g 0.0172 Tc 4.101 0 Td (nine )Tj 0.251 g 0.0333 Tc 2.013 0 Td (children )Tj 0.0158 Tc 3.747 0 Td (with )Tj 0.0326 Tc 2.113 0 Td (asthma )Tj 0.0419 Tc 3.234 0 Td (and )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.05 Tc 9.8408 0 0 9.5 56.06 613.21 Tm (GOR )Tj EMC ET BT /T1_0 1 Tf 0.0419 Tc 9.5 0 0 9.5 80.54 613.21 Tm (and )Tj 0.251 g 0.0309 Tc 1.866 0 Td (showed )Tj 0.18 g 0.0407 Tc 3.548 0 Td (that )Tj 0.251 g 0.0338 Tc 1.869 0 Td (they )Tj 0.18 g 0.045 Tc 2.174 0 Td (were )Tj 0.0245 Tc 2.374 0 Td (more )Tj 0.251 g 0.0286 Tc 2.414 0 Td (susceptible )Tj 0.18 g 0.05 Tc 9.8951 0 0 9.5 263.5 613.21 Tm (to )Tj 0.0228 Tc 9.5 0 0 9.5 274.54 613.21 Tm (the )Tj 0.251 g -22.939 -1.112 Td (triggering )Tj 0.05 Tc 10.5727 0 0 9.5 99.26 602.65 Tm (of )Tj 0.0253 Tc 9.5 0 0 9.5 111.37 602.65 Tm (bronchoconslriction )Tj 0.05 Tc 9.7002 0 0 9.5 194.79 602.65 Tm (due )Tj 0.18 g 9.8951 0 0 9.5 212.62 602.65 Tm (to )Tj 0.251 g 0.0228 Tc 9.5 0 0 9.5 224.14 602.65 Tm (the )Tj 0.18 g 0.0291 Tc 1.62 0 Td (presence )Tj 0.05 Tc 10.0163 0 0 9.5 278.3 602.65 Tm (of )Tj 0.251 g 0.0388 Tc 9.5 0 0 9.5 56.06 592.09 Tm (acid )Tj 0.18 g -0.003 Tc 2.175 0 Td (in )Tj 0.048 Tc 1.118 0 Td (the )Tj 0.251 g 0.0342 Tc 1.559 0 Td (oesophagus )Tj 0.0028 Tc 5.304 0 Td (from )Tj 0.18 g 0 Tc 2.331 0 Td (4 )Tj 0.0338 Tc 0.912 0 Td (to )Tj 0.251 g 0 Tc 1.1 0 Td (5 )Tj 0.18 g 0.0037 Tc 0.862 0 Td (am )Tj 0.0169 Tc 1.625 0 Td (than )Tj 0.05 Tc 10.1194 0 0 9.5 237.02 592.09 Tm (at )Tj 0.09 g 0.0247 Tc 9.5 0 0 9.5 247.66 592.09 Tm (midni)Tj 0.251 g 0.018 Tc 2.469 0 Td (ght. )Tj 0.18 g 0.05 Tc 9.6048 0 0 9.5 55.64 581.05 Tm (From )Tj 0.251 g 0.0307 Tc 9.5 0 0 9.5 82.06 581.05 Tm (these )Tj 0.0296 Tc 2.519 0 Td (observations )Tj 0.18 g 0.05 Tc 9.5164 0 0 9.5 160.79 581.05 Tm (we )Tj 9.5178 0 0 9.5 175.66 581.05 Tm (may )Tj 0.251 g 0.0363 Tc 9.5 0 0 9.5 196.71 581.05 Tm (conclude )Tj 0.18 g 0.0407 Tc 4.201 0 Td (that )Tj 0 Tc 1.962 0 Td (a )Tj 0.251 g 0.0414 Tc 0.861 0 Td (lower )Tj 0.18 g 0.0217 Tc -21.821 -1.163 Td (threshold )Tj 0.251 g 0.0137 Tc 4.438 0 Td (for )Tj 0.18 g 0.0257 Tc 1.679 0 Td (bronchoconstrictive )Tj 0.251 g 0.0219 Tc 8.878 0 Td (stimuli )Tj 0.18 g 0.0264 Tc 3.397 0 Td (may )Tj 0.251 g 0.044 Tc 2.216 0 Td (occur )Tj 0.05 Tc 10.1194 0 0 9.5 278.78 570 Tm (at )Tj 0.18 g 0.0249 Tc 9.5 0 0 9.5 56.15 559.44 Tm (night, )Tj 0.251 g 0.0409 Tc 3.023 0 Td (due )Tj 0.0338 Tc 2.129 0 Td (to )Tj 0.18 g 0.05 Tc 9.546 0 0 9.5 118.07 559.44 Tm (nonnal )Tj 0.251 g 0.0188 Tc 9.5 0 0 9.5 152.07 559.44 Tm (circadian )Tj 0.018 Tc 4.454 0 Td (variation )Tj /T1_2 1 Tf 0.05 Tc 9.7494 0 0 9.5 235.01 559.44 Tm (in )Tj /T1_0 1 Tf 0.0285 Tc 9.5 0 0 9.5 248.17 559.44 Tm (bronchial )Tj 0.18 g 0.0263 Tc -20.213 -1.161 Td (hyperresponsivcness )Tj 0.251 g 0.0098 Tc 9.476 0 Td ([13]. )Tj 0.0229 Tc 2.649 0 Td (Alternatively, )Tj 0.05 Tc 10.1194 0 0 9.5 233.18 548.41 Tm (at )Tj 0.18 g 0.0305 Tc 9.5 0 0 9.5 246.71 548.41 Tm (night )Tj 0.0228 Tc 2.879 0 Td (the )Tj 0.0383 Tc -22.939 -1.163 Td (volume )Tj 0.251 g 0.05 Tc 10.5727 0 0 9.5 89.18 537.36 Tm (of )Tj 0.18 g 0.0388 Tc 9.5 0 0 9.5 101.18 537.36 Tm (acid )Tj 0.0281 Tc 2.081 0 Td (reflux )Tj 0.0264 Tc 2.879 0 Td (may )Tj 0.251 g 0.0266 Tc 2.176 0 Td (be )Tj 0.09 g 0 Tc 1.304 0 Td (l)Tj 0.251 g 0.0329 Tc 0.301 0 Td (arger )Tj 0.0373 Tc 2.476 0 Td (and/or )Tj 0.18 g -0.0025 Tc 3.091 0 Td (the )Tj 0.02 Tc 1.559 0 Td (distribu\255)Tj 0.0217 Tc -20.607 -1.112 Td (tion )Tj 0.251 g 0.05 Tc 11.1292 0 0 9.5 74.77 526.8 Tm (of )Tj 0.18 g 0.0228 Tc 9.5 0 0 9.5 87.34 526.8 Tm (the )Tj 0.251 g 0.0388 Tc 1.608 0 Td (acid )Tj 0.18 g -0.003 Tc 2.175 0 Td (in )Tj 0.0228 Tc 1.219 0 Td (the )Tj 0.251 g 0.0342 Tc 1.559 0 Td (oesophagus )Tj 0.18 g 0.0264 Tc 5.363 0 Td (may )Tj 0.0253 Tc 2.166 0 Td (involve )Tj 0 Tc 3.484 0 Td (a )Tj 0.0324 Tc 0.861 0 Td (larger )Tj 0.251 g 0.0372 Tc -21.782 -1.162 Td (surface )Tj 0.0392 Tc 3.489 0 Td (area )Tj 0.18 g 0.0169 Tc 2.181 0 Td (than )Tj 0.251 g -0.003 Tc 2.217 0 Td (in )Tj 0.18 g 0.0228 Tc 1.219 0 Td (the )Tj 0.0242 Tc 1.72 0 Td (upright )Tj 0.0221 Tc 3.386 0 Td (position. )Tj 0.0374 Tc -13.247 -1.111 Td (Therapy )Tj 0.251 g 0.0137 Tc 3.838 0 Td (for )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.05 Tc 9.8408 0 0 9.5 114.62 505.21 Tm (GOR )Tj EMC ET BT /T1_0 1 Tf 0.0476 Tc 9.5 0 0 9.5 138.64 505.21 Tm (in )Tj 0.0082 Tc 1.168 0 Td (this )Tj 0.0371 Tc 1.721 0 Td (patient )Tj 0.021 Tc 3.182 0 Td (unequivocally )Tj 0.251 g 0.0309 Tc 6.201 0 Td (showed )Tj 0.18 g 0.0399 Tc -21.014 -1.163 Td (improvement )Tj /T1_2 1 Tf 0.0201 Tc 6.154 0 Td (in )Tj 0.251 g /T1_0 1 Tf 0.0346 Tc 1.283 0 Td (pulmonary )Tj 0.0175 Tc 5.041 0 Td (function. )Tj 0.0229 Tc 4.303 0 Td (According )Tj 0.18 g 0.0338 Tc 4.901 0 Td (to )Tj 0.048 Tc 1.263 0 Td (the )Tj 0.0204 Tc -22.895 -1.162 Td (literature, )Tj 0.0368 Tc 4.394 0 Td (advice )Tj 0.251 g 0.0309 Tc 3.083 0 Td (on )Tj 0.18 g 0.0429 Tc 1.364 0 Td (diet )Tj 0.251 g 0.0419 Tc 1.919 0 Td (and )Tj 0.18 g 0.0231 Tc 1.872 0 Td (lifestyle )Tj 0.251 g 0.0114 Tc 3.774 0 Td ([5], )Tj 0.0337 Tc 1.733 0 Td (cimetidine )Tj 0.18 g 0.0158 Tc 4.836 0 Td ([6] )Tj 0.0419 Tc -23.026 -1.112 Td (and )Tj 0.0295 Tc 1.929 0 Td (ranitidine )Tj 0.251 g -0.0095 Tc 4.524 0 Td ([7] )Tj 0.18 g 0.0264 Tc 1.588 0 Td (may )Tj 0.0413 Tc 2.123 0 Td (result )Tj 0.0476 Tc 2.822 0 Td (in )Tj 0.0199 Tc 1.211 0 Td (amelioration )Tj 0.05 Tc 10.5727 0 0 9.5 244.7 472.56 Tm (of )Tj 0.0307 Tc 9.5 0 0 9.5 256.81 472.56 Tm (pulmo\255)Tj 0.09 g 0.0323 Tc -21.173 -1.161 Td (nary )Tj 0.251 g 0.033 Tc 2.564 0 Td (symptoms. )Tj 0.18 g 0.0291 Tc 5.308 0 Td (Objective )Tj 0.0273 Tc 4.802 0 Td (improvement, )Tj 0.041 Tc 6.563 0 Td (showed )Tj 0.0201 Tc 3.956 0 Td (by )Tj 0.0346 Tc -23.242 -1.112 Td (pulmonary )Tj 0.251 g 0.0124 Tc 5.041 0 Td (function )Tj 0.18 g 0.0098 Tc 3.899 0 Td (tests, )Tj 0.251 g 0.0274 Tc 2.476 0 Td (varied )Tj 0.0152 Tc 10.2 0 0 10.2 192.36 450.97 Tm (\(5-7\). )Tj 0.05 Tc 10.074 0 0 9.5 219.27 450.97 Tm (To )Tj 0.18 g 0.0253 Tc 9.5 0 0 9.5 234.14 450.97 Tm (ascertain )Tj 0.048 Tc 4.152 0 Td (the )Tj 0.251 g 0.0382 Tc -22.988 -1.162 Td (role )Tj 0.05 Tc 10.5727 0 0 9.5 74.3 439.93 Tm (of )Tj 0.0251 Tc 9.5 0 0 9.5 85.93 439.93 Tm (pathological )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0388 Tc 9.5 0 0 9.5 139.1015 439.93 Tm (GOR )Tj EMC ET BT /T1_0 1 Tf 0.038 Tc 9.5 0 0 9.5 163.583 439.93 Tm (as )Tj 0.18 g 0 Tc 1.213 0 Td (a )Tj 0.0197 Tc 0.867 0 Td (trigger )Tj 0.251 g 0.039 Tc 3.124 0 Td (for )Tj 0.18 g 0.0226 Tc 1.578 0 Td (bronchospasm )Tj 0.0476 Tc -18.148 -1.162 Td (in )Tj 0.0307 Tc 1.269 0 Td (these )Tj 0.251 g 0.0237 Tc 2.58 0 Td (patients, )Tj 0.18 g -0.0025 Tc 4.039 0 Td (the )Tj 0.251 g 0.0271 Tc 1.659 0 Td (efficacy )Tj 0.05 Tc 11.1292 0 0 9.5 182.29 428.89 Tm (of )Tj 0.18 g 0.0191 Tc 9.5 0 0 9.5 195.26 428.89 Tm (anti-reflux )Tj 0.0147 Tc 4.909 0 Td (therapy )Tj 0.251 g 0.0309 Tc 3.529 0 Td (on )Tj 0.18 g 0.0228 Tc -23.134 -1.112 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0246 Tc 9.5 0 0 9.5 71.9025 418.326 Tm (quantity )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.05 Tc 10.5727 0 0 9.5 108.86 418.33 Tm (of )Tj 0.022 Tc 9.5 0 0 9.5 121.82 418.33 Tm (acid )Tj 0.18 g 0.0281 Tc 2.182 0 Td (reflux )Tj 0.251 g 0.0377 Tc 2.968 0 Td (should )Tj /T1_2 1 Tf -0.035 Tc 9.1853 0 0 9.9 201.9 418.33 Tm (be )Tj /T1_0 1 Tf 0.0295 Tc 9.5 0 0 9.5 214.94 418.33 Tm (evaluated )Tj 0.18 g 0.0201 Tc 4.559 0 Td (by )Tj 0.251 g 0.05 Tc 9.5043 0 0 9.5 272.1 418.33 Tm (24-)Tj 0.18 g 0.0303 Tc 9.5 0 0 9.5 55.67 406.81 Tm (hour )Tj 0.251 g 0.05 Tc 9.8813 0 0 9.5 76.82 406.81 Tm (pH )Tj 0.18 g 0.0255 Tc 9.5 0 0 9.5 92.62 406.81 Tm (measurements. )Tj 0.0366 Tc 6.613 0 Td (This )Tj 0.0181 Tc 2.231 0 Td (has )Tj 0.0453 Tc 1.718 0 Td (not )Tj 0.0314 Tc 1.669 0 Td (been )Tj 0.251 g 0.0298 Tc 2.314 0 Td (carried )Tj 0.18 g 0.05 Tc 9.9072 0 0 9.5 261.5 406.81 Tm (out )Tj /T1_1 1 Tf -0.0144 Tc 10.3 0 0 10.3 277.31 406.81 Tm (in )Tj /T1_0 1 Tf 0.0419 Tc 9.5 0 0 9.5 55.1 396.25 Tm (any )Tj 0.05 Tc 10.0163 0 0 9.5 72.86 396.25 Tm (of )Tj 0.048 Tc 9.5 0 0 9.5 83.98 396.25 Tm (the )Tj 0.0206 Tc 1.62 0 Td (previously )Tj 0.0229 Tc 4.746 0 Td (mentioned )Tj 0.251 g 0.019 Tc 4.738 0 Td (studies. )Tj 0.0407 Tc 3.493 0 Td (In )Tj 0.18 g 0.05 Tc 9.5144 0 0 9.5 233.67 396.25 Tm (our )Tj 0.0287 Tc 9.5 0 0 9.5 250.09 396.25 Tm (patient )Tj 0.05 Tc 9.7985 0 0 9.5 280.24 396.25 Tm (it )Tj 0.251 g 0 Tc 9.5 0 0 9.5 54.73 385.69 Tm (p)Tj 0.09 g 0.604 0 Td (r)Tj 0.251 g 0.0497 Tc 0.295 0 Td (oved )Tj -0.029 Tc 10.3 0 0 10.3 86.85 385.69 Tm (to )Tj 0.18 g 0.05 Tc 9.7621 0 0 9.5 97.93 385.69 Tm (be )Tj 0.0261 Tc 9.5 0 0 9.5 110.8 385.69 Tm (impossible )Tj 0.251 g 0.0338 Tc 4.907 0 Td (to )Tj 0.18 g 0.0161 Tc 1.204 0 Td (fully )Tj 0.251 g 0.0322 Tc 2.274 0 Td (eradicate )Tj 0.0388 Tc 4.194 0 Td (acid )Tj 0.18 g 0.018 Tc 2.132 0 Td (reflux )Tj 0.251 g -0.003 Tc 2.873 0 Td (in )Tj 0.18 g 0.048 Tc -23.438 -1.162 Td (the )Tj 0.251 g 0.0286 Tc 1.862 0 Td (oesophagus )Tj 0.18 g 0.0158 Tc 5.516 0 Td (with )Tj 0.251 g 0.0288 Tc 2.417 0 Td (conventional )Tj 0.0191 Tc 6.012 0 Td (anti-reflux )Tj 0.18 g 0.0274 Tc 5.011 0 Td (therapy, )Tj 0.251 g 0.0292 Tc -20.823 -1.162 Td (including )Tj /T1_2 1 Tf -0.035 Tc 8.7096 0 0 10.3 97.72 363.61 Tm (H., )Tj /T1_0 1 Tf 0.0261 Tc 9.5 0 0 9.5 108.85 363.61 Tm (-receptor )Tj 0.0244 Tc 4.245 0 Td (antagonists. )Tj 0.0328 Tc 5.558 0 Td (Omeprazole )Tj 0.18 g 0.0289 Tc 5.611 0 Td (inhibits )Tj 0.251 g 0.0228 Tc -21.063 -1.112 Td (the )Tj 0.18 g 0.05 Tc 9.6779 0 0 9.5 73.42 353.05 Tm (tenninaf )Tj 0.251 g 0.0365 Tc 9.5 0 0 9.5 112.67 353.05 Tm (stage )Tj 0.05 Tc 10.5727 0 0 9.5 138.62 353.05 Tm (of )Tj 0.18 g 0.0228 Tc 9.5 0 0 9.5 153.58 353.05 Tm (the )Tj 0.022 Tc 1.861 0 Td (acid )Tj 0.251 g 0.0262 Tc 2.372 0 Td (secreting )Tj 0.18 g 0.0268 Tc 4.411 0 Td (pathway )Tj 0.05 Tc 9.6887 0 0 9.5 275.53 353.05 Tm (by )Tj 0.251 g 0.0305 Tc 9.5 0 0 9.5 54.64 342 Tm (inhibiting )Tj 0.09 g -0.0168 Tc 4.655 0 Td (th)Tj 0.251 g 0 Tc 0.749 0 Td (e )Tj 0.0255 Tc 0.972 0 Td (proton )Tj 0.05 Tc 9.5286 0 0 9.5 145.93 342 Tm (pump )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf -0.0013 Tc 9.5 0 0 9.5 173.65 342 Tm (\(W/1<+-ATPase\) )Tj EMC ET BT 0.09 g /T1_0 1 Tf 0 Tc 9.5 0 0 9.5 244.7195 342 Tm (l)Tj 0.251 g 0.0286 Tc 0.252 0 Td (ocated )Tj 0.18 g -0.003 Tc 3.235 0 Td (in )Tj 0.251 g 0.0228 Tc -23.438 -1.161 Td (the )Tj 0.032 Tc 2.161 0 Td (sec)Tj 0.09 g 0 Tc 1.326 0 Td (r)Tj 0.251 g 0.0475 Tc 0.344 0 Td (etory )Tj 0.09 g 0 Tc 3.141 0 Td (m)Tj 0.251 g 0.0364 Tc 0.8 0 Td (embrane )Tj 0.18 g 0.05 Tc 11.1292 0 0 9.5 171.73 330.97 Tm (of )Tj 0.251 g -0.0025 Tc 9.5 0 0 9.5 189.58 330.97 Tm (the )Tj 0.0212 Tc 2.125 0 Td (parietal )Tj 0.0319 Tc 4.032 0 Td (cell )Tj 0.0114 Tc 2.461 0 Td ([8]. )Tj 0.0271 Tc -22.817 -1.112 Td (With )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 10.2059 0 0 9.5 77.24 320.41 Tm (40 )Tj EMC ET BT 0.18 g /T1_0 1 Tf 9.7993 0 0 9.5 90.7 320.41 Tm (mg )Tj 0.251 g 11.1292 0 0 9.5 105.97 320.41 Tm (of )Tj 0.0348 Tc 9.5 0 0 9.5 117.51 320.41 Tm (omeprazole )Tj 0.0273 Tc 5.255 0 Td (daily, )Tj 0.0281 Tc 2.677 0 Td (an )Tj 0.18 g 0.0456 Tc 1.263 0 Td (almost )Tj 0.251 g 0.0286 Tc 3.134 0 Td (complete )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0341 Tc 9.5 0 0 9.5 274.0035 320.41 Tm (in\255)Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0257 Tc 9.5 0 0 9.5 54.715 309.371 Tm (hibition )Tj 0.251 g 0.05 Tc 10.5727 0 0 9.5 90.14 309.37 Tm (of )Tj 0.0304 Tc 9.5 0 0 9.5 102.64 309.37 Tm (gastric )Tj 0.18 g 0.0388 Tc 3.282 0 Td (acid )Tj 0.251 g 0.0262 Tc 2.22 0 Td (secretion )Tj 0.0244 Tc 4.299 0 Td (can )Tj 0.0266 Tc 1.931 0 Td (be )Tj 0.024 Tc 1.404 0 Td (obtained )Tj -0.0124 Tc 9.7 0 0 9.7 266.65 309.37 Tm ([14]. )Tj 0.18 g 0.0384 Tc 9.5 0 0 9.5 54.62 298.33 Tm (Omeprazole )Tj 0.0181 Tc 5.719 0 Td (has )Tj 0.251 g 0.0314 Tc 1.872 0 Td (been )Tj 0.0357 Tc 2.461 0 Td (shown )Tj 0.18 g -0.0168 Tc 3.296 0 Td (to )Tj 0.251 g 0.05 Tc 10.2502 0 0 9.5 192.97 298.33 Tm (be )Tj 0.18 g 0.0155 Tc 9.5 0 0 9.5 207.83 298.33 Tm (highly )Tj 0.251 g 0.0333 Tc 3.123 0 Td (effective )Tj 0.18 g -0.003 Tc 4.246 0 Td (in )Tj 0.0393 Tc -23.536 -1.163 Td (peptic )Tj 0.251 g 0.0301 Tc 3.072 0 Td (oesophagitis )Tj 0.0098 Tc 5.796 0 Td ([15]. )Tj 0.18 g 0.0392 Tc 2.442 0 Td (Improvement )Tj 0.05 Tc 10.5727 0 0 9.5 220.22 287.28 Tm (of )Tj 9.5144 0 0 9.5 232.71 287.28 Tm (our )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0451 Tc 9.5 0 0 9.5 250.57 287.28 Tm (patient's )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0308 Tc 9.5 0 0 9.5 54.148 276.2505 Tm (clinical )Tj 0.0297 Tc 3.587 0 Td (condition )Tj 0.05 Tc 9.6003 0 0 9.5 130.47 276.25 Tm (could )Tj 0.0266 Tc 9.5 0 0 9.5 157.45 276.25 Tm (be )Tj 0.18 g 0.0269 Tc 1.413 0 Td (noted )Tj 0.251 g 0.0158 Tc 2.829 0 Td (within )Tj 0.0294 Tc 3.077 0 Td (24 )Tj 0.18 g 0 Tc 1.471 0 Td (h )Tj 0.251 g 0.0381 Tc 0.951 0 Td (after )Tj 0.18 g 0.0228 Tc 2.434 0 Td (the )Tj 0.0351 Tc -23.048 -1.162 Td (first )Tj 0.251 g 0.0375 Tc 2.022 0 Td (dose, )Tj 0.18 g 0.05 Tc 9.7132 0 0 9.5 96.86 265.21 Tm (and )Tj 0.0341 Tc 9.5 0 0 9.5 114.15 265.21 Tm (disappeared )Tj 0.0158 Tc 5.415 0 Td (within )Tj 0.251 g 0.05 Tc 9.776 0 0 9.5 193.38 265.21 Tm (24 )Tj 0.18 g 0 Tc 9.5 0 0 9.5 206.39 265.21 Tm (h )Tj 0.251 g 0.0381 Tc 0.799 0 Td (after )Tj 0.18 g -0.0025 Tc 2.282 0 Td (the )Tj 0.0315 Tc 1.509 0 Td (last )Tj 0.0323 Tc 1.767 0 Td (dose )Tj 0.251 g 0.05 Tc 10.5727 0 0 9.5 54.14 254.65 Tm (of )Tj 0.0348 Tc 9.5 0 0 9.5 66.15 254.65 Tm (omeprazole )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.742 0 0 9.5 116.12 254.65 Tm (40 )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0471 Tc 9.5 0 0 9.5 129.58 254.65 Tm (mg, )Tj 0.251 g 0.0292 Tc 1.963 0 Td (correlating )Tj 0.0203 Tc 4.952 0 Td (directly )Tj 0.0326 Tc 3.545 0 Td (with )Tj 0.0333 Tc 2.163 0 Td (effective )Tj 0.0285 Tc -20.563 -1.162 Td (control )Tj 0.05 Tc 10.5727 0 0 9.5 88.22 243.61 Tm (of )Tj 0.18 g 9.5897 0 0 9.5 101.66 243.61 Tm (acid )Tj 0.09 g 0 Tc 9.5 0 0 9.5 124.31 243.61 Tm (r)Tj 0.251 g 0.0284 Tc 0.344 0 Td (eflux. )Tj 0.0482 Tc 2.983 0 Td (Thus, )Tj 0.18 g 0.0348 Tc 2.979 0 Td (even )Tj -0.003 Tc 2.579 0 Td (in )Tj 0.048 Tc 1.371 0 Td (the )Tj 0.0392 Tc 1.811 0 Td (absence )Tj 0.251 g 0.05 Tc 10.5727 0 0 9.5 276.38 243.61 Tm (of )Tj 0.0303 Tc 9.5 0 0 9.5 54.14 232.57 Tm (endoscopically )Tj 0.0286 Tc 6.822 0 Td (detectable )Tj 0.0236 Tc 4.749 0 Td (oesophagitis, )Tj 0.0348 Tc 5.962 0 Td (omeprazole )Tj 0.0496 Tc 5.405 0 Td (ap\255)Tj 0.18 g 0.0437 Tc -22.978 -1.112 Td (pears )Tj -0.0168 Tc 2.675 0 Td (to )Tj 0.05 Tc 9.7621 0 0 9.5 89.29 222.01 Tm (be )Tj 0.0256 Tc 9.5 0 0 9.5 102.23 222.01 Tm (highly )Tj 0.251 g 0.0218 Tc 3.022 0 Td (efficacious. )Tj 0.18 g 0.05 Tc 9.67 0 0 9.5 180.89 222.01 Tm (It )Tj 0.251 g 0.0332 Tc 9.5 0 0 9.5 190.07 222.01 Tm (would )Tj 0.0357 Tc 2.921 0 Td (appear )Tj 0.18 g 0.0196 Tc 3.133 0 Td (from )Tj 0.251 g 0.025 Tc 2.383 0 Td (this )Tj 0.0403 Tc -22.744 -1.162 Td (case )Tj 0.18 g 0.0382 Tc 2.08 0 Td (report )Tj 0.0239 Tc 2.929 0 Td (that )Tj 0.251 g 0.0414 Tc 1.812 0 Td (comp)Tj 0.09 g 0 Tc 2.376 0 Td (l)Tj 0.251 g 0.05 Tc 9.6522 0 0 9.5 143.9 210.97 Tm (ete )Tj 0.0257 Tc 9.5 0 0 9.5 158.75 210.97 Tm (suppression )Tj 0.05 Tc 10.5727 0 0 9.5 208.7 210.97 Tm (of )Tj 0.022 Tc 9.5 0 0 9.5 219.74 210.97 Tm (acid )Tj 0.0262 Tc 2.018 0 Td (secretion )Tj 0.18 g 0.007 Tc 4.148 0 Td (is )Tj 0.0329 Tc -23.639 -1.162 Td (necessary )Tj 0.0338 Tc 4.496 0 Td (to )Tj 0.251 g 0.05 Tc 9.7132 0 0 9.5 106.94 199.93 Tm (abo)Tj 0.09 g 0.017 Tc 9.5 0 0 9.5 121.84 199.93 Tm (li)Tj 0.251 g -0.0048 Tc 0.601 0 Td (sh )Tj 0.048 Tc 1.224 0 Td (the )Tj 0.18 g 0.0321 Tc 1.608 0 Td (GOR-induced )Tj 0.251 g 0.0251 Tc 6.277 0 Td (bronchospasm. )Tj 0 Tc 6.717 0 Td (A )Tj 0.0315 Tc -23.593 -1.112 Td (possible )Tj 0.0424 Tc 3.829 0 Td (direct )Tj 0.0294 Tc 2.739 0 Td (bronchospasmolytic )Tj 0.0346 Tc 8.881 0 Td (effect )Tj 0.05 Tc 10.5727 0 0 9.5 225.98 189.37 Tm (of )Tj 0.18 g 0.0348 Tc 9.5 0 0 9.5 237.51 189.37 Tm (omeprazole )Tj 0.05 Tc 9.6027 0 0 9.5 53.75 178.33 Tm (was )Tj 0.0453 Tc 9.5 0 0 9.5 73.43 178.33 Tm (not )Tj 0.251 g 0.0248 Tc 1.756 0 Td (studied, )Tj 0.0231 Tc 3.754 0 Td (but )Tj 0.18 g 0.007 Tc 1.759 0 Td (is )Tj 0.0206 Tc 1.069 0 Td (unlikely. )Tj 0.251 g 0.05 Tc 10.074 0 0 9.5 62.31 167.29 Tm (To )Tj 9.8542 0 0 9.5 77.19 167.29 Tm (our )Tj 0.18 g 0.033 Tc 9.5 0 0 9.5 94.54 167.29 Tm (knowledge )Tj 0.025 Tc 5.053 0 Td (this )Tj 0.007 Tc 1.914 0 Td (is )Tj 0.048 Tc 1.067 0 Td (the )Tj 0.251 g 0.0224 Tc 1.659 0 Td (first )Tj 0.18 g 0.0281 Tc 2.081 0 Td (report )Tj 0.251 g 0.05 Tc 10.5727 0 0 9.5 233.66 167.29 Tm (of )Tj 0.18 g 0.048 Tc 9.5 0 0 9.5 245.74 167.29 Tm (the )Tj 0.0396 Tc 1.609 0 Td (docu\255)Tj 0.0394 Tc -21.82 -1.162 Td (mented )Tj 0.0241 Tc 3.439 0 Td (beneficial )Tj 0.251 g 0.0398 Tc 4.384 0 Td (effects )Tj 0.05 Tc 11.1292 0 0 9.5 157.81 156.25 Tm (of )Tj 0.0348 Tc 9.5 0 0 9.5 169.35 156.25 Tm (omeprazole )Tj 0.0476 Tc 5.205 0 Td (in )Tj 0 Tc 1.109 0 Td (a )Tj 0.0287 Tc 0.769 0 Td (patient )Tj 0.0158 Tc 3.181 0 Td (with )Tj 0.18 g 0.0277 Tc -22.434 -1.162 Td (nocturnal )Tj 0.251 g 0.0427 Tc 4.235 0 Td (asthma )Tj 0.0419 Tc 3.335 0 Td (and )Tj 0.18 g 0.0297 Tc 1.78 0 Td (pathological )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.05 Tc 9.6221 0 0 9.5 195.26 145.21 Tm (GOR )Tj EMC ET BT /T1_0 1 Tf 0.0309 Tc 9.5 0 0 9.5 219.35 145.21 Tm (without )Tj 0.0317 Tc 3.478 0 Td (oesoph\255)Tj 0.0207 Tc -20.969 -1.163 Td (agitis. )Tj 0.18 g 0.0346 Tc 8.8 0 0 8.8 148.28 124.57 Tm (References )Tj 0.251 g -0.035 Tc 8.9497 0 0 9.1 53.45 104.4 Tm (1. )Tj 0.18 g 0.0173 Tc 8.8 0 0 8.8 71.48 104.4 Tm (Barish )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0112 Tc 8.8 0 0 8.8 97.8272 104.4 Tm (CF, )Tj EMC ET BT /T1_0 1 Tf -0.0182 Tc 8.8 0 0 8.8 114.204 104.4 Tm (Wu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0011 Tc 8.8 0 0 8.8 130.044 104.4 Tm (WC, )Tj EMC /Suspect <>BDC 0.0143 Tc 2.23 0 Td (Castell )Tj EMC /Suspect <>BDC 0.18 g -0.0205 Tc 3.224 0 Td (DO. )Tj EMC ET BT 0.341 0.341 0.337 rg /T1_0 1 Tf 0 Tc 8.8 0 0 8.8 195.736 104.4 Tm (-)Tj 0.18 g 0.0032 Tc 0.88 0 Td (Respiratory )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0216 Tc 8.8 0 0 8.8 247.5856 104.4 Tm (complica\255)Tj EMC ET BT /T1_0 1 Tf 0.0057 Tc 8.8 0 0 8.8 53.2552 94.7992 Tm (tions )Tj 0.05 Tc 10.0163 0 0 8.8 73.82 94.8 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0151 Tc 8.8 0 0 8.8 84.89 94.8 Tm (gasttoesophageal )Tj EMC ET BT /T1_0 1 Tf 0.0153 Tc 8.8 0 0 8.8 150.23 94.8 Tm (reflux. )Tj /T1_1 1 Tf 0.0194 Tc 8.9 0 0 8.9 177.26 94.8 Tm (Arch )Tj 0.0123 Tc 2.313 0 Td (Intern )Tj 0.18 g -0.0052 Tc 2.804 0 Td (Med, )Tj 0.251 g /T1_0 1 Tf -0.0128 Tc 8.8 0 0 8.8 245.46 94.8 Tm (1985, )Tj 0.0041 Tc 2.618 0 Td (145, )Tj 0.032 Tc -24.436 -1.199 Td (1882-1888. )Tj 0.0325 Tc 28.937 72.655 Td (2. )Tj 0.0362 Tc 2.019 0 Td (Boyle )Tj 0.18 g 0.0109 Tc 2.834 0 Td (IT, )Tj 0.251 g 0.0194 Tc 1.581 0 Td (Tuchman )Tj 0.18 g 0.0067 Tc 4.258 0 Td (DN, )Tj 0.251 g 0.0232 Tc 2.02 0 Td (Altschuler )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0152 Tc 8.8 0 0 8.8 461.1128 723.6128 Tm (SM, )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0298 Tc 8.8 0 0 8.8 479.0736 723.6128 Tm (Nixon )Tj 0.0369 Tc 2.933 0 Td (TE, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0305 Tc 8.8 0 0 8.8 521.2344 723.6128 Tm (Pack )Tj EMC ET BT /T1_0 1 Tf -0.0223 Tc 8.8 0 0 8.8 308.6176 713.5368 Tm (AI, )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0077 Tc 8.8 0 0 8.8 322.4688 713.5368 Tm (Cohen )Tj EMC /Suspect <>BDC 0.05 Tc 11.9557 0 0 8.8 348.26 713.53 Tm (S.-)Tj EMC ET BT /T1_0 1 Tf 0.0158 Tc 8.8 0 0 8.8 364.76 713.53 Tm (Mechanisms )Tj 0.18 g 0.0074 Tc 5.502 0 Td (for )Tj 0.251 g 0.0184 Tc 1.482 0 Td (the )Tj 0.0209 Tc 1.519 0 Td (association )Tj 0.18 g 0.05 Tc 9.4598 0 0 8.8 482.79 713.53 Tm (of )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0132 Tc 8.8 0 0 8.8 492.89 713.53 Tm (gasttoesoph\255)Tj EMC ET BT /T1_0 1 Tf -0.0056 Tc 8.8 0 0 8.8 308.5476 703.4364 Tm (ageal )Tj 0.0138 Tc 2.409 0 Td (reflux )Tj 0.0204 Tc 2.773 0 Td (and )Tj 0.0124 Tc 1.757 0 Td (bronchospasm. )Tj /T1_1 1 Tf 0.05 Tc 9.4102 0 0 8.9 426.38 703.44 Tm (Am )Tj 9.0393 0 0 8.9 441.19 703.44 Tm (Rev )Tj 0.18 g 0.0399 Tc 8.9 0 0 8.9 457.51 703.44 Tm (Respir )Tj 0.0281 Tc 3.021 0 Td (Dis, )Tj /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 502.74 703.44 Tm (1985, )Tj 0.251 g -0.0325 Tc 2.618 0 Td (131 )Tj 0.0014 Tc -24.686 -1.09 Td (\(Suppl.\), )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.9982 0 0 8.8 343.04 693.85 Tm (Sl6-S20. )Tj EMC ET BT /T1_0 1 Tf 8.8062 0 0 8.8 308.06 683.76 Tm (3. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0104 Tc 8.8 0 0 8.8 326.36 683.76 Tm (Perrin-Fayolle )Tj EMC ET BT /T1_0 1 Tf 0.017 Tc 8.8 0 0 8.8 381.5624 683.76 Tm (M, )Tj 0.0269 Tc 1.582 0 Td (Bel )Tj -0.035 Tc 8.763 0 0 8.8 411.82 683.76 Tm (A, )Tj 0.18 g 0.0264 Tc 8.8 0 0 8.8 423.32 683.76 Tm (Braillon )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0249 Tc 8.8 0 0 8.8 457.3496 683.76 Tm (G, )Tj EMC /Suspect <>BDC 0.18 g 0.0279 Tc 1.423 0 Td (Lombard)Tj 0.341 0.341 0.337 rg 0 Tc 3.813 0 Td (-)Tj 0.18 g 0.0176 Tc 0.334 0 Td (Platet )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 8.7402 0 0 8.8 530.36 683.76 Tm (R, )Tj 0.0109 Tc 8.8 0 0 8.8 308.12 673.68 Tm (Kofman )Tj -0.0309 Tc 3.708 0 Td (J, )Tj 0.0479 Tc 1.038 0 Td (Harf )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0136 Tc 8.8 0 0 8.8 369.5616 673.68 Tm (R, )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0213 Tc 8.8 0 0 8.8 381.0808 673.68 Tm (Monia-Gnon )Tj 0.18 g -0.0217 Tc 5.727 0 Td (B, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0206 Tc 8.8 0 0 8.8 442.9976 673.68 Tm (Pacheco )Tj EMC ET BT /T1_0 1 Tf 0.0171 Tc 8.8 0 0 8.8 476.6136 673.68 Tm (Y, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0172 Tc 8.8 0 0 8.8 489.0744 673.68 Tm (Perpoint )Tj EMC ET BT 0.251 g /T1_0 1 Tf -0.0217 Tc 8.8 0 0 8.8 522.6728 673.68 Tm (B. )Tj 0 Tc 1.248 0 Td (-)Tj 0.0123 Tc -25.627 -1.09 Td (Asthme )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.9571 0 0 8.8 341.19 664.09 Tm (et )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0138 Tc 8.8 0 0 8.8 352.79 664.09 Tm (reflux )Tj 0.251 g 0.0128 Tc 3.102 0 Td (gastro-oesophagien. )Tj 0.0199 Tc 8.894 0 Td (Rcsultats )Tj 0.0478 Tc 4.414 0 Td (de )Tj 0.0023 Tc 1.584 0 Td (Ia )Tj 0.0155 Tc 1.36 0 Td (cure )Tj 0.0096 Tc -24.436 -1.147 Td (chirurgicale )Tj 0.0334 Tc 5.618 0 Td (chez )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.9782 0 0 8.8 380.52 654 Tm (50 )Tj EMC ET BT /T1_0 1 Tf 0.0118 Tc 8.8 0 0 8.8 396.46 654 Tm (malades. )Tj ET BT /Suspect <>BDC 0.18 g /T1_1 1 Tf 0.013 Tc 8.9 0 0 8.9 434.95 654 Tm (Poumon-Coeur, )Tj EMC /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 500.82 654 Tm (1980, )Tj EMC ET BT /T1_0 1 Tf 0.0207 Tc 8.8 0 0 8.8 526.9384 654 Tm (36, )Tj 0.0285 Tc -24.867 -1.145 Td (231-237. )Tj 0.0289 Tc -0.053 -1.09 Td (4. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.019 Tc 8.8 0 0 8.8 325.7616 634.332 Tm (Sontag )Tj EMC /Suspect <>BDC 0.0467 Tc 3.218 0 Td (S, )Tj EMC /Suspect <>BDC 0.0333 Tc 1.208 0 Td (O'Connell )Tj EMC /Suspect <>BDC -0.0078 Tc 4.737 0 Td (S, )Tj EMC ET BT /T1_0 1 Tf 0.0172 Tc 8.8 0 0 8.8 417.0264 634.332 Tm (Greenlee )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.021 Tc 8.8 0 0 8.8 453.08 634.332 Tm (H, )Tj EMC ET BT /T1_0 1 Tf 0.0246 Tc 8.8 0 0 8.8 465.444 634.332 Tm (Schnell )Tj 0.18 g 0.05 Tc 9.1322 0 0 8.8 495.76 634.33 Tm (T, )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0121 Tc 8.8 0 0 8.8 507.27 634.33 Tm (Chintam )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0136 Tc 8.8 0 0 8.8 307.642 624.2364 Tm (R, )Tj 0.0143 Tc 1.264 0 Td (Nemchausky )Tj 0.0329 Tc 5.718 0 Td (B, )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0134 Tc 8.8 0 0 8.8 380.55 624.2364 Tm (Chejfec )Tj EMC ET BT /T1_0 1 Tf -0.0297 Tc 8.8 0 0 8.8 411.746 624.2364 Tm (G, )Tj 0.0449 Tc 1.317 0 Td (van )Tj 0.18 g 0.0255 Tc 1.852 0 Td (Druncn )Tj 0.05 Tc 8.961 0 0 8.8 469.88 624.24 Tm (M. )Tj 0.0235 Tc 8.8 0 0 8.8 483.81 624.24 Tm (Wanner )Tj 0.05 Tc 12.6334 0 0 9.6 515.45 624.24 Tm (J.-)Tj 0.251 g 8.8737 0 0 8.8 531.3 624.24 Tm (Is )Tj 0.18 g 0.0078 Tc 8.8 0 0 8.8 307.61 614.65 Tm (gastroesophageal )Tj 0.251 g 0.0138 Tc 7.261 0 Td (reflux )Tj 0.18 g 0 Tc 2.718 0 Td (a )Tj 0.251 g 0.0104 Tc 0.708 0 Td (factor )Tj 0.0028 Tc 2.676 0 Td (in )Tj 0.0327 Tc 1.031 0 Td (some )Tj 0.0153 Tc 2.458 0 Td (asthmatics? )Tj ET BT /Suspect <>BDC 0.18 g /T1_1 1 Tf 0.05 Tc 9.0617 0 0 8.8 500.3 614.65 Tm (Am )Tj EMC ET BT 0.251 g /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 514 614.65 Tm (J )Tj ET BT /Suspect <>BDC 0.18 g /T1_1 1 Tf 0.0404 Tc 8.9 0 0 8.9 520.62 614.65 Tm (Gas)Tj 0.341 0.341 0.337 rg 0 Tc 1.63 0 Td (\255)Tj EMC ET BT 0.251 g /T1_1 1 Tf -0.0144 Tc 8.9 0 0 8.9 307.5807 605.0469 Tm (troenJerol, )Tj /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 349.62 605.05 Tm (1987, )Tj 0.0198 Tc 2.635 0 Td (82, )Tj 0.036 Tc 1.728 0 Td (119-126. )Tj 0.0478 Tc -9.143 -1.145 Td (5. )Tj 0.0105 Tc 2.082 0 Td (Kjellen )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0 Tc 8.8 0 0 8.8 354.152 594.974 Tm (G)Tj 0.341 0.341 0.337 rg 0.812 0 Td (, )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0251 Tc 8.8 0 0 8.8 364.7296 594.974 Tm (Tibbling )Tj 0.18 g -0.0296 Tc 3.93 0 Td (L, )Tj 0.251 g 0.0126 Tc 1.148 0 Td (Wranne )Tj 0.18 g 0.0329 Tc 3.49 0 Td (B.)Tj 0.341 0.341 0.337 rg 0 Tc 1.193 0 Td (-)Tj 0.18 g 0.0166 Tc 0.878 0 Td (Effect )Tj 0.251 g 0.05 Tc 9.4598 0 0 8.8 482.79 594.97 Tm (of )Tj 0.009 Tc 8.8 0 0 8.8 492.87 594.97 Tm (conservative )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.0201 Tc 8.8 0 0 8.8 307.6564 584.894 Tm (tteatmcnt )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.05 Tc 8.9033 0 0 8.8 344.08 584.89 Tm (of )Tj 0.0155 Tc 8.8 0 0 8.8 353.68 584.89 Tm (oesophageal )Tj 0.0145 Tc 5.345 0 Td (dysfunction )Tj 0.05 Tc 9.324 0 0 8.8 445.83 584.89 Tm (on )Tj 0.18 g 0.0205 Tc 8.8 0 0 8.8 457.45 584.89 Tm (bronchial )Tj 0.251 g 0.0069 Tc 4.243 0 Td (asthma. )Tj 0.18 g /T1_1 1 Tf 0.026 Tc 8.9 0 0 8.9 524.22 584.89 Tm (Eur )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 307.12 575.29 Tm (J )Tj /T1_1 1 Tf 0.0075 Tc 8.9 0 0 8.9 314.95 575.29 Tm (Respir )Tj -0.0079 Tc 3.021 0 Td (Dis, )Tj 0.251 g /T1_0 1 Tf -0.0128 Tc 8.8 0 0 8.8 360.66 575.29 Tm (1981, )Tj -0.0127 Tc 2.64 0 Td (62, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0282 Tc 8.8 0 0 8.8 399.0632 575.29 Tm (190-197. )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.8 0 0 8.8 307.5696 565.6804 Tm (6)Tj 0.09 g 0.537 0 Td (. )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0115 Tc 8.8 0 0 8.8 325.3456 565.6804 Tm (Goodall )Tj EMC ET BT 0.18 g /T1_0 1 Tf -0.0199 Tc 8.8 0 0 8.8 357.5536 565.6804 Tm (RJR, )Tj 0.022 Tc 2.29 0 Td (Earis )Tj 0.251 g -0.0065 Tc 8.6 0 0 8.6 399.31 565.68 Tm (JE, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0268 Tc 8.8 0 0 8.8 413.19 565.68 Tm (Cooper )Tj EMC ET BT /T1_0 1 Tf 0.0067 Tc 8.8 0 0 8.8 443.0044 565.68 Tm (DN, )Tj 0.18 g 0.0287 Tc 2.018 0 Td (Bernstein )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf -0.035 Tc 8.763 0 0 8.8 499.66 565.68 Tm (A, )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.026 Tc 8.8 0 0 8.8 510.17 565.68 Tm (Temple )Tj 0.251 g -0.035 Tc 9.3542 0 0 9.7 307.63 555.61 Tm (JG. )Tj 0.341 0.341 0.337 rg 0 Tc 9.7 0 0 9.7 323.89 555.61 Tm (-)Tj 0.251 g 0.0123 Tc 8.8 0 0 8.8 334.04 555.61 Tm (Relationship )Tj 0.0197 Tc 5.733 0 Td (between )Tj 0.0255 Tc 3.97 0 Td (asthma )Tj 0.0204 Tc 3.491 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0124 Tc 8.8 0 0 8.8 468.4072 555.61 Tm (gaslro-oesophageal )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0138 Tc 8.8 0 0 8.8 307.1912 546.0004 Tm (reflux)Tj 0.341 0.341 0.337 rg 0 Tc 2.544 0 Td (. )Tj 0.251 g /T1_1 1 Tf -0.0028 Tc 8.9 0 0 8.9 334.38 546 Tm (Thorax, )Tj /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 366.42 546 Tm (1981, )Tj 0.0207 Tc 2.641 0 Td (36, )Tj 0.0282 Tc 1.777 0 Td (116-121. )Tj 0.18 g -0.0163 Tc -11.103 -1.145 Td (7. )Tj 0.251 g 0.0256 Tc 2.024 0 Td (Harper )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf -0.0192 Tc 8.8 0 0 8.8 353.7216 535.924 Tm (PC, )Tj EMC ET BT /T1_0 1 Tf 0.0218 Tc 8.8 0 0 8.8 369.5616 535.924 Tm (Bergner )Tj 0.251 g -0.035 Tc 8.763 0 0 8.8 401.74 535.92 Tm (A, )Tj 0.18 g 0.0071 Tc 8.8 0 0 8.8 413.72 535.92 Tm (Kaye )Tj 0.251 g 0.0293 Tc 2.455 0 Td (MD. )Tj 0.341 0.341 0.337 rg 0 Tc 2.23 0 Td (-)Tj 0.251 g 0.017 Tc 0.936 0 Td (Antireflux )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.0009 Tc 8.8 0 0 8.8 504.4216 535.92 Tm (IIeatment )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0074 Tc 8.8 0 0 8.8 307.5832 525.8528 Tm (for )Tj -0.0022 Tc 1.474 0 Td (asthma. )Tj 0.09 g 0 Tc 3.385 0 Td (I)Tj 0.251 g 0.0151 Tc 0.386 0 Td (mprovement )Tj 0.0028 Tc 5.503 0 Td (in )Tj 0.0251 Tc 0.991 0 Td (patients )Tj 0.0095 Tc 3.598 0 Td (with )Tj 0.018 Tc 2.118 0 Td (associated )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0074 Tc 8.8 0 0 8.8 501.0512 525.8528 Tm (gastroeso)Tj 0.09 g 0 Tc 3.869 0 Td (\255)Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0111 Tc 8.8 0 0 8.8 307.2048 516.2432 Tm (phageal )Tj 0.18 g -0.0029 Tc 3.598 0 Td (reflux. )Tj 0.251 g /T1_1 1 Tf 0.0374 Tc 8.9 0 0 8.9 365.42 516.24 Tm (Arch )Tj 0.023 Tc 2.367 0 Td (Intern )Tj 0.18 g -0.0052 Tc 2.912 0 Td (Med, )Tj /T1_0 1 Tf 0.0117 Tc 8.8 0 0 8.8 434.58 516.24 Tm (1987)Tj 0.341 0.341 0.337 rg 0 Tc 2.036 0 Td (, )Tj 0.251 g 0.0041 Tc 0.691 0 Td (147, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.9182 0 0 8.8 477.48 516.24 Tm (56-60. )Tj EMC ET BT /T1_0 1 Tf -0.0058 Tc 8.8 0 0 8.8 307.53 506.16 Tm (8. )Tj 0.0148 Tc 2.031 0 Td (Fellenius )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf -0.029 Tc 8.8 0 0 8.8 362.354 506.16 Tm (E, )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0214 Tc 8.8 0 0 8.8 373.882 506.16 Tm (Bcrglindh )Tj 0.18 g 0.0292 Tc 4.578 0 Td (T, )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0259 Tc 8.8 0 0 8.8 426.0748 506.16 Tm (Sachs )Tj EMC ET BT /T1_0 1 Tf 0.0249 Tc 8.8 0 0 8.8 451.586 506.16 Tm (G, )Tj /T1_1 1 Tf 0.0485 Tc 8.9 0 0 8.9 464.56 506.16 Tm (et )Tj 0.05 Tc 9.3867 0 0 8.9 475.14 506.16 Tm (al)Tj 0.09 g 0 Tc 8.9 0 0 8.9 482.8 506.16 Tm (. )Tj 0.251 g /T1_0 1 Tf 0.645 0 Td (-)Tj 0.0064 Tc 8.8 0 0 8.8 497.6 506.16 Tm (Substiruted )Tj 0.0096 Tc -21.581 -1.091 Td (benzimidazoles )Tj 0.0135 Tc 7.082 0 Td (inhibit )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0017 Tc 8.8 0 0 8.8 399.7704 496.5592 Tm (gasb'ic )Tj EMC ET BT /T1_0 1 Tf 0.013 Tc 8.8 0 0 8.8 430.4736 496.5592 Tm (acid )Tj 0.0298 Tc 2.397 0 Td (secretion )Tj -0.0086 Tc 4.542 0 Td (by )Tj 0.0083 Tc 1.691 0 Td (blocking )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.05 Tc 9.9151 0 0 8.8 307.08 486.97 Tm (\(W)Tj 0.341 0.341 0.337 rg 0 Tc 8.8 0 0 8.8 320.54 486.97 Tm (-)Tj 0.18 g 0.0077 Tc 0.334 0 Td (K\225\))Tj 0.341 0.341 0.337 rg 0.0054 Tc 1.466 0 Td (-A)Tj 0.18 g 0.0267 Tc 0.985 0 Td (TP-ase)Tj 0.341 0.341 0.337 rg 0 Tc 2.933 0 Td (. )Tj EMC ET BT 0.251 g /T1_1 1 Tf 0.0021 Tc 8.9 0 0 8.9 375.92 486.97 Tm (Nature, )Tj /T1_0 1 Tf 0.0144 Tc 8.8 0 0 8.8 407.22 486.97 Tm (1981, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.023 Tc 8.8 0 0 8.8 430.5136 486.97 Tm (290, )Tj EMC ET BT /T1_0 1 Tf 0.0438 Tc 8.8 0 0 8.8 450.428 486.97 Tm (159-161. )Tj 0.0385 Tc -16.286 -1.145 Td (9. )Tj 0.0096 Tc 2.078 0 Td (Johnson )Tj 0.0072 Tc 3.982 0 Td (LF, )Tj 0.0134 Tc 2.128 0 Td (DeMeester )Tj 0.0361 Tc 5.015 0 Td (TR. )Tj 0 Tc 2.233 0 Td (-)Tj 0.18 g 0.0311 Tc 1.149 0 Td (Twenty-four )Tj 0.0267 Tc 5.898 0 Td (hour )Tj 0.251 g 0.0415 Tc 2.457 0 Td (pH )Tj 0.0101 Tc -24.931 -1.145 Td (monitoring )Tj 0.05 Tc 9.4598 0 0 8.8 350.31 466.81 Tm (of )Tj 0.0184 Tc 8.8 0 0 8.8 360.94 466.81 Tm (the )Tj 0.0165 Tc 1.575 0 Td (distal )Tj 0.0148 Tc 2.617 0 Td (esophagus. )Tj 0 Tc 4.972 0 Td (A )Tj 0.0187 Tc 1.084 0 Td (quantitative )Tj 0.18 g 0.0188 Tc 5.243 0 Td (measure )Tj 0.251 g 0.05 Tc 9.4598 0 0 8.8 530.31 466.81 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0042 Tc 8.8 0 0 8.8 307.13 457.21 Tm (gasttoesophageal )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0029 Tc 8.8 0 0 8.8 369.5924 457.21 Tm (reflux)Tj 0.341 0.341 0.337 rg 0 Tc 2.435 0 Td (. )Tj ET BT /Suspect <>BDC 0.251 g /T1_1 1 Tf 0.05 Tc 10.9845 0 0 8.9 395.21 457.21 Tm (Ami )Tj EMC ET BT /T1_1 1 Tf -0.0095 Tc 8.9 0 0 8.9 415.02 457.21 Tm (GastroenJerol, )Tj /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 470.1 457.21 Tm (1974, )Tj -0.0127 Tc 2.476 0 Td (62, )Tj 0.0233 Tc 1.474 0 Td (325-332. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0166 Tc 8.8 0 0 8.8 307.8632 447.1164 Tm (10. )Tj EMC /Suspect <>BDC 0.0129 Tc 1.987 0 Td (Crausaz )Tj EMC ET BT /T1_0 1 Tf 0.0293 Tc 8.8 0 0 8.8 359 447.1164 Tm (F. )Tj 0.18 g 0.022 Tc 1.364 0 Td (Bischof)Tj 0.341 0.341 0.337 rg 0 Tc 3.157 0 Td (-)Tj 0.18 g 0.0172 Tc 0.389 0 Td (Delaloye )Tj 0.251 g 0.0156 Tc 4.202 0 Td (A, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0266 Tc 8.8 0 0 8.8 452.5528 447.1164 Tm (CTetin )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.05 Tc 9.1322 0 0 8.8 479.44 447.12 Tm (T, )Tj 0.251 g 0.0172 Tc 8.8 0 0 8.8 492.44 447.12 Tm (Delaloye )Tj 0.0329 Tc 4.2 0 Td (B, )Tj 0.0107 Tc -25.26 -1.09 Td (Gonvers )Tj -0.0146 Tc 3.768 0 Td (J-J, )Tj 0.18 g 0.0217 Tc 1.637 0 Td (Favez )Tj 0.251 g 0.05 Tc 11.3962 0 0 8.8 378.6 437.53 Tm (G.-)Tj 0.18 g 0.013 Tc 8.8 0 0 8.8 396.44 437.53 Tm (Reflux )Tj 0.251 g 0.0187 Tc 3.051 0 Td (gastro-oesophagien )Tj 0.05 Tc 8.9571 0 0 8.8 496.71 437.53 Tm (et )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0079 Tc 8.8 0 0 8.8 505.45 437.53 Tm (broncho\255)Tj EMC ET BT /T1_0 1 Tf -0.0001 Tc 8.8 0 0 8.8 307.5908 427.4364 Tm (aspiration )Tj 0.0075 Tc 4.209 0 Td (nocturne )Tj 0.0105 Tc 3.756 0 Td (dans )Tj 0.0259 Tc 2.128 0 Td (les )Tj 0.0136 Tc 1.373 0 Td (bronchopathies )Tj 0.0131 Tc 6.48 0 Td (chroniqucs. )Tj /T1_1 1 Tf 0.0012 Tc 8.9 0 0 8.9 509.27 427.44 Tm (Schweiz )Tj 0.0363 Tc -22.748 -1.079 Td (Med )Tj 0.18 g -0.01 Tc 2.219 0 Td (Wschr, )Tj 0.251 g /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 355.38 417.84 Tm (1985, )Tj 0.0041 Tc 2.727 0 Td (115, )Tj 0.0372 Tc 2.15 0 Td (994-995. )Tj 0.0107 Tc -10.332 -1.145 Td (11. )Tj 0.0128 Tc 2.042 0 Td (Quanjer )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf -0.0086 Tc 8.8 0 0 8.8 357.5536 407.764 Tm (PhH )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.05 Tc 11.0129 0 0 8.9 376.2 407.76 Tm (ed.-)Tj 0.0159 Tc 8.8 0 0 8.8 397.39 407.76 Tm (European )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0331 Tc 8.8 0 0 8.8 434.79 407.76 Tm (Coal )Tj EMC ET BT /T1_0 1 Tf 0.0204 Tc 8.8 0 0 8.8 455.426 407.76 Tm (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0278 Tc 8.8 0 0 8.8 471.1956 407.76 Tm (Steel )Tj EMC /Suspect <>BDC 0.0139 Tc 2.408 0 Td (Community. )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.015 Tc 8.8 0 0 8.8 307.0404 397.6928 Tm (Standardized )Tj 0.251 g 0.0127 Tc 6.01 0 Td (lung )Tj 0.0047 Tc 2.506 0 Td (function )Tj -0.0028 Tc 4.1 0 Td (testing. )Tj 0.18 g /T1_1 1 Tf 0.0384 Tc 8.9 0 0 8.9 449.35 397.69 Tm (Bull )Tj 0.251 g 0.026 Tc 2.426 0 Td (Eur )Tj 0.01 Tc 2.158 0 Td (Physiopathol )Tj 0.18 g 0.0006 Tc -20.548 -1.079 Td (Respir, )Tj 0.251 g /T1_0 1 Tf 0.0144 Tc 8.8 0 0 8.8 336.18 388.09 Tm (1983, )Tj -0.035 Tc 8.5945 0 0 8.8 360.66 388.09 Tm (19 )Tj 0.0081 Tc 8.8 0 0 8.8 372.38 388.09 Tm (\(Suppl. )Tj 0.0211 Tc 3.38 0 Td (5\), )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 8.8 0 0 8.8 415.1128 388.09 Tm (7)Tj 0.09 g 0.05 Tc 10.6171 0 0 8.8 419.4 388.09 Tm (-1)Tj 0.251 g -0.0193 Tc 8.8 0 0 8.8 429.03 388.09 Tm (0. )Tj EMC ET BT /T1_0 1 Tf 0.0107 Tc 8.8 0 0 8.8 307.3788 377.9964 Tm (12. )Tj 0.0078 Tc 2.048 0 Td (Davis )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.0015 Tc 8.8 0 0 8.8 349.8828 377.9964 Tm (RS, )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0152 Tc 8.8 0 0 8.8 366.6732 377.9964 Tm (Larsen )Tj 0.0074 Tc 3.214 0 Td (GL, )Tj 0.0206 Tc 2.018 0 Td (Grunstein )Tj 0.0276 Tc 4.478 0 Td (MM. )Tj 0 Tc 2.448 0 Td (-)Tj 0.0087 Tc 0.989 0 Td (Respiratory )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.0184 Tc 8.8 0 0 8.8 527.5196 377.9964 Tm (re\255)Tj EMC ET BT /T1_0 1 Tf 0.0172 Tc 8.8 0 0 8.8 307.0884 367.9292 Tm (sponse )Tj 0.251 g -0.011 Tc 3.23 0 Td (to )Tj 0.0132 Tc 1.249 0 Td (intraesophageal )Tj -0.0052 Tc 6.87 0 Td (acid )Tj 0.0174 Tc 2.13 0 Td (infusion )Tj 0.0028 Tc 3.818 0 Td (in )Tj 0.0209 Tc 1.198 0 Td (asthmatic )Tj 0.0028 Tc 4.418 0 Td (children )Tj 0.18 g 0.0143 Tc -22.908 -1.091 Td (during )Tj 0.251 g 0.0137 Tc 3.05 0 Td (sleep. )Tj /T1_3 1 Tf 0 Tc 8.7 0 0 8.7 357.52 358.33 Tm (J )Tj /T1_1 1 Tf 0.0233 Tc 8.9 0 0 8.9 364.94 358.33 Tm (Allergy )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.023 Tc 8.9 0 0 8.9 395.3513 358.33 Tm (Clin )Tj EMC /Suspect <>BDC 0.18 g 0.05 Tc 9.0404 0 0 8.9 414.14 358.33 Tm (lmmwwl, )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 453.3 358.33 Tm (1983, )Tj 0.0146 Tc 2.642 0 Td (72, )Tj 0.0389 Tc 1.69 0 Td (393-398. )Tj 0.0107 Tc -20.914 -1.145 Td (13. )Tj 0.0168 Tc 1.993 0 Td (Barnes )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf 0.0275 Tc 8.8 0 0 8.8 352.76 348.254 Tm (P, )Tj EMC ET BT /T1_0 1 Tf 0.0126 Tc 8.8 0 0 8.8 362.836 348.254 Tm (Fitzgerald )Tj 0.251 g 0.0249 Tc 4.412 0 Td (G, )Tj 0.18 g 0.0342 Tc 1.26 0 Td (Brown )Tj 0.017 Tc 3.164 0 Td (M, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0214 Tc 8.8 0 0 8.8 453.5552 348.254 Tm (Dollery )Tj EMC /Suspect <>BDC 0.05 Tc 11.9331 0 0 8.8 483.72 348.25 Tm (C.-)Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.012 Tc 8.8 0 0 8.8 501.64 348.25 Tm (Nocturnal )Tj 0.0146 Tc -22.106 -1.091 Td (asthma )Tj 0.0204 Tc 3.273 0 Td (and )Tj 0.0306 Tc 1.8 0 Td (changes )Tj 0.18 g 0.05 Tc 8.8796 0 0 8.8 384.89 338.65 Tm (in )Tj 0.251 g 0.0223 Tc 8.8 0 0 8.8 394.95 338.65 Tm (circulating )Tj 0.0115 Tc 4.855 0 Td (epinephrine, )Tj 0.18 g 0.0197 Tc 5.518 0 Td (histamine )Tj 0.251 g -0.0069 Tc 4.409 0 Td (and )Tj 0.0058 Tc -24.764 -1.091 Td (cortisol. )Tj /T1_1 1 Tf 0 Tc 8.9 0 0 8.9 339.44 329.05 Tm (N )Tj 0.18 g 0.0139 Tc 1.076 0 Td (Eng/ )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 369.04 329.05 Tm (J )Tj /T1_1 1 Tf -0.0052 Tc 8.9 0 0 8.9 376.89 329.05 Tm (Med, )Tj ET BT /Suspect <>BDC 0.251 g /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 399.06 329.05 Tm (1980, )Tj EMC ET BT /T1_0 1 Tf 0.029 Tc 8.8 0 0 8.8 422.3008 329.05 Tm (303, )Tj 0.0363 Tc 2.242 0 Td (263-267. )Tj 0.18 g -0.0166 Tc -15.301 -1.145 Td (14. )Tj 0.251 g 0.0095 Tc 2.048 0 Td (Prichard )Tj ET BT /Suspect <>BDC 0.18 g /T1_0 1 Tf -0.0171 Tc 8.8 0 0 8.8 358.0432 318.974 Tm (PJ, )Tj EMC ET BT /T1_0 1 Tf 0.0177 Tc 8.8 0 0 8.8 371.0232 318.974 Tm (Yeomans )Tj 0.251 g 0.0257 Tc 4.098 0 Td (ND, )Tj 0.0249 Tc 2.009 0 Td (Mihaly )Tj 0.0318 Tc 3.213 0 Td (GW, )Tj 0.0059 Tc 2.295 0 Td (Jones )Tj 0.18 g -0.0198 Tc 2.565 0 Td (DB, )Tj 0.0058 Tc 1.909 0 Td (Buckle )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0171 Tc 8.8 0 0 8.8 307.1704 308.414 Tm (PJ. )Tj EMC ET BT 0.341 0.341 0.337 rg /T1_0 1 Tf 0 Tc 8.8 0 0 8.8 320.5464 308.414 Tm (-)Tj 0.251 g 0.0101 Tc 0.928 0 Td (Omeprazole: )Tj 0 Tc 5.727 0 Td (a )Tj 0.0103 Tc 0.869 0 Td (study )Tj 0.05 Tc 9.4598 0 0 8.8 409.83 308.41 Tm (of )Tj 0.0002 Tc 8.8 0 0 8.8 420.89 308.41 Tm (its )Tj 0.0186 Tc 1.364 0 Td (inhibition )Tj 0.05 Tc 9.4598 0 0 8.8 471.75 308.41 Tm (of )Tj 0.0133 Tc 8.8 0 0 8.8 482.81 308.41 Tm (gastric )Tj 0.0415 Tc 3.118 0 Td (pH )Tj -0.0069 Tc 1.68 0 Td (and )Tj 0.0346 Tc -24.817 -1.091 Td (oral )Tj 0.0255 Tc 1.974 0 Td (phannacokinetics )Tj 0.0092 Tc 7.734 0 Td (after )Tj 0.0181 Tc 2.244 0 Td (morning )Tj 0.05 Tc 9.4598 0 0 8.8 445.83 298.81 Tm (or )Tj 0.0216 Tc 8.8 0 0 8.8 457.35 298.81 Tm (evening )Tj 0.18 g 0.0064 Tc 3.656 0 Td (dosage. )Tj ET BT /Suspect <>BDC 0.251 g /T1_1 1 Tf -0.0121 Tc 8.9 0 0 8.9 520.14 298.81 Tm (Gas\255)Tj EMC ET BT 0.18 g /T1_1 1 Tf -0.0059 Tc 8.9 0 0 8.9 306.6201 288.7174 Tm (troenJerology, )Tj 0.251 g /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 362.1 288.72 Tm (1985, )Tj -0.0074 Tc 2.69 0 Td (88, )Tj 0.05 Tc 8.9938 0 0 8.8 400.21 288.72 Tm (64-69)Tj 0.09 g 0 Tc 8.8 0 0 8.8 423.18 288.72 Tm (. )Tj 0.251 g 0.0107 Tc -13.214 -1.144 Td (15. )Tj 0.18 g 0.0244 Tc 2.048 0 Td (Klinkenberg)Tj 0.341 0.341 0.337 rg 0.0139 Tc 5.284 0 Td (-Kno)Tj 0.18 g 0 Tc 2.185 0 Td (l )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0071 Tc 8.8 0 0 8.8 399.7896 278.6528 Tm (EC, )Tj EMC ET BT 0.251 g /T1_0 1 Tf 0.0361 Tc 8.8 0 0 8.8 420.9096 278.6528 Tm (Jansen )Tj 0.0246 Tc 3.6 0 Td (JBJW, )Tj 0.18 g 0.0164 Tc 3.656 0 Td (Festen )Tj 0.0162 Tc 3.491 0 Td (HPM. )Tj 0.251 g 0.0098 Tc -23.727 -1.091 Td (Meeuwissen )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0058 Tc 8.8 0 0 8.8 353.6072 269.052 Tm (SGM, )Tj EMC ET BT /T1_0 1 Tf 0.0144 Tc 8.8 0 0 8.8 377.7192 269.052 Tm (Lamers )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.5789 0 0 8.8 406.46 269.05 Tm (CBHW.-)Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0149 Tc 8.8 0 0 8.8 445.4 269.05 Tm (Double )Tj 0.251 g 0.0207 Tc 3.224 0 Td (blind )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.3201 0 0 6.72 494.4 269.05 Tm <006D0075006C00740069007E006E0074007200650020>Tj EMC ET BT /T1_0 1 Tf 0.0176 Tc 8.8 0 0 8.8 306.63 258.97 Tm (comparison )Tj 0.05 Tc 9.4598 0 0 8.8 352.71 258.97 Tm (of )Tj 0.024 Tc 8.8 0 0 8.8 363.76 258.97 Tm (omeprazole )Tj 0.0204 Tc 5.29 0 Td (and )Tj 0.0233 Tc 1.918 0 Td (ranitidine )Tj 0.05 Tc 8.8796 0 0 8.8 466.01 258.97 Tm (in )Tj 0.0184 Tc 8.8 0 0 8.8 477.58 258.97 Tm (the )Tj 0.0131 Tc 1.691 0 Td (treatment )Tj 0.05 Tc 9.4598 0 0 8.8 529.83 258.97 Tm (of )Tj 0.18 g 0.0138 Tc 8.8 0 0 8.8 306.23 248.89 Tm (reflux )Tj 0.251 g 0.0101 Tc 2.883 0 Td (oesophagitis. )Tj /T1_1 1 Tf 0.0086 Tc 8.9 0 0 8.9 382.17 248.89 Tm (Lancet, )Tj 0.18 g /T1_0 1 Tf 0.0144 Tc 8.8 0 0 8.8 412.98 248.89 Tm (1987, )Tj -0.0199 Tc 2.699 0 Td (i, )Tj 0.251 g 0.0467 Tc 0.924 0 Td (349-351. )Tj /T1_1 1 Tf -0.0023 Tc 8.9 0 0 8.9 306.3 186.01 Tm (Effet )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0301 Tc 8.9 0 0 8.9 325.8533 186.01 Tm (benifique )Tj EMC ET BT /T1_1 1 Tf 0.0113 Tc 8.9 0 0 8.9 362.8328 186.01 Tm (de )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0226 Tc 8.9 0 0 8.9 374.3049 186.01 Tm (l'omiprazole )Tj EMC /Suspect <>BDC 0.0241 Tc 5.451 0 Td (chez )Tj EMC /Suspect <>BDC -0.0151 Tc 2.157 0 Td (un )Tj EMC /Suspect <>BDC 0.0002 Tc 1.174 0 Td (palienJ )Tj EMC ET BT /T1_1 1 Tf -0.0109 Tc 8.9 0 0 8.9 480.4285 186.01 Tm (atteinJ )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0001 Tc 8.9 0 0 8.9 505.8825 186.01 Tm (d'asthme )Tj EMC ET BT /T1_1 1 Tf 8.9 0 0 8.9 306.6649 175.9263 Tm (bronchique )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0087 Tc 8.9 0 0 8.9 348.5216 175.9263 Tm (severe )Tj EMC ET BT /T1_1 1 Tf 0.0045 Tc 8.9 0 0 8.9 373.3882 175.9263 Tm (avec )Tj 0.0091 Tc 2.051 0 Td (reflux )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0015 Tc 8.9 0 0 8.9 414.3282 175.9263 Tm (gastro-oesopllagien )Tj EMC ET BT 0.341 0.341 0.337 rg /T1_1 1 Tf -0.035 Tc 8.0058 0 0 8.9 485.68 175.93 Tm (.. )Tj 0.251 g -0.0151 Tc 8.9 0 0 8.9 491.66 175.93 Tm (A.C. )Tj 0.18 g -0.0113 Tc 1.989 0 Td (Delpa*. )Tj -0.0095 Tc -22.865 -1.133 Td (J.F. )Tj 0.0184 Tc 2.37 0 Td (Bartel)Tj 0.341 0.341 0.337 rg 0.035 Tc 2.53 0 Td (sman)Tj 0.18 g 0.0134 Tc 2.166 0 Td (**)Tj 0.341 0.341 0.337 rg 0 Tc 1.07 0 Td (, )Tj ET BT /Suspect <>BDC 0.251 g /T1_1 1 Tf 0.0199 Tc 8.9 0 0 8.9 386.7112 165.8463 Tm (C.M. )Tj EMC /Suspect <>BDC 0.0042 Tc 2.885 0 Td (Roos***, )Tj EMC ET BT /T1_1 1 Tf 0.05 Tc 9.4993 0 0 8.9 453.41 165.85 Tm (GN. )Tj 0.0092 Tc 8.9 0 0 8.9 476.94 165.85 Tm (Tytgat**. )Tj -0.0132 Tc 4.667 0 Td (H.M. )Tj ET BT /Suspect <>BDC 0.18 g /T1_1 1 Tf 0.0022 Tc 8.9 0 0 8.9 305.8553 155.7574 Tm (Jansen***. )Tj EMC /Suspect <>BDC /T1_0 1 Tf 0.006 Tc 8.8 0 0 8.8 306.2 146.16 Tm (RESUME: )Tj EMC /Suspect <>BDC 0.251 g 0.0377 Tc 4.803 0 Td (Un )Tj EMC ET BT /T1_0 1 Tf 0.012 Tc 8.8 0 0 8.8 362.388 146.16 Tm (hornme )Tj 0.0478 Tc 3.428 0 Td (de )Tj 0.0007 Tc 1.312 0 Td (25 )Tj -0.0059 Tc 1.414 0 Td (ans )Tj 0.0233 Tc 1.687 0 Td (souffre )Tj 0 Tc 3.277 0 Td (d)Tj 0.09 g 0.598 0 Td (')Tj 0.251 g 0.0255 Tc 0.274 0 Td (asthme )Tj 0.0167 Tc 3.23 0 Td (bronchique )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0185 Tc 8.8 0 0 8.8 306.112 136.0928 Tm (severe )Tj EMC ET BT /T1_0 1 Tf 0.047 Tc 8.8 0 0 8.8 332.072 136.0928 Tm (dont )Tj 0.0264 Tc 2.292 0 Td (l'etiologie )Tj 0.0249 Tc 4.534 0 Td (reside )Tj 0.004 Tc 2.882 0 Td (en )Tj -0.0176 Tc 1.374 0 Td (un )Tj 0.0138 Tc 1.362 0 Td (reflux )Tj 0.0123 Tc 2.884 0 Td (gastro-oesophagien )Tj 0.0133 Tc -18.318 -1.147 Td (pathologiquc. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0155 Tc 8.8 0 0 8.8 359.9768 125.9992 Tm (Une )Tj EMC ET BT /T1_0 1 Tf -0.0019 Tc 8.8 0 0 8.8 379.5744 125.9992 Tm (an1elioration )Tj 0.0169 Tc 5.728 0 Td (dramatique )Tj 0.05 Tc 8.9571 0 0 8.8 475.11 126 Tm (et )Tj 0.0071 Tc 8.8 0 0 8.8 486.65 126 Tm (immediate )Tj 0.0478 Tc 4.744 0 Td (de )Tj 0.0272 Tc -25.314 -1.144 Td (son )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0357 Tc 8.8 0 0 8.8 322.4684 115.9328 Tm (etat )Tj EMC ET BT /T1_0 1 Tf 0.0167 Tc 8.8 0 0 8.8 340.3324 115.9328 Tm (pulmonaire )Tj 0 Tc 5.17 0 Td (a )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0284 Tc 8.8 0 0 8.8 394.47 115.9328 Tm (ete )Tj EMC ET BT /T1_0 1 Tf 0.0308 Tc 8.8 0 0 8.8 408.8756 115.9328 Tm (obtenue )Tj 0.0483 Tc 3.774 0 Td (par )Tj 0.0042 Tc 1.909 0 Td (b'aitement )Tj -0.0047 Tc 4.68 0 Td (au )Tj 0.0302 Tc 1.372 0 Td (moyen )Tj 0.0259 Tc -23.461 -1.147 Td (d'omeprazole, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0061 Tc 8.8 0 0 8.8 361.8396 105.8392 Tm (apres )Tj EMC /Suspect <>BDC 0.0233 Tc 2.509 0 Td (echec )Tj EMC ET BT /T1_0 1 Tf 0.0203 Tc 8.8 0 0 8.8 407.92 105.84 Tm (des )Tj 0.0161 Tc 1.799 0 Td (autres )Tj 0.0278 Tc 2.79 0 Td (mesures )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0094 Tc 8.8 0 0 8.8 482.3856 105.84 Tm (therapeutiques)Tj 0.09 g 0 Tc 5.932 0 Td (, )Tj EMC ET BT 0.18 g /T1_0 1 Tf 0.0075 Tc 8.8 0 0 8.8 306.1568 96.248 Tm (ayant )Tj 0.251 g 0.0093 Tc 2.566 0 Td (inclu )Tj 0.0478 Tc 2.453 0 Td (de )Tj 0.0403 Tc 1.307 0 Td (fones )Tj 0.0061 Tc 2.784 0 Td (doses )Tj 0.0478 Tc 2.673 0 Td (de )Tj 0.18 g 0.0123 Tc 1.372 0 Td (ranitidine. )Tj /T1_1 1 Tf -0.0009 Tc 8.9 0 0 8.9 305.82 86.16 Tm (Eur )Tj 0.0183 Tc 1.889 0 Td (Respir )Tj 0.251 g /T1_3 1 Tf 0 Tc 9.2 0 0 9.2 349.35 86.16 Tm (J )Tj -0.035 Tc 7.1196 0 0 9.2 354.12 86.16 Tm (.. )Tj /T1_1 1 Tf 0.0011 Tc 8.9 0 0 8.9 361.76 86.16 Tm (1988, )Tj 0.05 Tc 9.3902 0 0 8.9 385.53 86.16 Tm (I. )Tj 0.0486 Tc 8.9 0 0 8.9 395.45 86.16 Tm (966-968 )Tj ET endstream endobj 10 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 30201/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream G A A# 8h]m% $!3G-ٽ$MAیLZViЖ lT""PYW Z U֬]y)"4 ^ڥJSPx?7zr9zX#va. sVp:r@ 1le7Y-I*wq52F}y{cPWe/9yT a{=dԇ8t=t{ȅϧK2|z~gA BDF~~den01l˟ꑫ3!ҽ%`3|*j uU3蟯]UBQge32$/Rff"u=5;Y3l6E䀆DEYSbhbC>*ZWp=|ۭ1"8x6]jr y[m=rT`.{˶P x4F H;a"@26 -xW]dkDzM#* 24sgd8 炗Xi}i ^sor|'%h?ak&*Mԝ/"cOz#9֦?gpNKҨ`)@@2ͨ"Д5):Nv 8"קO ڞ t h:J n-KKRta|U'iV w!._g%0}.{EB]ԗݩcpqan<%G*<:uEx,_3 [SB%tnۘ˛agb-nKrݢ# U r/甬Ζ$k|kP 0W+^vʓ`eO |iZp>+hWohvp.ch94~o4h hn :ѱSf[>ʨQ|聭k4MDuA~?ޖw;Xh,j`w&W CqcowM7 7>3c0)Qh" !LKW)pbQ4Kțb1_]A|xuȺ@FetW%["cNA1KxN{*&jPH--o@ijH)UVxNA]&׺z7Oef-؝gIzZnUZUWxAzb޾̨0{M8iwl pŕty:UT.>B4\3 CQQgob+yz^N6ۿwb@wqBBd*H}XbK/~{{=ܽ=|WӅx3,O1ajxFhuD s{^LQJPRuI"x!laf2I&C:waLI{Ӑ2HSvr@ ww'eLE,͚rH~MpGvPk$2Qnw4$kagրIjppT[ HdhQ%A\_eYxR9M r7UPck܊=7@:I1)F`xʚHt$(ǘOTB;u|VV ow ?C?c =4Ur:̭ڏ& 6S_&8$UGcB6)WO{1{\21d_ B4xNcg-^hk%C.l&];9-fYpAg, х"-$6ԍ2V-Vk}Ša=:$tmYa$(OaVݞJET k$f,wZ#{g0`)(;}0U<aOy"кLzvC ,zژB NܸyYX!$O"COYEUI5! !8 g Nр)ډӞlho옚8Z/+b౿GD[[/sO:xkk;޺W̫}}ώrnkQ:E?R6Jl+`֡+aW+*,A:?+~ 4 .< lRssD:8, l^;S#ErXѢV 5eSmZd Znj=w*k(( 0Z\lڌI|)^bΩ7*2ܒԶ%'q{UGyIAĶxx8pOa`/bRyN6)  #&hE?tjG9w_懍R=ړG<_q}?!C0XgD꥕mBUWM9їajSxEDav-}Me`~F]m+a'Uba8ɷ ~/ =N h@֯F!^ڱ ;c~&|| nznrQK!V=&9JKYVb,=Dz8i'\͹TFݳ^Q&s' ?{oy'FX>+ԒK.@ʗMrbC׮= =DxEW <a1aN6UVX->K#)?Ky$,o2GZ_h8*&!r٦&>I <Լ TuF$URR+Hbp5m}DNbw;\u2PrDJ4Osvbۇ 93ɒ6gmd8+в!Kw]]8BEPܞ8Bu09{f"e}kZNfFƖ1{EGW$$JgUvR]HZ@p w=&2^w"&$K8s7^@V[e)$5X )F4j;dM:3#Y ×"̅o̜Nr*W?I(\T?{–U:𔱨Bx>Ibʧ<xk ozTv@Ǿ(Evd]c'}y8$mgd.O.X>$oo<{4_9:Xa=$Iڃ30fP%BV1^7ȉR;އѓ}'3ΫW7,85Mks ϰ >HLpzOȸPS[-9'48kaxs5T8,aK8=,f~-"5niO+M0tb"h_sfʱuuBxc5}f>f.2f}fMdP1-YCa]υSYF~q۱?<$0HKtؑGO)s8櫣Z|g\Mwo7:-#GaNE/7 M|ʫX`G4xP(VJ#,q(yXAekUt˔^B^€@sQ*mUM)T2Ő|b]kh"J' =dُ(y&9S~?ΨeHu% kU2v+GaHHh1c(g[&Ý{D'"("_i?*2?B s'tnnCч"|<]moj6I8 v` g%<(lg㌟rF;߈DGM,sZ(^v_'̓(D%:1z<,ʽ瓖j6&`/RƄoTx O袰'XJ\x2~?Ə-[Z!mR9&ZR\hBm |.va1Dok/vqL4pQڷ#%,6[7_jj1Gĥ g\˕XZ?hqSc@8W&{GHKhvOsigYzݥb߻,oأ&ai!";V>s{rgRvO,HQQ:1 ^B~#$~'xV~))I,𛚗'XH'R@2V>pɊ8ஹz,9[{m,G#q$mg쀖ĺ& wԍ/W[7 $Bi>+tVYm: dILs)G4]&jz\s_ܾ cNTnI@ O^ު9Dџ/Ѫ c歷1js:+:I9kydf_#}(13㥝ݿPg!%ֻ'x *C l:Rxjs=ֳhc(Lˋ$ 捚 Om4nӷ{uF 'd-€,*W#ɘ32~_ kF"e0z o|7p2uZtPu ӫ"UoZ$d+j_MV I`Uw#SCeS;z;-8-M1"9u0ݢ[3hԈ` Xg;9DL>ܔ;?l3öRu1ԥ< –rim:Vrڠ'ĎVNZqcAFB tkD-S%MӖ*'ֺIR,m=\9x0r{JHidao\)?5kh7ʫQ=aZO8zOML"4ÚHBd-pUP<׋ByByeB\8 {WaK#r=">GDWB>nM ƼC#ܐB>]`p$x5_N!Bמ踌͌)e?ap -Ymb^R-Zޞnڡ)rEPu9@SxD7\V7uJ'v} RE¯G*"5l]m|kR@87fj %9B&^pQ%ںgRщ<|(&)>q"0oM@iG}pF90.<ML!y#QeW4</SvH2'mwja`p??k'$Gȁ{ ]XPKᨤ ;6*1oZ/@NIֹPS`r rǬWv(4I[~`rhȧmTScjiUPJn}@Ts TB=(V6gky I%}?s„,|P[XƘ jh8Y,h5a2Gg&D})]6nOp:^= ĚsC5 X0odx˲r=tg֜ ¿b9HJ%byK$\@ևb mx8?41!ӎ k`--mNeIv''&k& cbAwumﱨxeHn5s {bGʨ{< A)TμۇDK44t/0L9 LfIl*ysj CR_ *E4/P24ﭼ s4=Ž/)xfhPVQ+L!,Uu`F()EFOnigROMԡBl>YQ [N7۸P9›Nl{$E bl<>^2~IYu8 u Jl:ʩ]8^GC8t{۽Ou O{NinFv)'/_ѽ@,3Q.1ΣU45lA Э 货gɑ.C0[˄F7vuu2t?9o@;=,z=`.?tVW:jyolۜJ5hbX)/>Uď=ĪC! ww ]Ξ*Ze{g kW!,i=ORE~ y"R5N/\1l=!Rr7!z!JOpJ) OѦYT|߬ o Ê~W{VPv\˙uA˗׮{ȃx K`R5CI q1G +ޫ#ě)3?ە5^x0xiz>!I2i ]c{ĵ[2vPާ(taţrvp&_b_SqiiA]Kj[d0GSQgabAt9p5E&;G5]`74v)h A2 c!*8e'S}ՔS&SQϼ-;P6Uxk}jqEW#_fJ7~ S*O"iDG &S.Uշ*5uXe4]$U%Ƥ ܩ؊[pmq{d =uYrcÀ/T X1bÞ5HeoG+=ĩ}%G@z[f \'&]fo3vRdKb G:ė:=̨LJA7B2L;;1Ul'՟SRpt>A֬q"qwL2 ιid :)f' t}KسL B 70BuyY?A3p ?bh eLFq}ڍ(Z{R.)ry6;y%X=m[*l7ƍ?c6gatt?+yYT-ϮHKFm vŞm:h aMS񈁌}`j>5j0Å2SUx=ܧ p  IȳΏC p!LhRS|Kka ,lhiCMm1W<(֎T;E ޷u#Ӟ#4]V 7RmM"E>{:)jU۝ݧk8eû9$4ɯ4[zZ${}GT<u/͓\5/W[V"K;t$ߡI%y4|ƶc!~Q;.Ψ{GVS@\qҰd7Sz$uLb^Xƕ4 jFJ&')}l(VG t9KkgV ȘX䋻&iKWeNAx[H (%rHŖ>m"Z z  ebeO\'2_'L"K4Q QW}u/8|Fu[(Tɶ@s/ @C*4Q;iMOicaZ4%_Ao o:%_ ,fĭ]6Hٝ}@)^;r5g"<B+^j° 먄 2$\ƴ"V}$n# E Ǣ^ ^W{^Fȥз]n=cxhgx)|v>O`},sOS.x]MN9$x}v9!s~%YPu+IZqOZ}Lbx_N^$̌DbKW49a[Wx@y?zRG?= ̐f#~ X^1f:oŏ(} ! B &mDa{5w{-Zy7(!5iI1%A {ˎQB?i6&@O&jq+ %#cYfuv;?4]Nqܾ Wş  G7<#Y54 ycs}5&W.-#՚[]Jy0ӆE}Fz够@[4 ԝ~`r d^Bq.Gyc5{\!;}s+~;Բ9x,T#Ϯ{S˺k߲pľ<(B.Yg<if~He)hu#"떟g` e.Oywe6\\rS `L/?*o;@CײyІ˵T}9TȺ&ԡUJfdg2O%\~yLٛg+L6޺wkB~DS5B(hTSEzqmzW;toO=݅я9ΌP!K F#9g!:1.=7^Yy6.ԟ4z5b`JMG0F#cw(31G@+ M0aI~uH[; z sc*êN'ZFZ;L8ZOE xCO[_t73Jn um|%:h(Mzv{w>)G=#Zv95RFa+]})oP;#kK_jQx Tb+?mc=T,i t=2cAv` BwVY?CiogK}D cgҢ hhƋ$>jE 8cPq{2 Nd%=jA 3uvj,/c/|U6k/\β8xΕC7_W9>I[ Nhq8:'qƇOUj}l>D؞dl"ãk:=^Qv/eT:&H<:!˗1ȑmr<^)"Ae jry)E ^Թ 10P=nGݨe`_dU d$Z ^Votc}yZ}\JjW0Uue/jDAL|דil`UϥnŨ 3Ov?& ~_Ԉ[X <1>h)H Kh,o9d Liv v޻b; L;L3&^AԯsU…ۓwJꂋixR,qQa9=eu^~6w`džNtCz(܎yԄ|KF!R*oH }侐 xZann{Zj=c;JUk֔Z5Ft :ָqGe RM ,YݮdȘ&yz2$:uaf+>גG侦6:6B4@Raq1<9ڀOp*cK汭M/k![؋+Lhy-&'=DD}2F!JI6F Pg * h:ۉ$2Pئ8`OQ9cՂDqttY@e'6f0!Vy%M!PL#u3}Z$i /ԭ%}r>{εnKGhO{bNlѰE"^w֖Ӡyޚ:y OOƈ괈x{5KژX?AU_(\]fTP#ywBv̷qI̮9".{n0jlvQLJAMz]f<cfR]JߍRKx12!wB6w(>8=X%0t.y+ZiўsJS9 Ցoty!NB-sd$?^'bǺPjߺ[)^h補wFNcRwt_ڻvZ$+_.˪̀H(t.x'[b\%R>2 jOU\K_[vu9ӆzI$cs} fN( \\;̓IEf_4WȚ% 7*M);'^w:nQ|}i] |"^J4<:͆8ߚB+<Z<.!#255_;VYzpo_d4nE1g>'9 cLXi#n&_AWq`)D_`"; ;C Wb;"P VBaD- X1³_NFgs%]:\K ˻yt!E= ւ4S~Om)^~r4oQnI~D3#32f4yxiK m0Ź;v2ːɺ7D)H, +̄1GD!@^FuDDs^@ν5udqxP6"&9"ĕ3 r,L@%yVuAkL 9|0W&s!,Hժ=7CIc+GmY6 luZJg?fWwKI!>R.XU1@W 8ǍimM;KqxF0{ 1 3!Đ4 .~Я³̻rzl~C0d# = ZL.؈V7S\l S+&A6 (nVo|;pZDG,ʒ!,:Xcgg]%#rmR60.S-IpJ{tIؾ&ҞEa\Xse 4)6 ,xߙ" ZI=h|C)/ŨUdʏriZT#66Lﭖhx0@ -Fk~`,nHyaD.&;ۜʗܫ~%2d=D3L42pMy+Xa1}P JX yK/s')vn4A&VDSDc?\ 8 46\>p5RD˸%}ƀ ?q% OC1Ț:"-4K%Zup&**Rf-}8i 䥵&(bT*0ʡ~JYMR]Le fpnOnWp0fO6nhl*%38mfݮ7FA ʦ\)X ]i  Y.g8z}bsC~ف 9eZot헂 8dzDC[1|"_"ִl vgtCqe5i"fJg3H3);OKkApط'4?`ƾӇ}0le^y︙HEy; ʜDb'A 鶑8~{cMc\m8f@έYBo$!XNbtB ?DRj1lU{S^{<ؾSK+ua1t7c$MO( Uྐ2sVx $J %9Atd^(λs<"4#r=?M,=_ـKd٤r2i /;V3ӳ"JjTx^ 9ES*a5Qa\.N\j"4s6u$iMU؄䩖zQ@}Vѽ{Y藟k6|=1pq&bz 9̗>JpNJ&̳6& rXUL{T4#t3 FfڝUd ZmR"!ՋEr*hq7fTI! ]] ]I\B-rm#$ j+>]i/:0 i!wz~1FW/^;#U}PUJ\ѱK?&ITcfE l#_۳O(񕭟`YPsxsYIIF j#?*N"9]uuZȕRV|!EUrz-dE#y!c?|H-[jOZzwRZ|6wG#&}ghe̹`T0 jyԿiX7_=_RĚR \2͇Hhϕ"}!vwӆe^24aK,$ pC)+̕uve8&? {Q*`!jAƈt- (UG9y$©aӌYwi#y buw2kY3_ #3E{'Uoiq3 gXQޅ~q@#&x.4̄ZQ~?2;,\ZIf ;a$ZhUy E)Úq~N:Ɉ< 3;6jEk]-̾~ >ةs ̍PLJfgrt韽5aug3QK? 1"_ĚuF;O5>o,IU쾝 O ![( њ wvd|V?9t{!Q\7~`wlxS=ywcdS+SD޹a;KkVUg}M+ąIa鱦A,iq:ÕL{=WFZdAPA>s,3p-z#L+;5SROڍn]UÞj%{<8nakcxn8lzZ:cK3vMYm7UOGA'$G Q,yR𝗕6Gu՘{9< Uh2ܚG?(S HQ^?ڄtVbWK: ,*Q,M|G:qg]ѝա܈]'4Mi\Ca ~LmgvE|-&ST %QA^6729 nvZUH~/FF>{cq] BE#댟rys8!*MAE%p)mWѣ=cˢٹiV0o?㮵,/e SCWIs[qC~_2=cͥr~q[ smw~~~}u+=~ |#$ruz2#DOs ˀr&M.+\.\4mH#!INNiL(w{de7u.t6 #tՃ K1#\pf7v5E: h:1+&ՙ~鳳ODdJ\G+Ӕ!y6R'&SD~3H(:oHX(Lc2ʣuW%KvXTAIP#s?V0Du:i<@_>~~}4H{{OݖAZû-hC;VI{fהZ֭7L&O.lgc.IJ!#q_oƲ==Mj /mHCsp*kɲ? + ĀE2 }`-r> [-Wa@Z89#tKUXUj~1F5`+鋌dMA)jq'/ Թ;C"웇|!q7+MMSh'p9mE*2`0i3#޻ę_^:*_V47[Z,8Z<'wG52Ϭd@ׂ*LB˖Mzo%yPtersbOfI޳.Ng]0ǐNIF~n ȠAΛ{xtmߛkK4[>6#g[>:;XJnJJY @Dh咛\t"+,XZ'ϬwtYt;A?ʉ&h ׷A6OL3/[8;`,k9T% 'wp %9wFW!M񸄾Τ[uI?r>rUv0U3jS싄f- 1JzsX1=VPJ:3?#d7}VEIiיl]o?YaP^y}]M'~|jzwѓwqzői v ^4)ix ~= c& e2C9X9<5X[b'QڒF'VSc^\ݐqc-p" 0C d- clbmW}txS[Nq5ôGw>Qt̄-w')8l9/78+ kϦ142p|q ]][jOJV$u/aXmWs|ڻS:>D kTRZV@C#dJCrmgJW:#d/xe:/}t!ױXfu :i\ GɇdXbP:>^;/ﴨթ'AcD4ܚzy<w_#2sY@Rp=ooCKAi5s;nAϬpI>B=O UP8Cz*u%y C}*[ܟeN&]Fwډ>7ȴx-u;$Ps9+H5ԙ9If%oH\u1q5U';zoL(} WאY9(v={m 阣mwwC!eٜ:QF}Ek{jF@ pOve&$dۮC=Lk̥b\"5\QڤUM{;Vw9"'=2(+Œ ^zyn 4$ /smF dh$l]m + PEX1@fn}oPySO7?;x HWcDZW`2P'L2tnMlɠ2Q5ރrL&oןOVj욻G#t45ܖ d&;Fo:j W+t]Q_! "=y /`U h9"C*ϳB8FBID<Ŀ jlѥ怊viu-/5*֙X˙=mPF|,otkJO  )Ѫ#5Pi64E??𡚭Yͣ .5TN4ۻ&xXH#jT҄~U )k~@0x5bj܋&{FlZf ĤwRNy?sәt-,,4b5k%|_#Exs'dC$1 x:NXۙ+.-Ύ8q`ۋr^?GTSM>8.SxKrqu 6FcKc8vX ;bp0jY3AjSD 1+L]+{5kӄdKs9n`6U%Za7^o'(z2UQVȬ8z;G+Y8[NO;[zqk$[,S#wtgnl1]1`D/%ih̀ZjVkTHG򢐐= tVw\:y %Ħ-5Bq B=Few HPV$Cc- =L6scfSH^W@3G5Fep>Grxqiu$HAHH:˧TaO*e2n%yJM Qx-"Sy4S6 BbϝQ];[ԫ^dS&Y;rz*Z8EL%STzsb4uo#mr*}dCz-KsuW4 Ԧi61$YEa#=@ُ`q kd9t\I{2UDxI_dl3&Z9U#'0$/Swzב뭇x:n#,\YeάtɇeʓМWrdcĪ l\ijqz%N9GJ#T%gbN5/qY~(`D"9ǵb ׽N@68Sm"o{\݀#-. xΕ\ M✤_3ZC.$ aEVn㒿?h;il|>7DHc/3ѷ ,7*l\؉! ^LImD!|Bl۾P@yoܐ6ΊYsqi,ir4P[G1=%L;S8: sJe$/"- @*gl%%(#kǐ@ Ln#f` XPofj0 ^ΘoV*c#-@C ƽjMwtʊ#}xtN@6,L%h[y{39z>HK_E.:"=SU#hNZ(YqEW/o&tVSҾŠҨdR1Z0$0.֢#M`.Qݷbem=-^#hUUK5q\!%S`GOb)Q?uvp&̥6[ 7t p:i˧#иh6/Xr lBh"G!I:=zHQ%[a)HbHIQ;կ89h&GiBLMj+$P͛`9*uU(DFpkV '7%g@kiq'TsMuWm_`$pc.tΪ7 %></XP M34{fDnNY4mXHwԦMop33AB9{]ԭ\?b]?Cgtr˹Ȣ-K9Ǩ2!ή☊ܺ 񫳬c76A 8XW(7jwe}o-6rv6=R][} ?CF1,e]U"U{A/DW  B.@q~5y.:]Zm'uQsD1<$'O"J,)8zOff& Ml=ݺr[j< 9]z%pQC0e{yES07Pt u|w%YH2Ef} p[*Lv5 LǍOd[ijlzX}r)iXn_9z)Ad?,,j nUxVѿJϺ3t^KVM*E}G360@FV,D`loq1lʊ"upxiUo, !Ir~ݵFngzPQg?\,@QKgTd>eܸN)@EpP]W?u )0RɜwBWFXo`+(:h)k`~#WZq~i) V;~B-Oj5{,>0Z&"{ԋz;J;rRM[ d&Jy}=o!O/)sSuQ =*0)[m+V0fIVhpW`sHѾFDއ.ã^GFU5f%єG_Jq`oY@2UϐmJ8)_+ql2Qqb0ۇ8CRJtӗWۯles̄Zce6oYK@ :q1)dBR!zkñiY10H6^嚃F3o  3j坴OĈKdXF^(co78}(n$Kd|LX&ZϏpCg]<3K\jW*?>j+p폃ԏn-MLG؞[`v.U>F}${Nźh#-`+ф& kI)Kn)*&j\Y>(39:9 8#`fRԈٖ"iKN˾gv1i]*"QG+׵gz#Zk}%k%O8dsrIU9nhW]h PEM :w(8N;(\zo@9) Biڋ oS?NA#wF|*>@ZAywodVGV94Q"Z͡"e2" ,fx)1O2]Qid E #U.bwgjtd<&=SJ[lKr Bʔ}S';KkEeBRE.YK7?v>UjnI_;fGv泤?'P↶װuc! C jB7u42HG9]΄-3>U#P c&w aZoUz'&V~%)ME}c-T(@ljKg#G+Q1U9IL)p_I )F1CIGNTDJ0Bu.oDF# t4aJg灍t7T#^JoGD8BAHm_A u]lMOC<6kG*cH^d$#611p,_IT֒E_?/_FRM.kf {.#r&*Q4꽁)nC=F=(`+d 'fLSEIX$L6$t~uq_{Tl#[dbs#ȑ*ZRQ4M& T`aJg<7=GN wgi!Сw qy݉l7Q|Sø{jM:rࣗsN"O|\;ID{ sʫ€KbNC$q<9;돲E7ڷ|Z|-9st 鯯kL/E)醰YLy[Wbrwrm3`"0jJ+i`dpRFD |}ri=)>"tg8j1(N(oy)FfΈkp՝#Jd[h~<+8R[3ȨHg1/oIӯHq[)Y*R7ffURQBKnn1+STt$m[S)R#/^@[od\|?aVă[DXmم8,~ftUt ?#գsE CS , .3LbĪI MO輤!0e4(p2jiVw0޵1uKk~1Kqlh[.oyy] q ?dp_MKXSHŚ!Ea\1=pcVKh\x zTlAd" ky$M?{{3r6/Y*][Ud Ӫ F\\hZ0A0̬/M@AKtDT~?V _{!}RBC"=7`3rj'+ <+~Q]ndgwQ4LI~ږ7H gf@XU Fxm vr&fS an5}~_gv Ә[䄛M\ϲ)[ u't<{ZC2SjZmq^e΂5QJa~>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrwjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ! @ '`@:@>: @:    endstream endobj 13 0 obj <>stream h22V0P02Q0U02U0W0475R0Q04210=; endstream endobj 14 0 obj <>stream hRMK@+~%JAm%=băx& nxPCreüy3mAv4 PUhmH0ƁQP* FC`%˔ \%aW>M$j0Qņ?{KA}F1V@/Gcф穛Q#}w݈5b|2<~frt*R)n=Jo08 1 endstream endobj 15 0 obj <>stream h26S0P06W07T0P4U ($敄$QER+JS+C* RKJA%vv@c]KsAvv3! endstream endobj 16 0 obj <>stream 2012-10-24T09:31:02+01:00 2012-09-17T13:46:23+01:00 2012-10-24T09:31:02+01:00 Canon iR-ADV C2020L PDF application/pdf uuid:79936ac3-391b-4452-8dac-27082622cb0c uuid:7ecb8fe2-672f-4525-82b3-73bbb7cbf870 Adobe Acrobat 10.14 Paper Capture Plug-in endstream endobj 17 0 obj <>stream h2T0Pw/+Q0L)61 )I RYZlg`j endstream endobj 18 0 obj <>stream hḺ 0WMXbh ZGD(99P(}>ϱ3RXTߋ4>qQ Fתs#ƮG8Q1a'Hߢ[%{Kj h. endstream endobj 19 0 obj <>/Filter/FlateDecode/ID[<0CA41935217B874D9086C13DE4C5CEE2>]/Info 40 0 R/Length 111/Root 42 0 R/Size 41/Type/XRef/W[1 3 1]>>stream hbb&Fj L |@q; beAx$XM t@$s7dA$_X|*X=ƿ`]@d.ˆ!B<] l#@g endstream endobj startxref 116 %%EOF